China Strategy 2011
China Strategy 2011
China Strategy 2011
could weigh on equity market performance in the short term, we recommend investors China Railway Construction Corp
(1186 HK)
BUY 9.4 11.8
position themselves for resulting buying opportunities, since historically the market Gome Electrical Appliances (493 HK) BUY 3.2 4.3
tends to rally once inflation has peaked out. Our 10 stocks for 2011: Agile Properties, Perfect World (PWRD US)* BUY 23.7 37.0
Sinopec (386 HK) BUY 7.3 9.6
ABC, China Everbright International, China Life Insurance, China Mengniu Dairy, ZTE Corp (763 HK) BUY 29.4 36.0
CRCC, Gome, Perfect World, Sinopec and ZTE. Priced as at 1 December 2010 close; local currency
* Priced as at 30 November 2010 close
Any authors named on this report are research analysts unless otherwise indicated.
See the important disclosures and analyst certifications on pages 172 to 176.
Our sector scorecard — formulated by gauging a sector’s fundamentals (EPS Perfect World (PWRD US) * BUY 23.7 37.0
Sinopec (386 HK) BUY 7.3 9.6
growth and ROE), valuations (forward P/E, P/BV) and momentum change (price ZTE Corp (763 HK) BUY 29.4 36.0
performance during the previous year) — backs up our individual sector views. Priced as at 1 December 2010 close; local currency
* Priced as at 30 November close
earnings growth, with large-cap sectors such as Financials and Energy set for
Michael Shen
strong earnings; 2) attractive valuations (13x 2011F earnings, in line with the past
+852 2252 2140
10-year average; 2.5x P/BV with RoE of 20%); and 3) a positive liquidity outlook. michael.shen@nomura.com
Contents
Executive summary 4
Investment risks 19
Higher ground 20
Macro-economic growth will remain healthy in 2011… 21
… and corporate earnings growth too 22
Sufficient liquidity will add fuel 25
Undemanding looking valuations 32
Nomura insights 54
Nomura’s China coverage 54
Major calendar events in 2011 55
Stocks: historical performance recap 55
Nomura Survey – Ideas for 2011 55
MSCI China Index components 55
Sector summaries
Autos and Auto Parts 66
Banks 68
Cement 70
Container box manufacturing 72
Food & Beverages 74
China Healthcare & Pharmaceutical 78
Industrials 82
Insurance 84
Online gaming & media 88
Macau gaming 92
Oil and Gas 94
Retail 98
Shipping 102
Steel 104
Telecom services 106
Telecom equipment 108
Transport 110
Power, Utilities, Coal and Renewable 112
Property 116
Appendix
Valuation methodology and risks 162
Summary
Executive summary
We are positive on China’s equity market in 2011 after its rebound in 2009 and We forecast MSCI China and
consolidation in 2010. We forecast the MSCI China Index and HSCEI Index will reach HSCEI will offer >20% upside in
2011F
83 and 16,000 by the end of 2011, implying 24% and 25% upside potential,
respectively. We believe the strong performance will be backed by: 1) 21%+ earnings
growth, with large-cap sectors such as financial and energy set to post strong earnings;
2) attractive valuation (13x 2011F earnings, in line with the 10-year average; 2.5x
price/book with RoE of 20%). Note that 2011 will also be the first year of China’s 12th
Five Year Plan, and we think the sectors set to benefit, such as the seven emerging
industries with strategic importance, will receive a boost in sentiment. We believe
fundamental support will remain the most important factor to drive equity market
performance in 2011. In our view, sectors with an improving earnings outlook and
strong RoE tend to outperform. Earnings growth outlook and RoE will become
increasingly important and be rewarded when there are still uncertainties on the policy
side, and cost of capital is on the rise, in our view.
We think China’s economic outlook will remain positive in 2011, supporting equity 21%+ y-y EPS growth in 2011F
market performance. Our economic team forecasts GDP growth of 10.2% in 2010,
9.8% in 2011 and 9.5% in 2012. With strong economic development, we estimate that
bottom-line growth for corporates will be 21.4% and 19.0% for 2011 and 2012,
respectively. We think accelerating urbanisation, booming consumption, healthy export
growth, robust investment and implementation of China’s 12th Five Year Plan (FYP)
will be the major drivers.
Our 2011 EPS forecast for the market is slightly higher than consensus (currently
3.1% higher for 2011 and 5.4% for 2012).
YTD, consensus 2011 EPS has been consistently revised up, driven by earnings
upgrades for the industrial, healthcare, consumer discretionary, energy and IT
sectors. In our view, further upward EPS revisions may come from the financial
sector when 1Q11 earnings start to confirm margin expansion after interest hike
benefits materialise.
Apart from the solid bottom-line growth, we believe liquidity is also sufficient in 2011 to Liquidity should be supportive in
support the current P/E level. We estimate new bank loans of about RMB8trn for 2011 2011
(vs a government loan quota of around RMB6.5trn), which may translate into around
18% M2 y-y growth. Although this is off from the recent peak of 27.7% y-y growth in
2009, our forecast 2011 M2 growth is still slightly higher than the historical average
growth of 17.6% for the past decade. In addition, we believe there is likely to be more
liquidity flowing from developed markets to emerging markets in search of higher
returns. Growth in ‘unexplained’ foreign capital inflow to China has been high in the
past several quarters.
In 2010, more than 50% of Nomura-rated China stocks in terms of market cap have The market has not fully
not performed well. Financials are among the weakest-performing sectors, in contrast recovered from the 2008 crisis
to outperformers such as Industrials, Macau Gaming, Airlines, Internet and Healthcare.
Banks in Western countries have continued to struggle with weak balance sheets and
capital shortage. Meanwhile, the PBoC’s two surprising required reserve ratio (RRR)
hikes in early 2010 sent tightening signals to the market. A crackdown on the property
market and slowdown in new loan additions further hurt investor confidence in banking
stocks. As a result, YTD, the MSCI China index is still 21.7% below its 2007 closing
level and 35.7% below its peak in October 2007; while on the fundamentals side,
MSCI China index EPS in 2010 has already recovered to the 2007 level.
120
Interest rates hiked (10 times, of which 7 in a row for
2006-07 bull market) R
R R
0
Jan-00
Apr-00
Jul-00
Oct-00
Jan-01
Apr-01
Jul-01
Oct-01
Jan-02
Apr-02
Jul-02
Oct-02
Jan-03
Apr-03
Jul-03
Oct-03
Jan-04
Apr-04
Jul-04
Oct-04
Jan-05
Apr-05
Jul-05
Oct-05
Jan-06
Apr-06
Jul-06
Oct-06
Jan-07
Apr-07
Jul-07
Oct-07
Jan-08
Apr-08
Jul-08
Oct-08
Jan-09
Apr-09
Jul-09
Oct-09
Jan-10
Apr-10
Jul-10
Oct-10
Note: Interest rate hike using one year lending rate and RRR changes represents large depository institution.
Source: WIND, CEIC, Bloomberg, Nomura research
We think the equity market performance during the 2003-04 inflation cycle has
important implications for the 2011 market outlook, given both factors are inversely
correlated, especially during periods of high inflation.
For the period of 4Q03 – 1Q04: when inflation (monthly CPI over 3%) surprised the Timing is everything and depends
market on the upside and was gaining momentum, the market tended to post on where we are in the inflation
cycle
negative returns due to concern over rising inflation. The MSCI China index was
down by more than 30% from the peak during the period February 2004 – April
2004. Similarly, the MSCI China index has corrected by 9% during the current
inflation cycle.
For the period around mid-2004: the market was in consolidation as the CPI
peaked.
For the period post-3Q04: a market rally followed the decline in the CPI, ushering in
a three-year bull market.
If the equity market in 2011 follows the pattern of the 2003-04 inflation cycle, market
performance in the first quarter may not yield positive returns. Moreover, we highlight
the following as factors that are potentially not supportive of market performance in
1Q11: 1) the CPI continues to surprise the market in the upside; 2) the MSCI China
and HSCEI have posted negative returns in January in 12 of the past 17 years; 3)
possible interest rate and RRR hikes; and 4) release of full-year loan quotas,
reinforcing tightening measures.
Exhibit 6. MSCI China index performance vs monthly CPI change during 2003-04 inflation cycle
25 3%
Market down
30% from peak
20 0%
Jul-05
Jul-04
Jun-04
Jan-05
Feb-05
Sep-04
Mar-05
Jun-05
Feb-04
Jan-04
Nov-04
Dec-04
May-05
May-04
Dec-03
Mar-04
Oct-04
Sep-05
Nov-03
Oct-03
Aug-04
Aug-05
Apr-05
Apr-04
67
5%
64
58 3%
May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 * Nov-2010
15
% 5
% (5)
(15)
(25)
(35)
Jan-94
Jan-95
Jan-96
Jan-97
Jan-98
Jan-99
Jan-00
Jan-01
Jan-02
Jan-03
Jan-04
Jan-05
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
With lower new loan quotas in 2011, the profitability outlook for banks in 2011 will be We are bullish on China financials
more dependent on the interest rate outlook, in our view. We forecast four quarterly
symmetrical interest rate hikes in 2011, for a total increase of 100 bps. This should
help banks to achieve better profits in 2011, driving sentiment on banking stocks.
Despite share price underperformance due to fund raising and policy uncertainties,
banking sector earnings have been on the rise since 2008. On the valuation side, we
find that China banking stocks are trading at only 9.2x 2011F earnings and 7.3x 2012F
earnings, and 1.7x and 1.5x price to book for 2011F and 2012F, respectively, with
RoEs in both years forecast to exceed 20%. Also, we think insurance stocks will have
greater scope to outperform when interest rates are on the rise.
Exhibit 10. MSCI China financial index relative performance against index
(%) MSCI China price (RHS)
% 3 MSCI China Financial index relative to index performance 74
% 0 70
% (3) 66
% (6) 62
% (9) 58
% (12) 54
% (15) 50
May-10
Nov-09
Mar-10
Nov-10
Aug-09
Sep-09
Oct-09
Dec-09
Feb-10
Apr-10
Jul-09
Jan-10
Jun-10
Aug-10
Sep-10
Oct-10
Jul-10
In our view, inflation will remain high in the near term. The question is: how long before Consumption-related stocks also
it peaks? During the 2007-08 inflation cycle, monthly CPI was above 3% for a period of likely to outperform
18 months (May 2007 to October 2008). Inflation had been on the rise for 12 months
until it started to slow from April 2008. Price controls were introduced in the ninth
month (January 2008) after the CPI first broke 3% in May 2007, and one month after
the price controls were rolled out, the CPI started to trend down (although it was above
3% for another eight months). This time, the CPI started to trend above 3% in July
2010.
The government will likely release a higher CPI target for 2011, just as it did in
2008 after the CPI started to surprise on the upside from the latter part of 2007. In
2003, 2007, and 2010 YTD, consumer stocks, including staples, tended to perform
well before inflation gained momentum and outperformed again when the CPI was
deemed to be under control in 2004 and 2008.
In the 2003-4 inflation cycle, the equity market experienced a short-term correction
in early 2004 when the CPI continued to rise, and gained momentum and started a
three-year bull market when the CPI peaked in 3Q04.
We are bullish on the China property sector in 2011. Trading at an NAV discount of Bullish on property sector
37%, vs an historical (2003 – 2010 YTD) average discount of 23%, with sector
earnings growth of 32% and 22% in 2011F and 2012F, respectively, value looks to be
emerging, in our view. Transaction volumes are lower compared with a year ago, partly
due to softening demand after the government’s attempt to crack down on property
market speculation. There have also been product launch delays by developers in
order to reduce supply and avoid property price cuts, contributing to lower transaction
volumes. Balance sheets remain healthy for Chinese property developers, with 2011-
12F net debt/equity ratios of 40-50%, in our view. Bringing inflation down will likely
remain the top priority of the government in the next six months, we think, making
more aggressive policies to discourage property market demand less likely. With
fundamental demand for property in China remaining strong, an eventual recovery in
transaction volume should be positive for Chinese property stocks in 2011, in our view.
Exhibit 12. Property price vs food CPI and SHSZ300 index performance
PY=100 Turnaround in property
125 Property Price Index: 70 City: Bldg (LHS) prices coinciding with CPI 6,000
China Food CPI (LHS) surge and market rally
120 SHSZ300 Index (RHS) 5,000
115 4,000
110 3,000
105 2,000
100 1,000
95 0
Oct-05
Jan-06
Apr-06
Jul-06
Oct-06
Jan-07
Apr-07
Jul-07
Oct-07
Jan-08
Apr-08
Jul-08
Oct-08
Jan-09
Apr-09
Jul-09
Oct-09
Jan-10
Apr-10
Jul-10
Oct-10
Source: WIND, CEIC, Bloomberg, Nomura research
150 20
100 15
50 10
0 5
(50) 0
(100) (5)
May-08
May-09
May-10
Mar-08
Nov-08
Mar-09
Nov-09
Mar-10
Jan-08
Jul-08
Sep-08
Jan-09
Jul-09
Sep-09
Jan-10
Jul-10
Sep-10
In our opinion, renminbi beneficiaries such as airlines could overshoot in 2011. As a Renminbi appreciation
sector, airlines were up 136% in 2009 and are up 81% YTD 2010. As we see it, there beneficiaries
is a likelihood of higher airline earnings in 2011 following record-high earnings in
2010F, though y-y earnings growth will likely slow sharply in 2011. Another sector that
we think could overshoot in 2011 is Macau gaming, following 46% and 95% gains in
2009 and 2010 YTD, respectively. A strong renminbi will likely trigger more Chinese to
travel overseas, including Macau. On the earnings growth side, after 346% and 153%
y-y sector earnings growth in 2009 and 2010F, we believe upside in 2011 will come
from a pickup in the mass market, though Macau gaming stocks will likely find it hard
to repeat the earnings growth of 2009 and 2010.
We think a weak US$ and QE will continue to boost commodity prices, including oil.
We forecast oil prices will reach US$110 per barrel by 2012F. Along with rising
commodity prices, manufacturing and service costs will likely increase. Companies
with solid RoEs should be able to pass on cost pressure, given their proven execution
track records during economic upturn and downturn cycles.
Deep cyclical sectors such as metal and mining may face a more challenging
operating environment as interest rates rise further and economic growth becomes
more quality oriented, we believe. These sectors also have relatively highly geared
balance sheets that may not bode well in times of money tightening.
We believe the government will continue to push for industry consolidation and
upgrades to enhance investment returns. The seven industries deemed to be of
strategic importance are: 1) energy efficiency and environmental protection; 2) next
generation IT; 3) bio-technology; 4) high-end manufacturing; 5) new energy; 6) new
materials; and 7) clean-energy vehicles. We expect these industries to grow in size in
the next five to 10 years with the support of the Chinese government. Exposure to new
energy and environmental protection will likely be rewarded, we believe.
We think the seven industries of strategic importance will enter a golden period of
development commencing in 2011. The government expects the value-added
production of these seven industries to reach to 8% of total GDP by 2015 and 15% by
2020. This implies significant upside potential for these seven industries. For example,
the banking and insurance sector accounted for only 5% of total GDP in 2009, similar
to the real estate sector’s contribution, according to CEIC. The proposed tax
preference measures for these seven industries will further boost their long-term
development, in our view.
Our top 10 China stocks for 2011: ABC, Gome, CRCC, ZTE, China Everbright
International, China Life Insurance, Agile Properties, China Mengniu Dairy, Sinopec
and Perfect World.
These stocks provide exposure to our major sector overweight calls, including
financials and property, consumer and on-line gaming;
Three stocks (ABC, Gome and China Everbright) are also in our Top 10 12th Five
Year Plan beneficiary list (see China Strategy: Twelfth Five Year Plan – a healthy
push, 29 September 2010);
Five stocks are either recently upgraded or among those we have initiated
coverage on with BUY calls in 4Q: CRCC (November), China Life Insurance
(November), China Mengniu Dairy (November), Perfect World (October), Agile
Properties (October);
We are not chasing momentum; stocks in this basket are mostly YTD share price
underperformers. We believe sound fundamentals (average RoEs above 15%),
forecast pick-ups in earnings growth in 2011F (average EPS growth of >20%) and
conservative balance sheets (most with net cash) will support share price
performance in 2011.
Risks
Investment risks
Economic development uncertainty
Surging inflation
If the CPI again surprises the market on the upside during 2011, equity market
performance could be negatively impacted, as surging inflation would likely trigger the
government to implement even more tightening measures on easing liquidity.
Assumption deviation
We derive our MSCI China index price target based on certain forecasts for China’s
macro data during 2011, including four interest rate hikes, three RRR rises and about
5.8% RMB appreciation against the USD. If the actual largely deviates from our
estimation, this could significantly affect our price target for the MSCI China index.
Liquidity fluctuation
We believe liquidity will be sufficient in 2011 to support the market. Any major change
in money supply or extreme tightening measures could substantially hit the market
valuation level, causing market volatility.
2011 outlook
Higher ground
We are positive on China’s equity market in 2011 after its rebound in 2009 and We forecast MSCI China and
consolidation in 2010. We forecast the MSCI China Index and HSCEI Index will reach HSCEI will offer >20% upside in
2011F
83 and 16,000 by the end of 2011, offering 24% and 25% upside potential,
respectively. We believe the strong performance will be backed by: 1) 21%+ earnings
growth, with large-cap sectors such as financial and energy set to post strong earnings;
2) attractive valuations (13x 2011F earnings, in line with the 10-year average; 2.5x
price/book with RoEs of 20%). Note that 2011 will also be the first year of China’s 12th
Five Year Plan, and we think the sectors set to benefit, such as the seven emerging
industries with strategic importance, will receive a boost in sentiment. We believe
fundamental support will remain the most important factor to drive equity market
performance in 2011. In our view, sectors with an improving earnings outlook and
strong RoE tend to outperform. Earnings growth outlook and RoE will become
increasingly important and be rewarded when there are still uncertainties on the policy
side, and cost of capital is on the rise, in our view.
1) continuing from 2010, consumption will remain one of the major storylines in 2011;
2) inflation changes both company earnings expectations and market sentiment. We
have found that in the past, the equity market has tended to experience a short-term
correction when inflation continued to surprise on the upside, before picking up and
gaining momentum after the CPI peaked. In addition, consumer-staple stocks tended
not to perform well when inflation was out of control, but tended to perform very well
during the early and latter stages of an inflation cycle;
3) implementation of China’s 12th Five Year Plan (FYP) will likely trigger more
investment opportunities for certain sectors, especially for emerging industries deemed
to be of strategic importance;
4) the domestic interest rate hike cycle together with RMB appreciation will likely boost
interest rate- and renminbi appreciation-sensitive sectors, including financials and
transportation. However, concerns on valuations may offset some of the benefits to
sectors such as airlines;
5) further global commodity price rises as a result of excess liquidity will likely
eventually affect the China market and lead to divergent performance;
6) share price laggards with robust bottom-line growth and strong RoEs are included in
our stock picks.
We think China will continue to deliver solid economic data in 2011, and this Solid bottom-line growth
fundamentally makes us quite optimistic about China’s equity market in 2011. Our
economic team forecasts GDP growth of 10.2% in 2010, 9.8% in 2011 and 9.5% in
2012. With strong economic development, we forecast bottom-line growth for
corporates of 21.4% and 19.0% for 2011 and 2012, respectively. We think accelerating
urbanization, booming consumption, healthy export growth, robust investment and
implementation of various measures as part of China’s 12th Five Year Plan (FYP) will
be the major drivers.
Apart from the solid bottom-line growth, we believe liquidity is also sufficient in 2011 to Liquidity should be supportive in
support the current P/E level. We estimate new bank loans of about RMB8trn for 2011 2011
(vs a government loan quota of around RMB6.5trn), which may translate into around
18% M2 y-y growth. Although this is off from the recent peak of 27.7% y-y growth in
2009, our forecast 2011 M2 growth is still slightly higher than the historical average
growth of 17.6% for the past decade. In addition, we believe there is likely to be more
liquidity flowing from developed markets to emerging markets in search of higher
returns. Growth in ‘unexplained’ foreign capital inflow to China has been high in the
past several quarters.
During the 2008 bear market following the outbreak of the financial crisis, the index
gave up more than it had put on during the 2007 bull run (the MSCI China index closed
at 41 in 2008, after rallying from 52 in 2006 to 86 in 2007). With governments around
the world launching more easing policies from 2Q09 onward, the market rebounded
quickly from its 2008 low. Consumption stocks, both staple and discretionary, led the
rally in 2009, joined by materials and financials – two important sectors that are
contributing to the economic recovery. Meanwhile, booming liquidity as a result of
quantitative easing around the globe has bid commodity prices higher, hence the
outperformance of energy stocks.
Complicating the outlook for 2011, alongside these external uncertainties, China also
faces its own challenges. The recent interest rate hike by the PBoC and three RRR
rises signify the government’s intention to tame excess liquidity and curb surging
inflation. Plus, 2011 is the first year of China’s Twelfth Five-Year Plan (FYP). We
believe structural reform will be the major theme and, increasingly, the quality of
economic growth is likely to hold more weight than the headline GDP growth number.
We estimate China’s economic development will remain strong over 2011 and 2012, But still optimistic on China
with growth of 9.8% y-y and 9.5% y-y, respectively, providing a solid basis for
corporates’ bottom-line growth. We think consumption will play an increasing role in
terms of its contribution to GDP over the medium term, fuelled by the government’s
intention to shift the structure of economic development towards consumption and
income distribution reform, including raising the minimum wage. Investment should
also remain strong over the next two years, triggered by the rapid development of
central and western China as the larger theme of industry transferring inland from
eastern China, especially capital-intensive secondary industry, plays out.
Consumer prices 3.5 4.5 4.1 4.5 4.9 4.4 5.0 5.2 3.3 4.5 5.0
Core CPI 1.1 1.6 2.0 2.2 2.4 2.5 2.3 2.4 1.0 2.3 2.5
Retail sales (nominal) 18.4 18.6 20.1 19.7 19.9 20.1 20.3 20.6 18.4 20.0 21.0
Fixed-asset investment (nominal, ytd) 24.0 23.5 23.0 23.5 22.5 22.0 20.5 22.5 23.5 22.0 21.0
Industrial production (real) 13.5 13.7 12.8 14.2 15.1 16.0 15.1 14.1 15.8 14.5 14.2
Exports (value) 32.3 17.0 18.0 10.0 9.5 12.0 17.5 11.2 29.0 12.0 12.0
Imports (value) 27.1 18.5 12.0 14.0 13.0 16.0 14.0 17.0 35.6 13.8 16.0
Trade surplus (US$bn) 65.7 35.4 35.3 31.4 59.1 61.9 53.2 12.1 189 188 147
Current account (% of GDP) 5.0 4.1 3.1
Fiscal balance (% of GDP) -2.5 -1.3 -1.0
120 60%
MSCI China price (LHS)
60
0%
30
0 -30%
Oct-06
Feb-07
Feb-09
Feb-10
Jun-07
Oct-07
Feb-08
Jun-08
Oct-08
Jun-09
Oct-09
Jun-10
Oct-10
Exhibit 19. Relationship between MSCI China index price and EPS growth
110
y = 74.343x + 48.754
R2 = 0.7287
90
MSCI China price
70
50
30
-20% -10% 0% 10% 20% 30% 40% 50% 60%
EPS y-y growth %
Note: Using monthly data sets for the period from October 2006 – 2010 YTD
Source: CEIC, Bloomberg, Nomura research
40%
15,000
10,000
0%
5,000
0 -40%
Oct-05
Feb-06
Jun-06
Oct-06
Feb-07
Feb-09
Jun-07
Oct-07
Feb-08
Jun-08
Oct-08
Jun-09
Oct-09
Feb-10
Jun-10
Oct-10
25,000
y = 14904x + 8525.7
R2 = 0.6294
20,000
HSCEI index price
15,000
10,000
5,000
-20% -10% 0% 10% 20% 30% 40% 50% 60%
EPS y-y growth %
Note: Monthly data sets for the period from October 2005 – 2010 YTD
Source: CEIC, Bloomberg, Nomura research
Our EPS forecasts are slightly higher than market estimates (currently 3.1% higher for Our 2011 EPS forecast is slightly
2011F and 5.4% for 2012F). We forecast that the Media & Internet, Property, higher than consensus
Consumer, Healthcare, and Financials sectors will outperform in 2011, whereas
sectors including Industrials, Telecoms, Utilities, Transport and Macro gaming will
likely underperform the index’s bottom-line growth. This is one of our central
considerations in assessing investment opportunities for 2011.
The market has been revising up its forecast of the index’s bottom-line growth for 2011,
narrowing the spread between our forecast and the consensus estimate. The market
estimate for 2011 EPS for the MSCI China index has been revised up by 5% in 2010
YTD to 4.8%, from 4.6% at the beginning of this year. The Industrials and Healthcare
sectors have seen the biggest upward revisions in estimated EPS. We attribute this to
earnings upgrades for airline, commercial vehicle, construction machinery and
healthcare companies after strong 1-3Q10 operating results. If the financial sector
delivers better-than-expected 1Q11 operating results by confirming margin expansion,
we believe further earnings upgrades and revisions will follow.
31%
29%
24% 23%
25% 22%
19% 17% 17% 16% 16% 15% 14%
9% 7%
0%
Property
Media & Internet
Technology
Basic Materials
Solar
China - Total
Consumer Related
Financials
Industrials
Transport/Logistics
Gaming, Hotels &
Pharmaceuticals
Gas/Chemicals
Telecoms
Health Care &
Leisure
Oil &
0
-MSCI China
-Material
Discretionary
-Energy
-Healthcare
-Financial
-Industrial
-Utilities
-Information
-Consumer--
-Telecom
-Consumer--
services
technology
Staple
4.7 965
4.6 950
4.5 935
Nov-10
Jun-10
Jul-10
Aug-10
Sep-10
Oct-10
Source: Bloomberg, Nomura research
Exhibit 25. MSCI China consensus 2011 EPS % revisions by sector (TYD)
(%)
45
32
30 26
18
15 12 11
5
2 2
0
(5) (6) (7)
(15)
MSCI China
-Material
Discretionary
-Energy
-Healthcare
-Industrial
-Financial
-Utilities
-Information
-Consumer--
-Telecom
-Consumer--
technology
services
Staple
3) wealth transfer – household savings are likely to an extent flow into the equity
market and out of commercial banks, which will likely boost liquidity.
Sufficient money supply is partly the reason for China’s hitherto booming economy.
During the past decade, China has recorded much higher growth in money supply than
GDP growth. When the real economy is in good shape, sufficient money supply will
provide a solid base for economic development, such as financing the capital
expenditure of enterprises. On the other hand, any slowdown in economic
development could result in significant money oversupply relative to the needs of the
real economy, causing excess liquidity for the overall economy. The likely outcome:
asset bubbles, including rising commodity prices, increasing property prices and/or a
surging equity market.
We think excess money supply is becoming more of a concern for the authorities, Measures to be carried out to rein
which will likely lead to tightening measures in 2011. Our economics team forecasts in liquidity, but these may not be
four interest rate hikes, for a total 100bps, and three RRR increases totalling 150bps effective
over the course of 2011. We think these tightening open market measures could help
mop up some liquidity, but history shows that excess liquidity may not be fully reined in.
In the 2006-07 bull market, we note seven consecutive interest rate hikes and 11
successive RRR rises as the government relied solely on open market measures.
15 10
10
0
5
0 (10)
May-03
May-04
May-05
May-06
May-07
May-08
May-09
May-10
Jan-03
Sep-03
Jan-04
Sep-04
Jan-05
Sep-05
Jan-06
Sep-06
Jan-07
Sep-07
Jan-08
Sep-08
Jan-09
Sep-09
Jan-10
Sep-10
15 10
10
0
5
0 (10)
May-03
May-04
May-05
May-06
May-07
May-08
May-09
May-10
Jan-03
Sep-03
Jan-04
Sep-04
Jan-05
Sep-05
Jan-06
Sep-06
Jan-07
Sep-07
Jan-08
Sep-08
Jan-09
Sep-09
Jan-10
Sep-10
25 35
30
20
25
15
20
10
15
5 10
0 5
May-03
May-04
May-05
May-06
May-07
May-08
May-09
May-10
Jan-03
Sep-03
Jan-04
Sep-04
Jan-05
Sep-05
Jan-06
Sep-06
Jan-07
Sep-07
Jan-08
Sep-08
Jan-09
Sep-09
Jan-10
Sep-10
Source: CEIC, Bloomberg, Nomura research
30 40
25 35
30
20
25
15
20
10
15
5 10
0 5
May-03
May-04
May-05
May-06
May-07
May-08
May-09
May-10
Jan-03
Sep-03
Jan-04
Sep-04
Jan-05
Sep-05
Jan-06
Sep-06
Jan-07
Sep-07
Jan-08
Sep-08
Jan-09
Sep-09
Jan-10
Sep-10
M2 in circulation reached RMB69.6trn by end-3Q10, about RMB42.8trn higher than M2 growth remains high
nominal GDP amounting to RMB26.9trn for 1-3Q10 — the largest such gap in the past
decade. This underlines the current abundance of liquidity. Average growth in M2 over
the past decade is 17.5%, far outpacing GDP growth of 10.1%. The ratio of M2 to
nominal GDP reached 1.78 in 2009 and 2.59 for 1-3Q10, indicating that current money
supply is far in excess of the needs of the real economy. We think this ratio will shrink
in 2011 at a relatively slow pace and remain very high.
While the 2011 new loan quota will likely be lower — in the range of RMB6.0-7 trillion,
on our estimates — we expect actual loan demand in China to reach RMB8.0 trillion in
2011, on 9.8% GDP growth and 22% FAI growth. Aggressive tightening of monetary
policy is not likely, as we think the real economy still faces considerable downside risks
and needs to be further stimulated. Capital expenditure, a major indicator of the real
economy, is at its lowest in almost seven years, and there is no clear sign of a
recovery for 2011, according to the consensus view. We estimate M2 growth will
remain high, at 18.0% for China and 7-9% for Hong Kong in 2011.
40 2.8
30 2.1
20 1.4
10 0.7
0 0.0
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 3Q10
We note a trend of wealth transfer, with household savings going from commercial Wealth transfer further boosts
banks to the equity market amid a large number of newly opened stock accounts, liquidity
especially in periods featuring a stock-market rally and decreasing purchasing power
(negative real interest rates). With a year of possibly continued negative real interest
rates and our expected equity market rally, we expect the wealth transfer trend to play
out once again, which in turn should boost liquidity in 2011.
We have examined 46 monthly data sets covering changes in household savings and
the real interest rate, as well as index performance. The 11 instances of household
savings outflow generally coincided with the stock market recording a better-than-
average return and real interest rates being negative. At the same time, the number of
newly opened stock accounts also reached a high level. The only exception was in
April 2010, when there was a relatively small household savings outflow.
We also compared these data sets to changes in residential property prices, and found
the relationship does not hold in this case. We think this phenomenon is
understandable given: 1) people have an incentive to invest their money in the equity
market when it is rising, as they go in search of more capital gains; 2) this situation is
solidified when negative real interest rates start eating into household wealth; 3) the
generally large downpayment required for property purchases is a concern for many
interested parties; and 4) the stock market inevitably becomes the best pool for storing
up liquidity, apart from property investment, due to the lack of other effective
investment instruments in China.
Exhibit 33. Change in household savings vs index performance and real interest rate
Stock Change in
One year Monthly Real interest accounts household Residential
deposit rate CPI rate MSCI China HSCEI newly opened savings property price
(%) (%) (%) m-m % change m-m % change (mn) (RMBbn) m-m % change
Apr-07 2.8 3.0 (0.2) 3.6 4.4 4.8 (167.4) (0.2)
May-07 3.1 3.4 (0.3) 6.6 7.0 6.0 (278.4) 1.0
Jul-07 3.3 5.6 (2.3) 10.4 11.4 2.0 (9.1) 1.5
Aug-07 3.6 6.5 (2.9) 6.9 7.3 3.8 (41.8) 1.6
Sep-07 3.9 6.2 (2.3) 18.9 18.7 4.0 (14.1) 1.3
Oct-07 3.9 6.5 (2.6) 16.3 18.0 3.6 (506.2) 1.0
Jul-09 2.3 (1.8) 4.1 10.8 10.6 2.4 (19.2) 1.2
Oct-09 2.3 (0.5) 2.8 6.4 7.7 0.9 (250.7) 0.6
Apr-10 2.3 2.8 (0.5) (0.6) (1.7) 1.3 (41.9) 2.6
Jul-10 2.3 3.3 (1.1) 4.1 3.8 1.1 (42.5) (1.1)
Oct-10 2.5 4.4 (1.9) 3.8 6.1 1.2 (700.3) 1.2
Average * 1.1 1.2 1.8 288.8 1.1
* Average represents the average monthly number for the period from January 2007 to October 2010.
Source: WIND, CEIC, Bloomberg, Nomura research
0.8
0.6
0.4
0.2
0.0
(0.2)
Jan-00
Jul-00
Jan-01
Jul-01
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
The ‘unexplained’ foreign capital inflows to China and Hong Kong are another support ‘Unexplained’ foreign capital
for liquidity in 2011, in our view. The recent QE2 plan implemented by the US inflow is favourable for liquidity
government further pushes liquidity flows from developed markets into emerging
markets like China.
We have seen the ‘unexplained’ foreign capital inflows and FX reserve accumulation
accelerating at the fastest pace in a decade in search of capital gains from renminbi
appreciation, with the highest interest spread for the past decade between China and
the US as well as the EU. During 2009, ‘unexplained’ foreign capital inflows reached a
peak of US$160.9bn, on our estimate, accounting for 7.3% of A-share market cap in
circulation and hitting US$88.1bn for 1-3Q10, accounting for 4.0% of A-share market
cap in circulation. Moreover, ‘unexplained’ foreign capital inflows in Hong Kong
reached some HK$600bn in 2009, with HK$400bn heading into the equity market,
according to the HK government. We expect this trend to accelerate during the next
two years.
We do not think potential IPO fund raising will significantly impact market performance
on the downside, since IPO fund raising tends to expand when the market is booming.
20 40
10 20
0 0
(10) (20)
(20) (40)
1Q06
2Q06
3Q06
4Q06
1Q07
2Q07
3Q07
4Q07
1Q08
2Q08
3Q08
4Q08
1Q09
2Q09
3Q09
4Q09
1Q10
2Q10
3Q10
20 40
10 20
0 0
(10) (20)
(20) (40)
1Q06
2Q06
3Q06
4Q06
1Q07
2Q07
3Q07
4Q07
1Q08
2Q08
3Q08
4Q08
1Q09
2Q09
3Q09
4Q09
1Q10
2Q10
3Q10
500,000 15,000,000
0 10,000,000
(500,000) 5,000,000
(1,000,000) 0
1Q07
2Q07
3Q07
4Q07
1Q08
2Q08
3Q08
4Q08
1Q09
2Q09
3Q09
4Q09
1Q10
2Q10
3Q10
Source: WIND, CEIC, Bloomberg, Nomura research
5 5
0 0
(5) (5)
Oct-97
Apr-98
Oct-98
Apr-99
Oct-99
Apr-00
Oct-00
Apr-01
Oct-01
Apr-02
Oct-02
Apr-03
Oct-03
Apr-04
Oct-04
Apr-05
Oct-05
Apr-06
Oct-06
Apr-07
Oct-07
Apr-08
Oct-08
Apr-09
Oct-09
Apr-10
2 2
0 0
(2) (2)
Jun-99
Dec-99
Jun-00
Dec-00
Jun-01
Dec-01
Jun-02
Dec-02
Jun-03
Dec-03
Jun-04
Dec-04
Jun-05
Dec-05
Jun-06
Dec-06
Jun-07
Dec-07
Jun-08
Dec-08
Jun-09
Dec-09
Jun-10
Exhibit 40. Index return vs IPO fund raising by China stocks (HK market)
(HK$mn) IPO Fund Raising - H Shares & Red Chips
H Shares & Red Chips fund raising as % to Total (RHS)
350,000 MSCI China Return (RHS) 100%
80%
280,000
60%
210,000 40%
20%
140,000 0%
-20%
70,000
-40%
0 -60%
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
(YTD)
Exhibit 41. Index return vs IPO fund raising by China stocks (China market)
400,000 100%
300,000 50%
200,000 0%
100,000 -50%
0 -100%
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
(YTD)
We forecast MSCI China corporate earnings will grow by 21.4% and 19.0% in
2011F and 2012F, respectively. This compares with MSCI China average earnings
growth of 18% since 1994;
Most sectors are still trading in line with or below their respective historical
averages. Sectors with valuations substantially above the historical average include
Consumer staples, IT and Healthcare.
When taking earnings growth and RoE into account, large-cap sectors including
Financials, Properties and Oil & gas still look attractive, we find.
180 32x
150
26x
120
20x
90
13x
60
7x
30
0
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
Source: WIND, CEIC, Bloomberg, Nomura research
38,000
32x
30,400
25x
22,800
19x
15,200
12x
7,600
6x
0
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
35
30
25
+2 std. dev=21.2x
20
+1 std. dev=16.9x
15 Mean=12.6x
10
-1 std. dev=8.4x
5
-2 std. dev=4.1x
0
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
35
30
25
+2 std. dev=21.2x
20
+1 std. dev=16.9x
15 Mean=12.6x
10
-1 std. dev=8.4x
5
-2 std. dev=4.1x
0
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
Source: CEIC, Nomura research
Exhibit 46. Forward P/E comparison by MSCI China index sector breakdown (January 2003 – 2010 YTD)
40 ±1 std. Average forward PE Current forward PE
High High High
High
High
30 High
High High
High High
High
20
10
Low Low
Low Low Low Low
Low Low Low
Low Low
0
-MSCI China
-Material *
Discretionary
-Energy
-Financial
-Healthcare
-Industrial *
-Utilities
-Information
-Consumer--
-Telecom
-Consumer--
services
technology
Staple
* Adjusted, as there is a significant outlier number in 2009 which we believe does not objectively reflect market valuation
Source: WIND, CEIC, Bloomberg, Nomura research
IT
30%
Consumer-Staple
Consumer-Discretionary
ROE
MSCI China
Healthcare
20%
Energy
Financial
Telecom Material
Utilities
Industrial
10%
5% 15% 25% EPS growth 35% 45%
Industrials
22% Financials
Consumer Related
ROE
Healthcare
Technology
18%
Oil & Gas
Material
Property
14%
Solar
Utilities
* Size is the forward PE by Nomura estimates
10%
12% 17% 22% EPS growth 27% 32%
Catalysts
We believe that in 2011, a number of developments will impact company earnings and Key investment strategy for 2011
market sentiment, and thus present opportunities for equity market investment:
1) continuing from 2010, consumption will remain one of the major storylines in 2011;
3) implementation of China’s 12th Five Year Plan (FYP) will likely trigger more
investment opportunities for certain sectors, especially for emerging industries deemed
to be of strategic importance;
4) the domestic interest rate hike cycle together with RMB appreciation will likely boost
interest rate- and renminbi appreciation-sensitive sectors, including financials and
transportation. However, concerns on valuations may offset some of the benefits to
sectors such as airlines;
5) further global commodity price rises as a result of excess liquidity will likely
eventually affect the China market and lead to divergent performance;
6) share price laggards with robust bottom-line growth and strong RoEs are included in
our stock picks.
After examining the consumer-staple index performance relative to the MSCI China Consumer sector investment to
index during the high inflation periods of 2004 and 2007-2008, we find that the avoid high inflation period
consumer-staple sector underperformed the index during periods in which the monthly
CPI exceeded 3%. The consumer-staple index, by contrast, outperformed the MSCI
China index in both pre-inflation and post-inflation periods.
high inflation, including administrative and market measures such as price controls and
interest rate hikes, likely drag down the already priced-in consumption sector; and 3)
post-inflation period: easing concern on high inflation likely boosts the consumer-staple
sector. Moreover, throughout the whole inflationary period, the consumer-staple sector
benefits by recording higher top-line growth and improved margins, which by rights
ought to be rewarded by the market.
6% 25%
CPI=3%
3% 0%
0% -25%
During inflation period:
During inflation period: consumption
Consumer-Staple sector
sector underperform the market
UNDERPERFORMS the market
-3% -50%
Jan-01
Apr-01
Oct-01
Jan-02
Apr-02
Oct-02
Jan-03
Apr-03
Oct-03
Jan-04
Apr-04
Oct-04
Jan-05
Apr-05
Oct-05
Jan-06
Apr-06
Oct-06
Jan-07
Apr-07
Oct-07
Jan-08
Apr-08
Oct-08
Jan-09
Apr-09
Oct-09
Jan-10
Apr-10
Oct-10
Jul-01
Jul-02
Jul-03
Jul-04
Jul-05
Jul-06
Jul-07
Jul-08
Jul-09
Jul-10
& Consumer-Staple sector relative performance against MSCI China Index (Under/Outperform) (RHS) Monthly CPI
6% 25%
CPI=3%
3% 0%
0% -25%
During and post-inflation period:
During inflation period: consumption
Consumer-Discretionary sector
sector underperform the market
UNDERPERFORMS the market
-3% -50%
Oct-01
Oct-08
Oct-09
Jan-01
Apr-01
Jul-01
Jan-02
Apr-02
Jul-02
Oct-02
Oct-03
Jan-03
Apr-03
Jul-03
Jan-04
Apr-04
Jul-04
Oct-04
Oct-06
Jan-05
Apr-05
Jul-05
Oct-05
Jan-06
Apr-06
Jul-06
Jan-07
Apr-07
Jul-07
Oct-07
Jan-08
Apr-08
Jul-08
Jan-09
Apr-09
Jul-09
Jan-10
Apr-10
Jul-10
Oct-10
& Consumer-Discretionary sector relative performance against MSCI China Index (Under/Outperform) (RHS) Monthly CPI
We think this would not bode well for the equity market in the short term, since
historically the China H-share market has tended not to reward investors when inflation
has exceeded 3%. Between October 2000 and October 2010, of the 33 months in
which the CPI exceeded 3%, the H-share index posted negative returns in 18 months.
China has experienced two bouts of high inflation (CPI over 3%) in the past decade. Inflation: repeat of 2003-04 or
2007-08?
December 2003 – October 2004, lasting 11 months, with the CPI taking around
eight months to peak out
May 2007 – October 2008, lasting 18 months, with the CPI taking about 10 months
to peak out
The current run of inflation started in July 2010 (again, we take consecutive monthly
CPI readings of over 3% as our definition of inflation) and has so far lasted four
months. We think that a repeat of the historical CPI trajectory would be supportive of
our positive view on the equity market for 2011.
The high inflation rate will in particular affect the downstream Food & Beverage sector
due to raw material cost rises, in our view. We think highly concentrated sectors with
relative strong bargaining power are likely to pass on rising costs to end-customers.
According to Stats China, monthly PPI rose to 5.0% in October, from 4.3% in the prior
month, for a 2010 YTD PPI reading of 5.5%. We think PPI will fall to 3.5% in 2011.
Together with our forecast that the CPI will trend up to 4.5% in 2011, from the current
YTD reading of 3.0%, we believe both factors are on course for a reversal in trend in
the coming year. We think this is likely to benefit the material and industrial sectors —
both tend to experience margin expansion due to material costs decreasing, stemming
from a declining PPI growth rate, together with rising product selling prices resulting
from rising inflation and relatively strong bargaining power. However, we view the auto
sector as prone to facing margin pressure in the face of rising costs, since auto
companies have very little bargaining power with end consumers.
We think it is possible that price controls are in place on certain daily necessities to
curb inflation, mirroring the situation in 2004 and 2008, including meat and grains. The
government imposed price controls on pork and wheat in mid-2007, when the monthly
CPI reached 4.4%, and price controls were expanded to grain, edible oil, pork, beef,
eggs, milks and LPG when the CPI surged to 7.1% in January 2008. In general, we
think price controls will be effective for consolidated sectors or industries dominated by
large SOE companies (autos, utilities, telecom, oil and chemical, agriculture), but not
for segmented and privately owned industries such as F&B and retail. We think the
price controls were mainly aimed at upstream products. As a result, downstream
companies enjoyed the benefits from 2H07 onwards, and this was reflected in their
share price outperformance in 2007 (during the market rally) and 2008 (during a
market collapse). We think such short-term share price weakness could present buying
opportunities, as the downstream would likely be among the first to feel the benefits of
price controls when raw material costs fall while end-product prices remain firm or
even go up.
Exhibit 51. Monthly CPI vs M2 y-y growth % M2 growth has historically led
inflation by about six months
(%) Monthly CPI - China (6 months lag) (LHS) (%)
12 M2 growth y-y % - China (RHS) 33
9 28
6
23
3
18
0
(3) 13
(6) 8
Jan-00
Jul-00
Jan-01
Jul-01
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
Source: CEIC, Nomura research
20
Food inflation
15 started to pick Food CPI hit 10.1%
up in Jan 07 in in Oct 2010
last cycle
10
12
6
Food inflation
3 started to pick
up in Sep 03 Month
0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Housing
13%
Recreation,
Foodstuffs
education and
34%
services
14%
Tobacco and
Transportation
alcohol
and
4%
communications
10% Clothing
9%
10
5 CPI=3%
(5)
May-01
May-02
May-03
May-04
May-05
May-06
May-07
May-08
May-09
May-10
Jan-01
Sep-01
Jan-02
Sep-02
Jan-03
Sep-03
Jan-04
Sep-04
Jan-05
Sep-05
Jan-06
Sep-06
Jan-07
Sep-07
Jan-08
Sep-08
Jan-09
Sep-09
Jan-10
Sep-10
% 6
% 0
(6)
(12)
Jan-97
Jan-98
Jan-99
Jan-00
Jan-01
Jan-02
Jan-03
Jan-04
Jan-05
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
Nomura
(10)
0
10
20
30
40
(%)
Aug-2006
0
15
30
45
(15)
Aug-2006
(%)
Aug-2006 Oct-2006
Oct-2006
Strategy | China
Oct-2006 Dec-2006
Dec-2006
Dec-2006 Feb-2007
Feb-2007
Feb-2007 Apr-2007
Apr-2007
Exhibit 57. Rice CPI
Apr-2007 Jun-2007
Aug-2007 Aug-2007
41
Henry Wu, CFA
Oct-2010 Oct-2010
Oct-2010
7 December 2010
Strategy | China Henry Wu, CFA
Items that rallied and were eventually subject to price controls in 2008
14-Jan-08 State Council announced prices of fuel, gas, electricity, tap water, heating, public transportation and entrance tickets to tourist
destinations would not be allowed to rise in the near future. It also instructed local authorities not to raise school tuition and fees for
accommodation, medical services and fertilizers. Mobile phone roaming fees were ordered to be cut.
15-Jan-08 New law on the temporary price intervention of essential commodities and services implemented:
Intervened Grain, edible oil, pork, beef, mutton, milk, eggs and liquefied petroleum gas
products
Measures Price raising report scheme Price adjustment report scheme
Targets Production enterprises Wholesale and retail sale traders
(with annual sales over RMB20mn for wholesale and
RMB5mn for retail)
Details 1) Major enterprises are required to submit price- 1) Big wholesale and retail sales traders are required
raising application to the government for official to report to the government about sales conditions
approval 10 working days before they intend to within 24 hours of raising prices: 1) by over 4% in
raise prices one price rise; 2) in several increments totalling
more than 6% within 10 days; 3) incrementally by
more than 10% in 30 days.
2) The government should notify the enterprises 2) The price regulation agencies have the right to ask
within 7 working days after receiving application wholesale and retail sales traders to return prices to
on whether it will approve or reject on the basis of normal or reduce the price rise range if they regard
whether the price rise is deemed to be the rise as unreasonable within 3 working days
reasonable
3) When surging prices of commodities become 3) When surging prices of commodities become
stable, the government will lift interventions in a stable, the government will lift interventions in a
timely manner timely manner
Source: Chinese government including NDRC, Nomura economics team
(5)
0
5
20
40
60
80
100
10
20
30
40
50
(40)
(20)
0
(10)
0
(%)
(%)
Aug-2006 (%)
Aug-2006 Aug-2006
Strategy | China
initiated
Aug-2009 Aug-2009 Aug-2009
initiated
initiated
Oct-2009 Oct-2009 Oct-2009
Price control
Price control
Price control
Feb-2010 Feb-2010 Feb-2010
Apr-2010 Apr-2010 Apr-2010
Pork CPI
Jun-2010 Jun-2010 Jun-2010
Bean product CPI
44
Henry Wu, CFA
7 December 2010
Strategy | China Henry Wu, CFA
50
40 Price control
initiated
30
20
10
0
Aug-2006
Oct-2006
Dec-2006
Feb-2007
Apr-2007
Jun-2007
Aug-2007
Oct-2007
Dec-2007
Feb-2008
Apr-2008
Jun-2008
Aug-2008
Oct-2008
Dec-2008
Feb-2009
Apr-2009
Jun-2009
Aug-2009
Oct-2009
Dec-2009
Feb-2010
Apr-2010
Jun-2010
Aug-2010
Oct-2010
Source: CEIC, Nomura research
45
Price control
30 initiated
15
(15)
(30)
Aug-2006
Oct-2006
Dec-2006
Feb-2007
Apr-2007
Jun-2007
Aug-2007
Oct-2007
Dec-2007
Feb-2008
Apr-2008
Jun-2008
Aug-2008
Oct-2008
Dec-2008
Feb-2009
Apr-2009
Jun-2009
Aug-2009
Oct-2009
Dec-2009
Feb-2010
Apr-2010
Jun-2010
Aug-2010
Oct-2010
The upcoming rate hike cycle presents a dilemma, we believe. On one hand, given the
CPI surpassed the one-year deposit rate in February 2010 and has been above it for
nine straight months, rate hikes will help to address the currently negative real interest
rate, which could become a serious problem in eroding wealth due to decreasing
purchasing power — especially since China’s savings rate is so high. On the other
hand, expected rate hikes will expand the already historically high interest rate spread
between China and the US, as well as the EU. This could potentially attract more fund
inflows (“hot money”) in pursuit of capital gains, together with possible renminbi
appreciation. The likely result: even more money supply within the domestic market,
which is contrary to the objective of rate hikes. Nevertheless, we believe more interest
rate hikes will come through in step with the government’s stricter scrutiny of its capital
account.
We believe the four expected interest rate hikes in 2011 will have significant
implications for China’s equity market. Theoretically, rising interest rate will help tame
liquidity, which tends to have a negative impact on equity market performance. Despite
the policymakers’ efforts, we think liquidity will remain sufficient. M2 growth reached an
historical high of 27.7% y-y in 2009 amid the government’s aggressive stimulus plan
aimed at boosting the economy. For 1Q-3Q10, M2 growth stood at 19.0% y-y — the
third highest level for the past one and a half decades. In absolute terms, the M2 to
GDP ratio reached an historical high of 1.8x by end-2009, and expanded to 2.6x for
the first three quarters in 2010. Both of these data points argue that liquidity should
remain sufficient for the whole of 2011, in our view.
The expected interest rate hike cycle has varying implications across sectors. Given
our forecast for four symmetric interest rate hikes, we highlight the banking sector as a
clear beneficiary, since commercial banks ought to experience margin expansion
during this period. We think the insurance sector should report higher interest income,
since a large proportion of insurance premiums are term deposits, which tend to have
a relatively high negotiable rate. But the property sector is likely to be negatively
affected, since: 1) rising mortgage rates tends to curb demand from potential home
buyers; 2) rising rates are likely to increase property developers’ debt burden, which
would eventually translate to lower bottom-line growth and RoEs; and 3) it will become
harder for developers to finance new projects via bank loans or other financial
instruments. Moreover, we think rising rates will have a negative impact on sectors
with relatively high debt to asset ratios, such as utilities, materials and industrials.
3.6% 250%
3.4% 150%
3.2% 50%
3.0% -50%
Jan-00
Jan-01
Jan-02
Jan-03
Jan-04
Jan-05
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
(3)
(6)
Jan-00
Jul-00
Jan-01
Jul-01
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
We expect increased M&A activity and see outdated capacity being phased out during
the 12th FYP period, resulting in greater efficiency and improved investment returns.
The backdrop here is that the positive effects of the investment spree of the past two
decades, especially in secondary industries, are diminishing. Moreover, recent
measures by the government underscore our view that the government is encouraging
industries such as textile and garments, toys, electrical appliances, agricultural product
processing and equipment manufacturing to relocate their plants inland, from
Guangdong, Zhejiang and other coastal provinces that are facing rising land and
labour costs. We expect the government to reinforce this relocation trend to inland
areas by circulating stimulus measures including financial support, tax treatment,
industry allocation and government subsidiaries.
appreciation should also devalue China’s massive foreign exchange reserves, a large
portion of which are denominated in US dollars. And the expected renminbi rally will,
we think, help China to curb surging inflation as imported products will become
‘cheaper’, dragging down the CPI.
We highlight the property and airline sectors as two beneficiaries of this scenario.
Ironically, the renminbi is appreciating in the international market but devaluing
domestically, due to surging inflation and negative real deposit rates. We flag two
possible outcomes: 1) foreign investors are drawn to renminbi assets in pursuit of
capital gains through renminbi appreciation — property is one of the most effective and
direct investment instruments for such investors, likely fuelling demand; and 2)
domestic investors opt for property assets or head for the equity market in a bid to
preserve wealth amid surging inflation and negative actual deposit rates, creating new
demand. The expected renminbi appreciation should also benefit the airline sector,
where approximately 30% of companies’ costs are for fuel, which is typically priced in
dollars.
Negative impact
F&B
China Green 904 HK -1% 53 100
Utilities
Yingli Green Energy YGE US -1.85% 10% 70%
Oil
CNOOC 883 HK -0.2% 88% 94%
Source: Nomura
0.15 96
0.14 72
0.13 48
0.12 24
0.11 0
Jan-00
Jul-00
Jan-01
Jul-01
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
Source: WIND, CEIC, Nomura research
0.16 12
0.15 9
0.14 6
0.13 3
0.12 0
0.11 (3)
Jan-00
Jul-00
Jan-01
Jul-01
Jan-02
Jul-02
Jan-03
Jul-03
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
Effects of QE
Sector scorecard
EPS growth – fundamental parameter: we are gauging expected EPS y-y growth
for 2011F and hence our outlook on the sector’s future profitability. Empirical
research illustrates that rapid bottom-line growth tends to be rewarded with
relatively high valuations. On our estimates, sectors such as consumer related and
property are likely to deliver relatively high EPS growth in 2011.
By examining the 2010 YTD data, our sector scorecard methodology suggests the top
five-performing sectors are Airline, Autos – commercial vehicles, Capital goods –
construction machinery, Gaming, and Autos – passenger vehicles. The average return
from these sectors’ share price performance YTD stands at 67% — more than 5.2x our
covered sector index price return of 13% and more than 5.8x the average rate of return
of the bottom five sectors on our scorecard.
Similarly, for 2009, the average actual return of the top five sectors indicated by our
sector scorecard — including Autos – commercial vehicles, Technology, Capital
goods – construction machinery, Online gaming and Gaming — was 186.0%, whereas
the bottom five sectors reported a 102% return. The HSCEI index annual return was
62% for 2009.
Exhibit 76. Top five vs bottom five sector performance by scorecard for 2010 YTD
Top five sectors’ performance Score Actual
EPS EPS
growth ROE PE PB * perf. growth ROE PE PB * perf. Total * perf.
2010 2010 2010 2010 2009 2010 2010 2010 2010 2009 2010YTD
1 Airline 225% 45% 4.7 1.5 136% 38 39 40 38 14 37.6 82%
2 Gaming 389% 37% 12.0 4.8 49% 39 37 32 7 32 35.0 105%
3 Capital goods - Construction machinery 43% 45% 5.9 2.2 164% 29 38 39 21 8 32.7 82%
4 Auto - PV 91% 28% 11.0 2.7 328% 36 35 34 17 2 32.6 36%
5 Oil & Gas 40% 19% 10.1 1.7 52% 28 23 37 29 31 28.3 14%
Average 64%
Exhibit 77. Top five vs bottom five sector performance by scorecard for 2009
Score Actual
EPS EPS *
Top five sectors’ performance growth ROE PE PB * perf. growth ROE PE PB perf. Total * perf.
2009 2009 2009 2009 2008 2009 2009 2009 2009 2008 2009
1 Auto - CV 74% 29% 3.3 0.5 -58% 34 38 38 40 27 36.2 278%
2 Capital goods - Construction machinery 43% 28% 3.2 0.8 -64% 29 37 39 38 29 34.3 164%
3 Technology 193% 25% 7.4 1.4 -11% 39 35 34 25 5 34.2 396%
4 Auto - PV 127% 16% 6.0 1.0 -57% 38 22 36 34 25 31.2 328%
5 Online gaming 28% 39% 9.2 2.8 -4% 24 39 29 6 2 28.3 55%
Average 244%
Appendix
Nomura insights
Nomura’s China coverage
Note: Our stock pool includes all the Hong Kong listed China companies as well as Nomura covered offshore listed China companies. Pricing as 1 December 2010
Source: Bloomberg, Nomura research
Note: Our stock pool includes all the Hong Kong listed China companies as well as Nomura covered offshore listed China companies. Pricing as of 1 December 2010
Source: Bloomberg, Nomura research
2. If there is an interest rate hike this year, do you think it will be symmetric or asymmetric? 38
Symmetric 14
Asymmetric 24
4. Do you think tightening policies for the property market will eventually bring down property 41
prices?
Yes 4
No 12
Will have some effect 25
6. Nomura is forecasting a 6.22 RMB/US$ exchange rate at the end of 2011. Do you think this is 41
Aggressive 15
In line 22
Conservative 4
10. In 2011, what do you think are the biggest risks to China economic growth? 37
Global economic growth uncertainty 10
High inflation 25
Credit tightening 9
Hot money inflow 8
RMB appreciation 6
High crude oil price 4
Source: Nomura research
12. In 2011, you think the H-share market will post a year-end return of 35
>20% 9
10-20% 17
0-10% 7
-10%-20% 2
>-20% 0
13. In 2011, you think the China property market will post a year-end return of 35
>20% 3
10-20% 5
0-10% 20
-10%-20% 7
>-20% 0
14. Which three sectors are you most positive on for 2011? 35
Airlines 2
Agriculture 10
Autos 6
Insurance 7
Banks 10
Cement 1
Steel 1
Technology 13
Utilities (water and electricity) 1
Chemicals 2
Consumer goods 21
Commodities 12
Engineering and machinery 7
Food 12
Property 2
Shipping 3
Telecoms 7
15. Which three sectors are you most negative on for 2011? 32
Airlines 8
Agriculture 2
Autos 4
Insurance 0
Banks 2
Cement 6
Steel 15
Technology 2
Utilities (water and electricity) 10
Chemicals 5
Consumer goods 1
Commodities 1
Engineering and machinery 4
Food 2
Property 9
Shipping 9
Telecoms 1
Source: Nomura research
affordability, while government policy remains a swing factor for product mix. Priced as of 1 December 2010; * Changed on 29 Nov
Exhibit 89. Auto demand breakdown in China Exhibit 90. Major OEM capacity utilisation and gross
margin trend
(%) First car Replacement demand (%) Utilization rate 2009 (LHS) (%)
100 160 Utilization rate 2010F (LHS) 35
8% 10% 30.4 Gross margin 2009 (RHS)
90 16% 140 30
25% 26.6 Gross margin 2010F (RHS)
80 120 29.3 22.4 25
22.9 21.4
70 100 25.5 19.6 19.1 18.9
20
60 80 21.7 16.6
18.5 19.0
60 18.1 18.6 17.3 15
50 14.7
92% 90% 10
40 84% 40
75%
30 20 5
20 0 0
GZ Toyota
SGM
Geely
DF Honda
DF Nissan
GZ Honda
DF PSA
SVW
Great Wall
10
0
2006 2007 2008 2009
57
60 51
47 46 45
40
20
0
Ford Mazda
GZ Toyota
Roewe
SGM
BJ Hyundai
Chery
Geely
BYD
BJ Benz
DF Nissan
DF Honda
GZ Honda
DF Yueda Kia
DF PSA
Brilliance
FAW Xiali
FAW Toyota
BMW
SVW
FAW Car
Great Wall
FAW VW
Changan
Changhe
Suzuki
Suzuki
Changan
Banks BULLISH
Action Stocks for action
We reiterate our Bullish stance on Chinese banks and expect 16-35% y-y net profit We remain positive on the sector,
growth in 2011F, despite likely lower new loan growth as well as tighter liquidity. with BOC, ICBC, CMB and ABC our
We think any substantial policy change will likely come with phase-in periods and, top H-share picks, and Industrial
hence, should not have a significant earnings impact. With the overhang from Bank our preferred A-share stock.
capital-raising probably gone by early next year, we recommend a basket of
Price
Chinese banks with their own themes. Our top picks: BOC, CMB and ABC. Stock Rating Price target
Catalysts ABC-H (1288 HK) BUY 4.13 4.70
CCB-H (939 HK) BUY 7.03 8.50
Rate hikes could serve as a catalyst to expand the sector’s NIM. BOC-H (3988 HK) BUY 4.22 5.30
Anchor themes BOCOM-H (3328 HK) BUY 8.22 11.00
CMB-H (3968 HK) BUY 20.50 26.36
The operating environment for Chinese banks remains favourable in 2011F, but the CITIC Bank-H (998 HK) BUY 5.46 6.60
negative sentiment from uncertainties over policies and asset quality continues to Minsheng-H (1988 HK) NEUTRAL 6.91 7.40
weigh on valuation. Better visibility on regulatory policies (capital and provisioning) Note: All as of 1 December, 2010. All in local currency.
Source: Bloomberg, Nomura research
could trigger a re-rating in the near term.
We forecast 16-35% y-y earnings growth for Chinese banks in 2011F, due to Donger Wang
expanding NIMs, moderate new loan growth and benign asset quality trends. +852 2252 1590
Despite that liquidity tends to be becoming less abundant and, according to the donger.wang@nomura.com
government, new loan growth is likely to be lower in 2011F, we believe the likely
introduced four rate hikes, as expected by our economics team, will boost banks’
NIMs by 6-16bps, thus underpinning banks’ earnings growth in FY11F.
Asset quality should remain benign in the next year
We think the market has generally over-reacted to concerns about asset quality
and policy risks. Based on our estimates as well as the managements of Chinese
banks, asset quality should continue to be benign in 2011F. According to our
sensitivity analysis, we believe NPL ratios would only increase by 0.4-0.5pct if
property prices drop by 20% and 0.03-0.49pct if an additional 2% of LGFV loans
become NPL. In addition, we understand that banks have already tightened
lending standards, which should help reduce the risk of loan defaults in the future.
As a result, even if PBOC hikes interest rate by 60bps, we do not think it would
weigh much on Chinese banks’ asset quality in the following year.
Cement BULLISH
Action Stocks for action
Cement prices across most parts of China were solid in Oct, thanks to strong Sinoma and Anhui Conch are our top
demand and power rationing since end-August. We remain upbeat on Northwest picks in the China cement space. We like
China’s cement market prospects and believe the strong profitability clocked this Sinoma for its significant exposure to the
year should continue into 2011F. We remain Bullish on China’s cement sector. Our lucrative West China market, while Anhui
top two picks in the China cement space: Sinoma and Anhui Conch. Conch stands out for its leading market
Catalysts share.
Stronger-than-expected demand growth, faster-than-expected cement price hikes, Stock Rating Price Price target
Anhui Conch (914 HK) BUY HK$33.2 HK$40.0
industry consolidation and favourable government policies.
CNBM (3323 HK) BUY HK$18.26 HK$22.0
Anchor themes Asia Cement (1102 TT) BUY NT$30.70 NT$36.2
Taiwan Cement
We consider cement the best proxy for China’s investment-driven economic (1101 TT) BUY NT$32.20 NT$40.8
Sinoma (1893 HK) BUY HK$7.19 HK$8.70
growth, as it is used 100% in the construction sector. Nomura’s China economics
Prices as of 1 Dec. market close.
team calls for 30% y-y FAI growth in 2010F, providing solid support to the cement
demand outlook.
We believe Northwest China will remain the promised land for cement business
over the next five years as the West China Development Plan will continue into
12th FYP period, meaning continued massive government investment.
Exhibit 96. Cement price movements in West China versus national average
500
300
100
Jul-08
Jul-09
Jul-10
Jan-08
Mar-08
Jan-09
Jan-10
Mar-10
Sep-08
Mar-09
Sep-09
Sep-10
May-08
Nov-08
May-09
Nov-09
May-10
Source: China Cement Net, Nomura research
Catalysts
Price
Catalysts include stronger container demand, lower-than-expected containership Stock Rating Price target
delays/cancellation driven by stronger container activity and rise in ASP of boxes. CIMC (000039 CH) BUY 18.66 21.00
Singamas (716 HK) BUY 2.41 2.22*
Anchor themes
Local currency; prices as at 1 December market close
We remain Bullish on the box manufacturing sector due to strong box demand * PT under review
(from old box replacement, new box demand from new ships), coupled with tight
control on capacity. We expect box shortage would remain a global issue for at
least 18 months, leading to support to ASP of boxes and high margins.
While current global box production capacity is still lower (we estimate about 3.0
TEUs by end-2010F) than the 5.9mn TEUs peak capacity in 2007 (when all
factories operated under double shifts), we foresee tight capacity control in 2011F,
and hence, capacity is likely to increase only gradually. Eg, only some factories
with stronger, more stable demand (such as in Shanghai) may operate under
double shifts, while the remainder may be under one shift plus some overtime, in
our view. We estimate production capacity will reach 3.6mn TEUs in 2011F, from
3.0mn TEUs at end-2010.
Exhibit 98. Global box production vs container Exhibit 99. ASP trend of a 20” dry container box
activity
(US$/TEU) ASP of a 20' dry container (LHS) (%)
('000 TEU) Global container boxes production (LHS) (%) 2,500 y-y % chng (RHS) 50
4,500 Global container activity growth (RHS) 20 40
4,000 2,000 30
15
3,500 20
10 1,500
3,000 10
2,500 5 0
1,000
2,000 0 (10)
1,500 500 (20)
(5)
1,000 (30)
500 (10)
0 1998 (40)
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010F
0 (15)
2002
2003
2004
2005
2006
2007
2008
2009
2010F
2011F
2012F
Exhibit 100. Year-end slot ratio Exhibit 101. Incremental slot ratio
('000 TEU) Global container boxes (LHS) (x) (x) Incremental slot ratio (LHS) (%)
35,000 Global containership capacity (LHS) 2.4 3.0 Incremental global container demand (RHS) 20
2.5 2.6
Year-end slot ratio (RHS) 2.5
30,000 2.2 15
2.0 2.1
2.0 2.0 1.5
25,000 1.9 2.0 2.0 1.6
1.9 1.9 1.8 1.5 1.0 10
1.3 1.2
1.0 1.0 1.4
20,000 1.7 1.6 1.8 5
1.6 1.6 1.1
0.5
15,000 1.6 0
0.0
10,000 1.4 (0.5) (5)
(1.0)
5,000 1.2 (10)
(1.5)
(1.3)
0 1.0 (2.0) (15)
2002
2003
2004
2005
2006
2007
2008
2009
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010F
2011F
2012F
2010F
2011F
2012F
Source: Container International, Nomura estimates Source: Containerisation International, Nomura estimates
We think now is the time for downstream F&B companies with pricing power to pass
on cost pressure through product price hikes. Based on our higher ASP assumptions,
we estimate average EPS growth for FY11F will pick up to 31% y-y and foresee better
share performance for the overall sector in 2011F.
Exhibit 102. China F&B sector's EPS growth vs share relative performance
70
CY09
Mkt Cap w.a. relative performance
60
50
to MSCI China (%)
40
30
CY08
20
10 CY07
CY10F
0
(10)
0 5 10 15 20 25 30 35
Mkt Cap w.a. EPS growth (%)
We categorise companies in the food value chain into three groups, according to the Food inflation has different
impact from food inflation. impact on F&B companies along
the food value chain
Group 1: beneficiaries of food inflation. These are either upstream or midstream
F&B suppliers. Both their inputs and outputs are soft commodities. They can directly
translate cost hikes into price hike and target a fixed margin. The companies are Yurun
(slaughtering business) and China Agri.
Group 3: deferred beneficiaries if they have strong pricing power. These are
downstream F&B companies. They use soft commodities as inputs and supply
processed packaged and branded food and beverage products. Due to fierce
competition, they could face a margin squeeze amid food inflation. Should they have
strong pricing power in the segment, however, the companies could pass on cost
pressure with product price hikes sooner or later and benefit from price rises.
Downstream companies: Mengniu, Tingyi, UPC, Want Want, Huiyuan, China Foods
and Tsingtao.
Most of the stocks in Groups 1 and 2 have outperformed the market y-t-d, ie, Huabao,
Yurun and CRE. Want Want (Group 3) has also outperformed, likely mainly because of
its turnaround at the top line from a low base. China Agri (Group 1) has slightly
underperformed the market, with market expectations of the company’s restructuring
turning less positive and potential price control concern amid inflation.
We expect that cost inflation in FY10F will translate into price inflation in FY11F for
downstream F&B plays. While they saw cost pressure and margin squeeze in FY10F,
now is the time for them to pass on cost pressure by direct product price hikes and
product mix upgrade, in our view. We expect steadier gross margins generally for this
sector in FY11F.
In Group 1, we continue to like Yurun and China Agri; in Group 2, we favour Huabao
given its solid growth and undemanding valuation; and in Group 3, we are positive on
Mengniu, Tingyi and Want Want given their pricing power.
(%)
50
40
30
20
10
0
(10)
(20)
(30)
Huiyuan
Yurun
Mengniu
Tingyi
Huabao
China
CRE
UPC
China
Tsingtao
Foods
Want
Want
China
Agri
China
China
China Agri and Yurun CRE and Huabao China Foods, Huiyuan, Mengniu, Inflation
Tingyi, Tsingtao, UPC & Want Want
- beneficiary; directly translate cost hike - limited impact from inflation - see margin squeeze due to cost
into price hike and target fixed GPM pressure but can pass on at the end if
have pricing power
Imposition of price controls would pose a downside risk to our investment view, since …but we see only limited
much of our investment thesis rests on pricing power. However, we think the negative downside risk
impact of price controls would be felt more in investment sentiment than in company
fundamentals.
Still, we think potential price controls are most likely to take the form of an approval
system (as they did in 2008) rather than direct price caps per se. Our expectation of
leading food suppliers’ product price hikes is based on the pre-condition that they have
already seen cost pressures and margin squeeze as a result.
Should we see the worst case, where the authorities put direct price caps on instant
noodles, liquid pure milk and consumer-pack edible oil, our earnings estimates for
related stocks, including Tingyi, Uni-president, Mengniu and China Foods, would not
be at significant downside risk, in our opinion. These companies have already raised
Also see our Asia Pacific
product prices, such that further hikes would likely not be significant, we believe. Strategy piece — China: an
inflationary surprise (IX) and the
Engel coefficient , 17 November,
2010
The key near-term policy risks may come from: 1) new regulations to control drug
and other medical product prices in the national drug reimbursement list; and 2)
new measures to reform industry processes and product quality, such as the
introduction of good manufacturing practices (GMP) and the streamlining of
distribution systems. These will likely lead to profit margin pressure in the short
term, despite prospects for long-term positive effects that will help accelerate
market consolidation and industry upgrades.
In view of the short-term policy overhang, we believe the re-rating impetus via
P/E value expansion should ease for most stocks in 2011F, which will likely
continue the sector’s on-going consolidation for a while. In the coming months,
we believe, some stocks face a risk of correction due to: 1) stretched valuations,
reflecting the high expectations; 2) unintended outcomes from some controversial
reform policies, especially for some single-product companies; and 3) other risk
factors, such as cost inflation, interest rate hikes and renminbi appreciation.
In this regard, we note buying opportunities for long-term winners in the sector, as long-
term growth prospects could heat up again against the backdrop of new growth
opportunities from future market consolidation and industry upgrades. Market leaders
post consolidation should enjoy a long-term re-rating, amid growth opportunities from
demand upgrade and M&A in China. We see re-entry opportunities after the market
clearly evaluates policy risks to the sector in mid-2011F.
We believe domestic leaders in the medtech, biotech and first-to-market generic drugs
segments will have better opportunities to achieve product and technology upgrades.
Meanwhile, leaders with superior market share and cost advantages in traditional
Chinese medicine (TCM) and generic drugs could benefit from market consolidation,
but their long-term re-rating potential looks less attractive than companies with industry
upgrade potential, in our view.
Exhibit 105. Sector profit growth hiccup in 2004-06 Exhibit 106. Sector profit margin contracted in
2004-05
(RMBbn) Profit (LHS) Change (RHS) (%) (%) Profit margins Average annual growth
100 As the policy risks led to sector earnings hiccup in 2004 50 Profit margin Average profit
and 2006, investors should be aware of the possible policy Average profit margin in 11th FYP
90 45 11 margin in 10th
contraction during the
uncertainties to the sector in 2011 reform period (2006-8M10)
80 40 FYP (2001-05)
10
70 35
60 30 9
50 25
8
40 20
30 15 7
20 10
6
10 5
0 0 5
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
8M10
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
8M10
Exhibit 107. Average segmental revenue growth per Exhibit 108. Average segmental profit growth per
annum (2006-8M2010) annum (2006-8M2010)
(%) (%)
40 60
35 50
30
40
25
20 30
15 20
10
10
5
0 0
Sanitation &
Sanitation &
medicine
medicine
instruments
medicine
prepared
chemicals
medicine
medicine
instruments
chemicals
medicine
prepared
medicime
medicime
Chemical
Chemical
Chinese
Chinese
Chinese
Chinese
Biology
Biology
finished
finished
herbal
herbal
products
products
Medical
Medical
material
material
Bulk
Bulk
Source: Nomura Research, CEIC Source: Nomura Research, CEIC
China Shineway 2877 HK Buy HK$ 25.00 2,662 Dec-09 (2.7) (7.4) 96.6 21.7 17.7 1.2 1.0 5.7 4.9 15.5 12.3 28.3 29.8
Lijun Int'l Pharmaceutical 2005 HK Reduce HK$ 2.51 793 Dec-09 (6.3) (6.3) 79.3 21.7 18.7 1.1 0.9 2.9 2.6 14.1 11.8 14.7 14.9
Sino Biopharmaceutical 1177 HK Buy HK$ 3.02 1,927 Dec-09 (1.9) (1.6) 24.8 31.7 24.9 1.4 1.1 4.0 3.7 16.3 13.6 15.1 15.6
Sinopharm Group 1099 HK Neutral HK$ 28.35 2,520 Dec-09 (0.4) (6.6) 5.2 47.6 33.9 1.2 0.8 5.1 4.6 24.7 17.7 11.2 14.3
United Laboratories 3933 HK Neutral HK$ 14.44 2,420 Dec-09 (9.1) 0.4 256.5 18.8 16.0 0.5 0.5 3.9 3.5 12.4 10.6 23.8 22.8
Nomura coverage Average (4.1) (4.3) 92.5 28.3 22.2 1.1 0.9 4.3 3.9 16.6 13.2 18.6 19.5
China Medical System 867 HK Not-rated HK$ 5.61 826 Dec-09 9.8 14.7 n.a. 26.8 21.2 1.1 0.9 n.a. n.a. 23.0 17.2 n.a. n.a.
China Pharmaceutical 1093 HK Not-rated HK$ 4.18 826 Dec-09 (2.6) (3.9) (7.5) 8.5 11.1 9.3 12.3 1.2 1.1 4.8 5.7 13.2 11.3
Dawnrays Pharmaceutical 2348 HK Not-rated HK$ 3.22 330 Dec-09 0.6 (4.7) 170.6 12.0 9.5 0.3 0.2 2.6 2.2 12.6 9.9 24.2 25.8
Golden Meditech 801 HK Not-rated HK$ 1.52 334 Mar-10 10.9 5.6 (16.9) 21.1 11.6 0.6 0.3 0.8 0.8 21.7 13.2 3.6 5.7
Guangzhou Pharmaceutical 874 HK Not-rated HK$ 11.02 312 Dec-09 3.2 31.5 108.7 26.0 20.7 1.1 0.8 2.2 2.0 41.6 34.2 8.0 9.3
Hua Han Bio-Pharmaceutical 587 HK Not-rated HK$ 3.22 664 Jun-10 15.4 23.8 91.7 16.6 12.5 0.5 0.3 1.9 n.a. 14.4 7.6 12.3 14.9
Lansen Pharmaceutical 503 HK Not-rated HK$ 3.90 208 Dec-09 (0.5) 6.3 n.a. 20.1 3.7 0.6 0.1 2.2 1.9 13.8 11.2 14.1 13.6
Lee's Pharmaceutical 950 HK Not-rated HK$ 3.72 216 Dec-09 12.7 0.3 118.8 23.3 16.9 n.a. n.a. 8.5 6.1 n.a. n.a. 36.0 36.0
Microport Scientific 853 HK Not-rated HK$ 7.51 1,394 Dec-09 0.7 (7.4) n.a. 29.3 26.1 1.5 1.4 4.4 3.8 27.0 20.0 17.1 15.3
Mingyuan MedicareLtd 233 HK Not-rated HK$ 1.25 602 Dec-09 5.0 15.7 (10.7) 25.0 19.5 0.8 0.6 2.5 2.2 14.7 12.8 12.5 13.6
Sihuan Pharmaceutical 460 HK Not-rated HK$ 5.92 3,954 Dec-09 4.8 (0.7) n.a. 39.1 31.7 1.9 1.5 4.6 4.1 n.a. n.a. 9.5 11.0
Shandong Weigao 1066 HK Not-rated HK$ 20.80 2,293 Dec-09 11.3 1.7 46.0 43.8 35.1 1.7 1.4 10.4 8.3 n.a. n.a. 24.7 26.7
Shandong Luoxin 8058 HK Not-rated HK$ 10.04 213 Dec-09 (1.6) (3.1) 54.5 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
Shandong Xinhua 719 HK Not-rated HK$ 3.48 67 Dec-09 0.6 (0.9) 20.0 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
Tong Ren Tang Tech 1666 HK Not-rated HK$ 22.75 256 Dec-09 (2.8) 0.7 48.7 18.9 16.6 1.3 1.1 2.4 2.1 11.8 10.1 n.a. n.a.
Trauson Holdings 325 HK Not-rated HK$ 3.66 365 Dec-09 1.7 5.8 n.a. 19.6 17.2 1.0 0.9 2.2 2.0 14.4 11.2 16.5 12.3
United Gene High-Tech 399 HK Not-rated HK$ 0.16 247 Jun-10 (1.3) (8.1) (62.1) 143.6 n.a. n.a. n.a. 4.5 n.a. 114.8 n.a. 4.2 n.a.
Wuyi International 1889 HK Not-rated HK$ 0.70 154 Dec-09 (2.8) (4.1) (12.5) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
HK listed stocks average 1.3 1.7 61.8 30.8 19.9 1.5 1.4 3.8 3.4 22.7 13.6 16.2 17.3
3SBio Inc SSRX US Not-rated US$ 15.35 330 Dec-09 (5.5) 1.7 9.3 25.2 18.9 0.9 0.7 2.0 1.8 11.5 8.9 9.2 10.2
China Biologic Products Inc CBPO US Not-rated US$ 11.64 141 Dec-09 13.7 19.4 21.3 6.6 8.6 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
China Kanghui Holdings Inc KH US Not-rated US$ 20.74 158 Dec-09 7.1 10.3 n.a. 41.7 37.2 2.8 2.5 2.4 2.1 n.a. n.a. 12.1 7.6
China Medical Technologies Inc CMED US Not-rated US$ 11.43 92 Mar-10 (16.4) (4.6) (13.8) n.a. 7.3 n.a. n.a. 13.3 1.1 12.3 11.1 (3.2) 14.9
Mindray Medical International Ltd MR US Not-rated US$ 26.25 444 Dec-09 (6.3) (9.3) (15.6) 18.3 16.1 1.0 0.9 3.7 3.0 12.8 10.8 21.7 21.6
Simcere Pharmaceutical Group SCR US Not-rated US$ 12.48 125 Dec-09 19.3 32.3 55.4 31.5 23.5 0.9 0.6 2.2 2.0 17.9 15.0 10.5 9.9
WuXi PharmaTech Cayman Inc WX US Not-rated US$ 16.75 167 Dec-09 (5.0) 1.4 (3.6) 16.9 15.5 1.1 1.0 3.4 2.9 10.2 9.2 22.6 21.4
US listed stocks average 1.0 7.3 8.8 23.4 18.2 1.3 1.1 4.5 2.2 12.9 11.0 12.2 14.3
Industrials BULLISH
Action Stocks for action
With detailed railway construction plans to be released shortly as part of the 12th We like CSR and CNR for the
Five-year Plan, we believe likely upward revisions will boost the railway sector. We benefits they enjoy from the railway
think CSR, CNR and Zhuzhou CSR stand to be major beneficiaries of the demand boom and margin expansion on
for trains and components, while CRCC and CRG benefit from enlarged railway better scale economies. We also
construction plans. After studying past experience overseas, we believe China can highlight that CRCC looks attractive
continue its large-scale, high-speed railway construction for some years to come on valuations after being hit by
despite the MoR’s weak balance sheet and cashflow. previously negative sentiment.
Catalysts
Price
Upward revisions to railway construction plans in the 12th Five-year Plan. Stock Rating Price target
CSR Corp (1766 HK) BUY 9.27 10.50
Anchor themes
China CNR (601299 CH) BUY 6.23 8.20
Despite the MoR’s weak balance sheet, we believe railway investment will Zhuzhou CSR (3898 HK) NEUTRAL 29.25 28.00
CRCC (1186 HK) BUY 9.42 11.80
continue, particularly given that China’s current railway network is far from
CRG (390 HK) NEUTRAL 5.5 6.60
excessive.
Pricing as of 1 December, 2010; local currency
Exhibit 111. Railway freight & traffic density (2005) Exhibit 112. China railway freight & traffic density
30 27.2 Railway freight density (mn tonne-km / km)
Freight traffic density (mn
tonne-km/km) Railway passenger density (mn persons-km / km)
25 35
30.7 31.1
19.5 28.2 29.0
20 Passenger traffic density 30 27.2 27.9
(mn persons-km/km) 25.7
25 23.4
15 12.1
9.28.6 20
10 8.0 7 6 15 11.6
5 2.6 2.5 2.22.0 8.6 9.3 9.8 9.2
1.51.8 1.3 0.2 10 7.7 8.0
6.6
0
5
Germany
Russia
China
Japan
Britain
France
India
US
0
2003 2004 2005 2006 2007 2008 2009 2020F
2012F
2005
2006
2007
2008
2009
2013F
2015F
2014F
2004
2010F
2012F
2011F
2007
2009
2008
300 400
20 300 252
155177 208
200 136 140
180
89 0 200 89 100
56 57 52 51 62 53 52 57 78
100 100 19 26 33 55
0 (20) 0
2010F
1998
2000
2002
2004
2011F
2012F
2010F
2011F
2012F
2013F
2015F
1999
2001
2003
2005
2006
2007
2008
2009
2014F
2008
2009
2005
2004
2006
2007
Exhibit 117. Railway (km) per thousand sq km Exhibit 118. Railway (km) per million people
140 2,000
1,759
117 1,800
120
1,600
1,383
100 1,400
80 70 1,200
1,000
60 53 730
800 625
600 509 465
40
23 19 400
20 208 143
5 5 3 5 8 200 55 59
0 0
Germany
Australia
Germany
Canada
Australia
Canada
France
Russia
France
Brazil
Russia
China
China
India
Brazil
Japan
India
Japan
USA
USA
Insurance BULLISH
Action Stocks for action
The consensus bullish view on rising rates has provided little more than downside We would recommend to BUY China
valuation support to the sector. With a “golden 10 years for insurance” still ringing in Life for relatively less uncertain
our ears, the concern over tighter liquidity in 2011 is now driving sentiment. With exposure to China’s life insurance
the overhang on investment market sentiment, demand in insurance is returning to industry, while CTIH remains a high-
basic par products, supporting our positive view on China Life and Taiping (CTIH). margin and multiple growth story.
Catalysts
Further rounds of rate hikes in 2011 could boost insurers’ earnings, together with Price
Price target
any positive sentiment on the A-share market or expectations of more liquidity. Stock Rating (HK$) (HK$)
Anchor themes China Life (2628 HK) BUY 33.70 40.00
CTIH (966 HK) BUY 26.00 35.00
Investor perception of Chinese insurers’ ability to control investment risk is a highly CPIC (2601 HK) REDUCE 30.70 28.00
valuable intangible asset and should not be taken for granted. Given the Chinese Ping An (2318 HK) NEUTRAL 91.00 90.00
PICC (2328 HK) NEUTRAL 11.64 12.00
insurance industry remains a growth story and investors’ focus on VoNB growth,
Note: Pricing as of 1 Dec 2010
we believe Chinese insurers should continue to trade at higher multiples.
Nonetheless, we think that bargaining power for this channel has shifted to banks
during this transitional period.
We note there are several forces that should drive future trends here:
The premium from this source is unlikely to slow significantly because banks would
still like commissions, but growth of Value of New Business could slow as it
becomes harder to sell regular premium products through this channel. Most
insurers we met acknowledged this, but some also said that insurers could continue
to have staff in bank branches to train them for insurance product sales.
Smaller sized insurers that are willing to pay higher commissions could benefit.
Although commission rates are generally capped, benefits could still be passed on
through other means. In the end, most insurers are likely to gain and lose access to
some branches, so the actual net impact remains uncertain.
More positively, though, insurance products from this channel could focus more on
risk protection-based products rather than investment.
In any case, the tighter liquidity environment next year will likely affect
bancassurance growth; hence, premium growth could be slower in 1H11F relative
to 1H10.
At this stage, we believe the most affected insurers are CPIC and Taiping, given their
reliance on bancassurance to sell regular premium products. China Life should not be
as affected, given its relatively higher bargaining power, especially in rural areas, and
its relatively lower reliance on the bancassurance channel for regular premium sales.
Additionally, most insurers do not see banks entering the insurers’ turf as a threat at
this stage. They point out that insurers need to have sub-branches in the provinces
before banks are allowed to sell insurance products there, and most of the smaller
insurers have only sub-branches in certain provinces. Having said that, when we
visited a joint-stock bank branch in Shanghai, we noticed it was already selling
products from its own insurance company although sales staff told us they used to sell
products from another insurer.
Exhibit 119. Total premium mix by distribution – Exhibit 120. Bancassurance premium mix – 1H10
1H10
* As at FY09 * As at FY09
Source: Company data, Nomura research Source: Company data, Nomura research
Agency reform – chicken and egg, but the impact could be less
than expected
While the China Insurance Regulatory Commission (CIRC) is clearly interested in
improving the social status and financial wellbeing of the agency force, which in turn is
likely to drive agency force productivity, there is a lot of push back from insurers.
As a result, we expect likely higher fixed costs (wage and welfare) but possibly lower
variable (commission) costs, which might actually be good for insurers on a net basis.
In addition, in our opinion, changing to an employee basis may not have a significant
impact or dramatically change the dynamics of the industry after all.
This is because it is already difficult for insurers to poach high-productivity agents from
competitors. By definition, these agents would already be receiving kick-back
commissions from the continued stream of regular premiums and therefore would be
very costly to poach.
Agents most susceptible to poaching are rising stars who have the potential to grow
and are not so expensive to poach. By joining a smaller insurer, these agents are likely
to get a better title, income and profit sharing going, and their opportunity costs are
also lower.
If a larger insurer can offer better welfare benefits to its employees, it would perhaps
make poaching of agents more difficult as, in the end, the commission level is
regulated and set by the actuary.
Generally, direct marketing usually has cheaper acquisition costs but higher claims
and losses, and generally applies more to P&C than life insurance. In fact, we
understand that in China, the penetration level for phone marketing is already very
high. For example, Ping An has already derived over a quarter of its motor business
from phone marketing. From overseas experiences, direct marketing usually becomes
saturated at certain levels and we believe in China, it could already be quite close to
this level given recent aggressive marketing by larger insurers, such as PICC and Ping
An.
For intermediaries, we see them becoming more active and in fact, an intermediary
guided that intermediaries have been allocated 2011 premium targets that are 2-3x
that of 2010 and in addition, they are guiding for higher commission rates. Having said
that, we note that commissions for life products are regulated and therefore, we
believe there could be some sort of a cap as to how far this rate could go. Additionally,
given life insurers focus on quality and premium margin rather than on pure volume,
we believe intermediaries will also need to have the same focus and therefore, costs to
train high productivity employees.
Likely outperformers
Heading into 2011, we like the sector underdogs or those that have significantly
underperformed in 2010, including Perfect World, Changyou and Shanda Games.
Ironically, we like these players for the same reason they vastly underperformed in
2010 — we see launches of new games that were pushed back from this year to
2011 as potential catalysts for next year, given that many of these companies
depend on their next game to drive incremental revenue growth.
Buying a basket
Given sector competition and the abundance of potential “hit” games slated for
launch in 2011, we recommend a basket of gaming names, including Netease,
Tencent, Perfect World, Shanda Games and Changyou. Year to date, this basket
has returned -14.3%, versus +107.6%, -10.9% and +74.8% in the three years prior.
We believe that this basket will outperform on new game launches in the coming
year.
Valuation
We believe that it is time to revisit this sector, considering our projections for free
cashflow yields of 10-22% and forward P/E trading discounts of 20-30% to
historical averages, coupled with catalysts on the horizon. Our sector top BUY is
Perfect World, given its pipeline of four new games over the next five quarters.
Business environment to improve. This has been a rather grim year for online
gaming companies, mainly owing to a perfect storm of heightened competition,
fickle users, delayed new products, climbing cost structures and regulatory
overhang. While this is likely to become the “new norm”, we take a more positive
stance on the sector, since new games delayed in 2010 will be ready to launch in
2011, which should help to stir interest from gamers and investors alike.
Margin relief ahead. We continue to believe that non-GAAP operating margins will
never again reach prior years’ historical highs (55%-plus). A lack of top-line
leverage for many of the game companies plus rising costs and licensing fees has
resulted in a dramatic drop in operating margins in 2010 of as much as 10%-plus
from last year’s levels. In 2011, we see margin run rates improving for gaming
companies, due largely to better top-line leverage as delayed new games will soon
hit the marketplace, providing incremental revenues.
The unlikely overachievers. Internet businesses are highly monopolistic, largely
due to strong networking impact. Hence, we see companies such as Tencent,
Baidu and Alibaba.com trading at a significant premium to peers. However, heading
into 2011, we like sector underdogs or companies that have significantly
underperformed in 2010, including Perfect World, Changyou and Shanda Games.
These companies do not possess the “edge” in maintaining sticky traffic, thus we
believe they will not be as structurally sound as Tencent or Baidu. However, we
believe these three companies will outperform peers in 2011, mainly on new game
catalysts. Ironically, we like these companies in 2011 for the same reason that they
significantly underperformed in 2010 — we see new game launches that were
pushed back from this year to 2011 as catalysts for next year, given that many of
these companies depend on their next game to drive incremental revenue growth.
Buying a basket. Given sector competition and the significant number of potential
“hit” games to be launched in 2011, we believe that buying a basket of gaming
names may prove to be prudent. On examining a basket of gaming names
including Netease, Shanda Games, Perfect World, Tencent and Sohu/Changyou,
we see a wave-like pattern where the basket of companies outperforms/
underperforms the NASDAQ every other year. Year to date, the basket has
returned -14.3%, versus +107.6%, -10.9% and +74.8% in the three years prior. We
believe the group can outperform given that various companies will be launching
new games in the coming year.
A basket approach
We recommend buying a basket of gaming names heading into 2011 rather than
taking a stock-picking approach, given the growing difficulty in pin-pointing winning
games and the relative underperformance of the online gaming sector in China.
Competition is stiff in the sector and there are a significant number of potential “hit”
games to be launched in 2011. While the top-three players are likely to continue to see
market-share gains, we also see growth opportunities for the smaller operators. In our
view, companies such as Perfect World, Changyou and Shanda Games, which have
clearly underperformed in 2010, will generate higher returns in 2011F on new game
launches and product upgrades.
We believe the sector deserves another look heading into the new year, as valuations
and cashflow yields look undemanding compared with recent history. Free cashflow
yields appear to be rising across the board, with our basket of companies offering
yields of 8-19% in 2010F, on our estimates. Further, our current forecasts show yields
climbing even higher to 10-22% in 2011F.
On a historical forward basis, many of the companies in our basket are trading near
historical lows, excluding periods of financial crisis. Save for Tencent, our basket of
proposed companies is trading at around 6-10x forward P/E, compared to the historical
average of 10-12x P/E.
Investing amount Jan 1, 2008 20,000 20,000 20,000 20,000 20,000 100,000
Value at Dec 31, 2008 23,312 19,412 12,374 17,366 16,667 89,132 (10.9) (40.5)
Investing amount Jan 1, 2009 20,000 20,000 20,000 20,000 20,000 100,000
Value at Dec 31, 2009 34,045 32,515 45,728 27,800 67,480 207,568 107.6 43.9
Investing amount Jan 1, 2010 20,000 20,000 20,000 20,000 20,000 100,000
Value at current price 20,298 15,028 12,018 17,712 20,628 85,683 (14.3) 10.1
* 39% is the return on SOHU from Jan 2009 to Mar 2009, compounded with the return on CYOU from Apr 2009 to Dec 2009, as we switched from SOHU to CYOU
upon the latter’s IPO.
Pricing as of 30 Nov 2010 for US listed companies and 1 Dec for HK listed companies.
Source: Nomura research
Jul-09
Nov-09
May-10
Jul-10
Sep-10
Nov-10
May-07
Sep-07
Jan-08
Mar-08
May-08
Jul-08
Jan-09
May-09
Sep-09
Jan-10
Jan-07
Mar-07
Jul-07
Nov-07
Mar-09
Mar-10
Note: The gaming basket initially included Tencent, Netease and Shanda Interactive. We added Perfect World on 1
Aug 2007 and Changyou on 8 Apr 2009. The media basket started with Baidu, Sina, Sohu and Focus Media, Alibaba
and AirMedia were added to the basket on 12 and 13 Nov 2007, respectively.
Source: Nomura research
In the above exhibit, using 1 January, 2007 as the base day, we can see that a
positive RPI indicates a better performance of the gaming sector compared with the
media sector, and vice-versa. The trough and peak on the curve show the possibility
that investors switched between the two sectors, instead of sticking to one of them.
The RPI reached its peak in 3Q09 and started to trend down in 4Q09, largely in line
with the time that gaming companies delayed their games. For instance, as early as in
July 2009, Changyou’s management was already talking about delaying Duke of
Mount Deer (DMD) in the 2Q09 financial results conference call. This chart indicates
that we may be nearing the trough of the gaming downturn (or the upcycle in media)
and hence, we would advise investors to pay closer attention to gaming names in the
near future.
Exhibit 123. Macau: gaming revenue Exhibit 124. Macau: total visitor arrivals
(MOP bn) Mass (LHS) VIP (LHS) (%) ('000) Total Visitor Arrivals (%)
300 60 3,500 y-y % 35
Slot (LHS) y-y % (RHS) 30
250 50 3,000
25
2,500 20
200 40 15
2,000 10
150 30 5
1,500 4
0
100 20 1,000 (5)
(10)
50 10 500
(15)
0 0 % 0 (20)
May-08
May-09
May-10
Mar-08
Nov-08
Mar-09
Nov-09
Mar-10
Jan-08
Jul-08
Sep-08
Jan-09
Jul-09
Sep-09
Jan-10
Jul-10
Sep-10
2004
2005
2006
2007
2008
2009
2010F
2011F
Exhibit 125. Macau: gaming table supply Exhibit 126. Macau: overall gaming revenue market
share (Oct 2010)
2006
2007
2008
2009
2010F
2011F
2012F
14%
Since the introduction of the pricing mechanism at end-2008, the NDRC followed the
mechanism strictly in 1H09 but then found that margins were extremely high. Since
1H09, margins have fallen and prices are now in line with regional levels, indicating the
government has already reset prices from the initially high levels. Going forward, we
believe margins are likely to be in line with regional levels and price changes will take
into consideration regional product prices rather than just crude oil prices.
Our view is that the government is unlikely to let the refiners incur losses, since losses
would deter future investment in the sector, which would ultimately lead to a shortage
in the system. However, we think it is unlikely that the government will allow windfall
profits, such as those in 1H09, especially in light of the inflationary environment. We
think the government will probably lower the VAT burden on the refiners and allow a
narrow margin that moves more in line with international prices.
On our reading, future product price hikes will be beneficial to Sinopec, Shanghai Pet,
Petrochina and Kunlun Energy. Even though Kunlun Energy is not a refiner, CNG
prices are linked to gasoline prices at a ratio of 1:0.75.
Exhibit 128. Oil price charts Exhibit 129. Nomura price forecasts
70 70 80
60
60 60
40
50 50 20
May-10
Nov-09
Mar-10
Nov-10
Dec-09
Feb-10
Apr-10
Jul-10
Aug-10
Sep-10
Oct-10
Jan-08
Apr-08
Jul-08
Oct-08
Jan-09
Apr-09
Jul-09
Oct-09
Jan-10
Apr-10
Jul-10
Oct-10
Jan-11
Apr-11
Jul-11
Oct-11
Jan-12
Apr-12
Jul-12
Oct-12
Source: Datastream Source: Nomura estimates
Exhibit 132. Asia Pacific petrochemical product margin trends & forecast
(US$/tonne) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010F 2011F 2012F
Ethylene-Naphtha 242 177 186 512 419 554 452 346 287 380 360 420
LDPE-Naphtha 412 351 393 718 631 645 733 740 584 600 540 660
HDPE-Naphtha 368 285 325 555 535 629 603 582 521 440 410 540
Propylene-Naphtha 201 219 279 434 456 518 392 371 343 460 400 460
PP-Naphtha 319 331 414 570 568 641 616 593 481 520 480 580
AN-Propylene 259 179 294 301 401 405 670 633 336 880 840 900
Butadiene-Naphtha 164 324 423 566 733 770 367 1,274 445 1,100 1,200 1,250
Benzene-Naphtha 93 114 171 445 338 303 337 167 136 200 220 240
SM-Naphtha 291 377 415 660 646 610 578 469 396 460 520 600
PS-SM 111 63 94 138 39 56 156 94 97 110 100 110
ABS-Naphtha 645 563 644 903 922 946 1,002 1,014 796 1,100 1,150 1,080
Phenol-Naphtha 310 332 409 752 559 597 869 558 300 800 750 780
BPA-Phenol 515 227 270 225 525 235 178 282 418 350 400 375
PVC-Ethylene 274 338 382 432 362 246 360 428 355 400 440 430
MEG-Ethylene 174 176 374 380 318 169 421 252 125 160 260 300
PX-Naphtha 228 186 336 431 419 577 440 340 432 300 350 400
PTA - Naphtha 247 252 293 388 325 317 182 55 275 230 270 250
Source: Thomson Reuters Datastream, Nomura estimates
Retail BULLISH
Action Stocks for action
We remain positive on China’s retail growth outlook in 2011F on rapid urbanisation, Gome is our top pick for the next 12
a young population and rising income. Mild inflation should be positive for retailers’ months. We expect margins to
ASP increases. Among all retail formats, we believe electronic retailers are most continue to improve in FY11F, which
geared to increasing demand from low-income groups and department stores are will be the key for earnings upside
well positioned to capitalise on the consumption upgrade trend. Valuations appear revisions, in our view.
fair and earnings upside revisions are key catalysts. Gome remains our top BUY.
Exhibit 134. Propensity to consume by income level Exhibit 135. Household consumption basket
(2008)
1.2 Services
30 Goods
1.0
0.8 15
0.6
0
0.4
T&C
REC
Food
Insurance
Residence
Healthcare
Clothing
Others
Financial
applicances
Home
0.2
0.0
Low L middle Middle U middle High
Source: CEIC, World Bank, Nomura research Source: CEIC, World Bank, Nomura research
We believe electronic retailers like Gome will continue to benefit the most from the
government policy to adjust the income distribution system. 2010 has been a fruitful
year, as the direct stimulus policy (rural subsidy/old for new programme) greatly
promoted the sales growth of electronic retailers. We expect rising minimum wages to
further drive up demand in a more sustainable manner. With additional disposable
income, rural households have a higher propensity to consume than their urban
counterparts, particularly in the case of low-income households.
To tap into the increasing demand from low-income groups, we believe electronic
retailers will further expand to third and fourth tier cities. As at end-3Q10, Suning
owned 95 county/town level stores out of 1,206 stores; Gome has announced plans to
focus more on lower-tier cities, where 3Q saw better SSS than first-tier cities.
Nevertheless, operating expense remains key as building logistics and winning
customer loyalty in a new market normally necessitate high initial costs.
For electronic retailers, product mix upgrades and operating efficiency improvement
will be key factors to sustain long-term growth, in our view. With its store-closure
programme largely done, Gome launched 185 projects during 3Q10 to optimise the
operation of its 185 stores in tier-2 markets. Margin upside could come from good
execution of such projects.
We believe department stores are well positioned to benefit from the consumption
upgrade trend. They are good proxies for the fashion/luxury segments in China, as
cosmetics, apparel, footwear and jewellery account for more than 70% of their total
sales, on our estimates. All department stores under our coverage target mid-high end
markets. As the economy grows, more people will fall into the middle class, their key
customers.
Benefiting from rising income and city expansion, department stores are now entering
a rapid expansion phase. Regional department stores are embarking on cross-regional
expansion, while national department stores are deepening their market penetration to
improve economies of scale. For example, PCD is expanding store GFA at a 37.7%
CAGR over FY10-12F, with self-operated stores targeted to double to 18 by end-
FY12F from 9 at end-FY09.
We think acquisitions could be key for earnings upside in 2011F. PCD and NWDS
have relatively good visibility on their pipeline of store acquisitions from their parent
companies and/(or) third parties. The possibility of Maoye and Intime making
acquisitions also appears higher than peers, given balance sheet improvements after
recent fund raisings and continued efforts to dispose non-core assets.
While concern over China’s inflation has escalated, we believe the retail sector outlook
remains positive. Unlike early 2008, when high inflation and decelerating income
growth resulted in a sharp consumption slowdown, the current situation seems less
challenging. In our view, with increasing disposable household income, consumption
growth can still be healthy.
Nomura economists expect CPI of 3.6% in 2011, which is benign for consumption
growth. China’s State Council has pledged to make more efforts to stabilise commodity
prices (‘price control’). While this may cloud investor sentiment, we believe retailers are
less affected then staple companies, as prices of apparel, appliances, etc are less
likely to be controlled.
May-10
Mar-09
Mar-10
Nov-09
Dec-09
Jan-09
Feb-09
Apr-09
Jun-09
Jul-09
Aug-09
Sep-09
Oct-09
Jan-10
Feb-10
Apr-10
Jun-10
Jul-10
Aug-10
Sep-10
Oct-10
(6)
1H09 2H09 1Q10 2Q10 3Q10
On average, retailers outperformed the Hang Seng Index by 10.0% and 43.3% in the
past 6 and 12 months, respectively. We believe the outperformance of the department
store sector is largely due to valuations in tandem with the market rally and solid
fundamentals, which have held up better than the market had expected.
The sector is trading at 21x FY11 P/E, or 1x PEG. Valuation multiples seem fair for the
next 12-months. We believe earnings upside revisions will be key share price catalysts.
We favour companies with turnaround potential and accelerating earnings growth and
have BUYS on Gome, PCD, Parkson, NWDS, Belle, Ports, Li Ning and Ctrip.
Gome is our top pick for the next 12 months. We think the worst is over for the
company with regard to conflicts between the ex-Chairman and existing Chairman.
We expect margins will continue to improve in the next 12 months given the product
mix upgrade and sales efficiency improvement. This will be the key for earnings upside
revisions in our view. We expect store expansion and SSS to be earnings drivers
beyond FY12, in line with the company’s 5-year plan.
Bulk shipping –
BULLISH
and will decline into 2011F, leading to weaker earnings. We are Bullish on drybulk Sinotrans (368 HK) BUY 2.98 4.60
CSCL (2866 HK) REDUCE 3.13 2.05
shipping (for now) as we see seasonally stronger 4Q and earnings improvement in
OOIL (316 HK) NEUTRAL 76.90 61.80
2011F. However, we note that drybulk supply is an increasing concern. Pricing as of 1 Dec. 2010
While container freight rates have already begun to decline 10% from the peak in
end-August (according to data from the Shanghai Shipping Exchange), we expect
this trend to continue into 1H11F. Further, margins are set to be further eroded
from high oil prices, as we expect the average Brent oil price to increase 14% to
US$95/bbl in 2011F. While idled capacity could help ease the oversupply, we
believe idled capacity is unlikely to reach the last peak (12% in December 2009),
give the overall sector is profitable this year while newbuilding delivery slippages is
likely to slow. We maintain a Bearish view on the sector and estimate freight rates to
decline 5% in 2011F.
Exhibit 141. Global bulk shipping demand, supply and freight rates
2002 2003 2004 2005 2006 2007 2008 2009 2010F 2011F 2012F
Nominal supply growth (%) 2.7 2.5 6.8 7.0 6.8 6.5 6.6 9.8 8.7 8.0 6.9
Global demand growth (%) 1.6 6.8 8.4 8.8 7.7 7.0 2.3 (4.0) 8.2 7.3 7.1
+/- balance (%) (1.1) 4.4 1.6 1.8 1.0 0.5 (4.3) (13.8) (0.5) (0.7) 0.2
Baltic Drybulk Index 1,145 2,626 4,515 3,353 3,197 7,088 6,355 2,623 3,436 3,436 3,891
Change (% y-y) (6) 129 72 (26) (5) 122 (10) (59) 31 0 13
Source: Containerisation International, Nomura estimates
Exhibit 142. Global container shipping demand, supply and freight rates
2002 2003 2004 2005 2006 2007 2008 2009 2010F 2011F 2012F
Global demand growth (%) 11.7 14.3 14.8 10.0 10.8 12.7 5.3 (9.9) 11.5 7.2 8.3
Nominal supply growth (%) 10.5 8.9 9.7 13.1 16.6 13.7 12.9 6.3 8.6 9.0 6.1
+/- balance (%) 1.2 5.4 5.0 (3.1) (5.8) (1.1) (7.6) (16.2) 2.9 (1.8) 2.1
Head-haul rates (avg. annual) 1,340 1,663 1,821 1,822 1,610 1,755 1,856 1,251 1,693 1,605 1,667
Change (% y-y) (13.2) 24.2 9.5 0.0 (11.6) 9.0 5.8 (32.6) 35.3 (5.2) 3.9
Source: Containerisation International, Nomura estimates
Exhibit 143. Drybulk shipping P/BV and ROE Exhibit 144. Drybulk shipping index and BDI
(x) Price to Book (LHS) (%) (Rebased 100) Nomura drybulk index (LHS)
ROE (RHS) 9,000 BDI (RHS) 14,000
7 70
8,000 12,000
6 60
7,000
50 10,000
5 6,000
40
5,000 8,000
4 30
4,000 6,000
3 20
3,000
10 4,000
2 2,000
0 2,000
1
1,000
(10)
0 0
0 (20)
Dec-10
Dec-00
Dec-01
Dec-02
Dec-03
Dec-04
Dec-06
Dec-07
Dec-08
Dec-09
Dec-05
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Source: Thomson Reuters Datastream, Nomura estimates Source: Thomsone Reuters Datastream, Nomura estimates
Exhibit 145. Container shipping P/BV and ROE – Exhibit 146. Container shipping index and overall
bearish sector view as ROE declining in 2011 container freight rates
May-08
Nov-02
Nov-06
Mar-09
Dec-98
Oct-99
Jul-00
Feb-02
Sep-03
Jun-04
Apr-05
Jan-06
Aug-07
Dec-09
Oct-10
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Source: Thomson Reuters Datastream, Nomura estimates Source: Thomson Reuters Datastream, Nomura estimates
Steel BULLISH
Action Stocks for action
We believe steel prices will be range-bound through 4Q10F, with short supply from Angang looks best positioned in our
power rationing and slowing demand towards year-end. We expect China steel China/Taiwan steel space, given its semi-
production to slow in 2011F, given the increasing focus on environmental integration to iron ore. China Steel, a low-
protection. We remain selectively positive on the China/Taiwan steel sector, with beta steel stock, tends to outperform peers
BUYs on Angang and China Steel, and NEUTRALs on Baosteel and Maanshan. when the steel cycle turns.
Catalysts
Price
Steel demand growth, steel price movements, government policy changes, interest Stock Rating Price target
rate changes and changes in raw material prices. Angang BUY HK$11.34 HK$16.00
(347 HK)
Anchor themes China Steel BUY NT$31.35 NT$37.0
(2002 TT)
Steel equities in China/Taiwan will likely see range-trading, as iron ore spot prices Baosteel NEUTRAL RMB6.29 RMB7.00
(600019 CH)
tend to move in tandem with steel prices. A major boost to steel makers’ margins is
unlikely if iron ore contract prices are reviewed on a monthly basis, as is being Pricing as of 1 December, 2010; local currency
On the cost front, the floating pricing system has taken away the inventory gains that
the steel industry used to enjoy. As it is likely to continue to be a seller’s market for iron
ore in 2011F, we believe steel mills with mining assets will gain a cost advantage
amidst spiralling iron ore prices.
That said, our top pick in our China steel universe remains Angang, for its semi-
integration to iron ore and strength in flat steel making. We also like China Steel, for its
low share-price volatility and stable dividend payout ratio. On the other hand, we
remain NEUTRAL on Baosteel and Maanshan, given: 1) Maanshan’s weak execution
and 2) Baosteel’s mixed product outlook.
Exhibit 147. Hot-rolled coil (HRC) prices, since 2004 Exhibit 148. Rebar prices, since 2004
(RMB/t) (RMB/t)
8,000 Current price=4,532 6,000 Rebar
Average price=4,354 HRC Current price=4,547
6,000 Average price=3,747
4,000
4,000
2,000
2,000
0 0
Jul-06
Jul-09
Jul-07
Jul-08
Jul-05
Jan-06
Jan-07
Jan-08
Jul-04
Jan-09
Jul-10
Jan-04
Jan-05
Jan-10
Jul-10
Jul-06
Jul-09
Jul-04
Jul-05
Jul-07
Jul-08
Jan-10
Jan-04
Jan-06
Jan-07
Jan-08
Jan-09
Jan-05
Investment summary
For China Unicom, we expect the company to continue benefitting from 3G net adds Our order of preference is China
(at relatively higher ARPU), outnumbering its 2G net adds. For China Mobile, we Unicom > China Mobile > China
Telecom
expect the company to benefit from: 1) inclusion of SPDB’s earnings; and 2) a
passionate and energetic CEO taking the driver’s seat. We expect consensus
estimates to rise to reflect the improving fundamentals.
At China Unicom, more visible 3G enhancing effect on blended ARPU. For With 3G monthly net adds
FY09, China Unicom’s 3G and 2G subscriber ARPU figures were RMB142 and outnumbering its 2G monthly net
adds, we expect Unicom’s
RMB41, respectively. We see two key drivers for Unicom’s blended ARPU: 1) 3G
blended ARPU to keep rising
ARPU; and 2) 3G subscriber additions. In our sensitivity exercise (shown below),
we assume 2G ARPU will stay at RMB40 and 2G monthly net adds will remain flat
at 0.7mn. Our sensitivity analysis suggests that a 3G ARPU of RMB120 and 3G net
adds of 10mn imply a blended ARPU of RMB48.1 for FY11F (FY08: RMB41.6) for
Unicom. Even if 3G ARPU is at RMB60 and 3G net adds for FY11F is 8mn, then
the blended ARPU of China Unicom could still be about RMB41.90.
Exhibit 149. Sensitivity analysis of blended ARPU to 3G ARPU and 3G subscriber base
3G net adds ARPU of 3G service (RMB)
(mn) 60 70 80 90 100 110 120 130 140 150 160
8 41.9 42.9 43.8 44.8 45.8 46.7 47.7 48.6 49.6 50.6 51.5
9 42.0 43.0 43.9 44.9 45.9 46.9 47.9 48.9 49.9 50.8 51.8
10 42.0 43.0 44.0 45.1 46.1 47.1 48.1 49.1 50.1 51.1 52.1
11 42.1 43.1 44.1 45.2 46.2 47.3 48.3 49.3 50.4 51.4 52.4
12 42.1 43.2 44.2 45.3 46.4 47.4 48.5 49.6 50.6 51.7 52.7
13 42.2 43.3 44.3 45.4 46.5 47.6 48.7 49.8 50.9 52.0 53.0
14 42.2 43.3 44.5 45.6 46.7 47.8 48.9 50.0 51.1 52.2 53.4
15 42.3 43.4 44.5 45.7 46.8 48.0 49.1 50.2 51.4 52.5 53.6
Source: Nomura estimates
Revenue and earnings growth rates for Chinese telecom operators have Earnings growth tends to
tended to rise significantly in the year when a new CEO assumes his position. accelerate with the appointment
If history repeats itself, we may see higher earnings growth at China Mobile of a new CEO (this has been the
case in the past 13 years for
in FY11F. In the following exhibit, we look at: 1) revenue y-y growth in the year Chinese telecom operators)
before and the year after a new CEO’s appointment and 2) net profit y-y growth for
the corresponding years. Our study suggests that in 40% of these cases, revenue
growth accelerated. Even more importantly, in every case, earnings growth
accelerated. If history repeats itself, we believe China Mobile’s FY11F earnings
growth will be higher than in FY10F.
(RMB$bn)
450 Wireline Cable Mobile
400
350
300
250
200
150
100
50
0
2004 2005 2006 2007 2008 2009 2010F 2011F 2012F
IT software
(10%)
Note: Percentage indicates vendors’ share of addressable market within operators’ capex. Rest of spending includes IT hardware (5%) and other (15%)
Source: Nomura research
Exhibit 153. Monthly net-add of 3G subscribers in Exhibit 154. Major entry-level smartphones
China
Model U8150 Ideos ZTE X850
(k subs) China Mobile Photo
5,000 China Unicom
4,500 China Telecom
4,000
3,500
3,000
2,500
2,000 Vendor Huawei ZTE
Screen 2.8 inch QVGA capacitive 2.8inch QVGA
1,500 touch Resistive touch
1,000 Communication GSM/HSPA GSM/HSPA
500 standard
0 OS Android 2.1 Android 2.1
CPU n.a. Qualcomm MSM 7227
May-10
Mar-10
Jan-10
Feb-10
Apr-10
Jun-10
Jul-10
Aug-10
Sep-10
Oct-10
Transport BULLISH
Action Stocks for action
We remain bullish on various Chinese transport segments. We see continued Our top picks are CEA for airlines,
strong China domestic demand incrementally driving growth for Chinese transport Jiangsu Exp for expressways,
players versus regional peers. Our top picks are Jiangsu Exp for expressways, Cosco Pacific for ports, and BCIA for
Cosco Pacific for ports, China Eastern Airlines for airlines and Beijing Capital airports.
International Airport for airports.
Catalysts
Price
With recent confirmation on sustained strong volumes and/or yield numbers in Stock Rating Price target
October 2010, full-year 2010F results may surprise on the upside. Jiangsu Expressway
(177 HK) BUY 8.57 11.95
Cosco Pacific
Anchor themes (1199 HK) BUY 12.34 15.50
China Eastern Airlines
Strong domestic demand has helped Chinese transport stocks weather the global (670 HK) BUY 4.54 5.90
economic downturn better than most regional peers. We see this trend continuing BCIA (694 HK) BUY 4.18 5.85
for the foreseeable future. Note: local currency, pricing as of 1 Dec, 2010
coming down in 2012F. Given the strong competition posed by railways (set to
intensify from 2012F onwards) and likely higher oil price (coupled with reduced oil
hedging exposure), net profit for Chinese airlines is likely to edge lower in 2012F.
We call BUY on CEA (M&A play) and CSA (1055 HK, domestic growth and
renminbi appreciation), and NETURAL on Air China (753 HK, stable growth).
utilities) and climate change (Asia renewable energy). Trina Solar (TSL US) BUY 22.32 36.00
* PT under review with upward bias. # PT under review
with downward bias
Anchor themes Pricing as of 1 Dec 2010
Climate change, water shortages, rising commodity prices, relief of gas supply
shortages. Risks: rising interest rates and fuel costs, and tariff cap
Due to the prevailing high inflation, while many IPPs have been loss making since
3Q10, the pressing tariff hike is likely to be delayed to early next year when CPI
inflation falls below 3% and when the 2011 contract coal price negotiation finishes.
Also, we hold the view that even though there is a tariff hike, coal is the ultimate winner.
This is because a higher contract coal price increase will likely be proposed in the next
round of price negotiation given the prevailing 30% plus discount on the contract coal
price to the spot price. In 2011, we expect the contract coal price to rise by 8% y-y. In
addition, with the high gearing of the China IPPs, ranging from 114% to 607%, the
expected 1% rise in interest rate in 2011 will negatively impact the IPPs’ bottom line.
Therefore, though IPPs can benefit from strong power demand growth (9.8% in 2011,
we estimate), there margins will be reduced dramatically in 2011 given that utilization
is the least earnings sensitive factor.
Also, due to the lack of a proper fuel cost pass through policy, any tariff hike can be
viewed as a short term positive and an opportunity to take profit. And last but not least,
in the 12th five year plan, Beijing’s determination to reduce energy intensity and to
create a low carbon economy do not bold well for IPPs.
Having said that, we believe a sector rerating is possible and is contingent on the
implementation of a “power pooling” system. However, this is likely to happen in 3-4
years’ time, ie 2013-14, given the current government would not carry out a big reform
close to the end of their term and the three preconditions of power pooling (sufficient
power capacity, 5 well-connected regional power grids, and an energy bureau) are
expected to be ready by that time, in our view. Therefore, without power pooling in
place, we maintain our neutral view on the China IPPs. We dislike the sector; China
Resources Power (836 HK, Buy) is our only BUY. We believe China Resources
Power’s ROE spread over peers will expand amid market turbulence, given its superior
cost control and lucrative coal portfolio.
be flowing to China to fulfil the strong gas demand; 3) neutral impact from any potential
gas pricing adjustments; and 4) more mid-to-large sized project M&A in the next few
years.
Besides the favourable gas demand/supply matrix, we also see limited macro
headwinds to the gas distribution sector. Based on the gas pricing history, any
wellhead price hike would be followed by an end user price hike. As such, despite the
concern on high CPI in the coming year, we believe the gas companies should be at
least be able to maintain their absolute dollar margin. For interest rate hike risk, we
estimate the impact to the gas distributors (except for China Gas Holdings) is limited,
given their low gearing ratios.
In our coverage universe, China Resources Gas (1193 HK, Buy) and Beijing
Enterprises (392 HK, Buy) are our top picks, given their potential to secure new
projects in the coming years and be the market consolidators in the long term. We do
not like China Gas Holdings (384 HK, Reduce), due to its exposure to the volatile LPG
business, option dilution risks and the high gearing.
China coal (Bullish): strong coal demand vs. short-term tight supply
We are long term fundamentally positive on the China coal sector given the strong
pricing power and sustainable demand growth. We see the balanced-to-tight supply/
demand outlook leading to a higher coal price over the next two years. The strong
GDP growth, rising power, steel and cement consumptions drive up coal demand;
while industry consolidation and transportation bottlenecks (to be eased in 2014F) will
cause short-term supply tightness. Given the large spot-to-contract price gap and
demand/supply outlook, we expect the contract price to rise by 8% y-y, and the spot
price to rise by 3% y-y in 2011F, with a stronger spot price in 4Q10-1Q11 due to winter
(cold) restocking.
Although the near-term outlook is clouded by NDRC's policy intervention, we expect
strong spot coal prices going into year-end and 1Q11, due to winter (cold) restocking,
lapse of power rationing to high energy-insensitive industries (steel and cement) and
potential positive news on volume and pricing during Jan contract coal price
negotiations.
We like China Shenhua (1088 HK, Buy), given: 1) its vertically integrated business
model which allows it to enhance third-party coal purchases and sales volumes, 2) it is
a major beneficiary of the contract coal price increase in 2011F, 3) its improving sales-
mix (to more spot) will drive up ASP and margin, and 4) its high production growth,
driven by existing mines upgrades, greenfield projects and potential parent injection.
Risks are a high CPI leading to government pressures on the 2011 contract price and
a potential 5% resources tax; extreme weather causing seasonal tightness. We hold
the view that any potential resource tax or electricity tariff hike will be imposed post the
determination of the 2011 contract coal price, likely in January, given the CPI inflation
pressure. Also, the net impact from a centralized resources tax should be minimal
given a number of other local levies and taxes will be eliminated.
CAGR. We believe that the Chinese wind industry could surpass this target and we
remain confident about the clear visibility into wind demand growth in China.
Nonetheless, we adopt a more selective approach on stock picks and prefer
equipment/component manufacturers that can start meaningful overseas sales and
sustain a high earnings growth profile. We retain our conservative stance on wind
turbine manufacturers and wind farm operators (Longyuan [916 HK, Reduce]) due to
downward tariff pressure, falling turbine prices, uncertainty on CDM, grid connection
bottleneck and increasing competition. Our top pick is China High Speed Transmission
(CHST, 658 HK, Buy).
Property BULLISH
Action Stocks for action
We believe the best time to enter China’s property sector will be in late-December We continue to like stocks with: 1) less
2010, as we expect transaction volume, as a share price indicator, to stabilise 2-3 exposure to overheated cities; 2) strong
months after the new round of tightening in late-September 2010. Trading at an balance sheets; and 3) high earning
average discount of 35% to our 12M forward NAV estimates, the sector looks visibility. Our top BUYs are COLI, Agile
attractively valued. We turn Bullish on the China property sector for 2011F. and KWG.
Catalysts Local Price
Stock Rating price target
Developers (under Nomura’s coverage) are likely to hit sales targets for 2010F and Agile (3383 HK) BUY 11.10 13.29
this should help to pare gearing. COLI (688 HK) BUY 15.36 21.00
CRL (1109 HK) REDUCE 14.18 14.87
Anchor themes Country Gdn (2007 HK) NEUTRAL 2.91 2.78
GZ R&F (2777 HK) REDUCE 10.88 9.98
We expect less aggressive policy measures in 2011F, with most of the impact from KWG (1813 HK) BUY 6.10 7.52
more frequently discussed measures, such as property tax and enforcement of LAT Poly (HK) (119 HK) BUY 7.36 9.98
Shimao (813 HK) BUY 12.06 15.39
largely priced in. Fundamental demand should continue to drive transaction
Sino-Ocean (3377 HK) NEUTRAL 4.75 5.30
volumes and annualised ASP is likely to continue to climb. Pricing as of 1 December, 2010; local currency
Source: Bloomberg, Company data, Nomura estimates; Note: Ratings and Price Targets are as of the date of the most recently published
report(http://www.Nomura.com) rather than the date of this document
20
15
10
(5)
May-06
May-07
May-08
May-09
May-10
Nov-05
Mar-06
Nov-06
Mar-07
Nov-07
Mar-08
Nov-08
Mar-09
Nov-09
Mar-10
Jul-05
Sep-05
Jan-06
Jul-06
Sep-06
Jan-07
Jul-07
Sep-07
Jan-08
Jul-08
Sep-08
Jan-09
Jul-09
Sep-09
Jan-10
Jul-10
Sep-10
Source: CEIC, Nomura research
Exhibit 157. China property share performance vs interest rate and RRR hike Raising interest rate and RRR
does not have a significant
Share performances (LHS) (%) impact on share performance
2,000 Lending rate: over 5 yrs (RHS) 20
Required Reserve Ratio (RHS)
1,500 16
1,000 12
500 8
0 4
Jan-04
Apr-04
Jul-04
Oct-04
Jan-05
Apr-05
Jul-05
Oct-05
Jan-06
Apr-06
Jul-06
Oct-06
Jan-07
Apr-07
Jul-07
Oct-07
Jan-08
Apr-08
Jul-08
Oct-08
Jan-09
Apr-09
Jul-09
Oct-09
Jan-10
Apr-10
Jul-10
Oct-10
Exhibit 158. China property: supply and demand forecast We expect 2011F transaction
volume to increase by 4% y-y in
2007 2008 2009 2010F 2011F the private housing market
Starts in ‘000 sqm
Total residential starts 787,955 836,421 932,984 1,288,777 1,546,532
Growth rate (% y-y) 22 6 12 38 20
Private housing 739,852 780,203 879,438 1,216,777 1,354,532
Growth rate (% y-y) 23 5 13 38 11
Economic housing 48,103 56,219 53,547 72,000 192,000
Growth rate (% y-y) 10 17 (5) 34 167
Available for sale in 000 sqm
Total residential available for sales 971,052 1,090,581 1,257,503 1,420,292 1,850,305
Growth rate (% y-y) 11 12 15 13 30
Private housing 930,807 1,052,766 1,222,310 1,367,324 1,734,214
Growth rate (% y-y) 12 13 16 12 27
Economic housing 40,245 37,815 35,192 52,968 116,092
Growth rate (% y-y) 2 (6) (7) 51 119
Sales in 000 sqm
Total residential sales 701,359 592,804 861,849 844,107 939,215
Growth rate (% y-y) 27 (15) 45 (2) 11
Private housing 666,284 556,531 831,260 799,084 828,928
Growth rate (% y-y) 28 (16) 49 (4) 4
Economic housing 35,075 36,273 30,589 45,023 110,287
Growth rate (% y-y) 5 3 (16) 47 145
4,000 15
3,500 10
3,000 5
2,500 0
2,000 (5)
2005 2006 2007 2008 2009 2010F 2011F
Exhibit 160. Developers’ gearing ratio comparison Gearing is still high but
manageable
(%)
2009 2010F 2011F
120
100
80
60
40
20
0
Poly (HK)
Country
Agile
CRL
Ocean
GZ R&F
COLI
Shimao
KWG
Garden
Land
Sino
(20)
Stock picks
With relatively low gearing (we forecast 53% at year end), high FY11F earnings Price target HK$13.29
(set on 5 Nov 10)
visibility (43% already secured) and attractive valuation (42% discount to NAV), we
Upside/downside 19.7%
see strong upside potential for Agile. We expect Hainan sales to continue to Difference from consensus 15.1%
surprise the market. We reiterate BUY and retain Agile as a top sector pick.
FY11F net profit (RMBmn) 4,409
Catalysts Difference from consensus 31.4%
Source: Nomura
We believe the stock will gradually be rewarded for its steady operations in
traditional markets. Street estimates will likely be revised up in the next six months.
Nomura vs consensus
Anchor themes
We are optimistic that the company can
We expect less aggressive policy measures in 2011F, with most of the impact from beat its own sales target for FY10F and
more frequently discussed measures such as property tax and enforcement of LAT comfortably achieve our higher-than-
largely priced in. Fundamental demand should continue to drive transaction consensus revenue estimate.
volumes and annualised ASP is likely to continue to climb.
Ample capacity for more land acquisitions Reported net profit 1,865 6,052 4,409 5,147
Normalised net profit 1,728 3,562 4,409 5,147
Agile looks set to exceed its own contract sales target of RMB24.7bn Normalised EPS (RMB) 0.48 1.01 1.27 1.48
for FY10F, with RMB22.6bn already achieved in the first 10 months of Norm. EPS growth (%) 51.1 109.8 26.1 16.7
Norm. P/E (x) 20.4 9.7 7.7 6.6
the year. We estimate net gearing will revert to around 53% levels by
EV/EBITDA (x) 11.2 5.5 4.9 4.2
year end if the company can achieve RMB26.9bn in sales this year. Price/book (x) 2.5 1.7 1.5 1.3
The company should have ample capacity for further land acquisitions Dividend yield (%) 1.6 3.7 4.6 5.3
RO E (%) 13.8 36.0 20.9 21.0
should the opportunity arise.
Gearing (% ) 27.3 24.9 21.8 20.9
Earnings surprise a key catalyst Earnings revisions
Previous norm. net profit 3,562 4,409 5,147
We believe the street has underestimated Agile’s FY10-11F earnings. Change from previous (%) - - -
Looking at the strong contract sales achieved so far, Agile has Previous norm. EPS (RMB) 1.01 1.27 1.48
secured 100% and 43% of our above-consensus FY10-11F sales Source: Company, Nomura estimates
Mar10
Apr10
May10
J un10
Oct10
Nov10
Dec09
Jan10
J ul10
Aug10
Sep10
Eastern China who prefer to have holiday homes away from the cold
1m 3m 6m
winter. Some 70-80% of buyers have purchased flats without
Absolute (HK$) 6.9 21.4 39.4
mortgages, making sales less vulnerable to the current policies. Absolute (US$) 6.7 21.6 39.9
Relative to Index 11.3 12.3 24.7
42% discount to NAV – attractive valuation Market c ap (US$mn) 4,963
Agile shares are trading at a 42% discount to our end-FY11F NAV Estimated free float (%) 36.1
52-week range (HK$) 13.22/7.47
estimate and 7.7x FY11F P/E. We see room for NAV upgrades later 3-mth avg daily turnover (US$mn) 21.77
stemming from new acquisitions and our valuation of the Hainan Stock borrowability Easy
project is very conservative. Our end-FY11F PT is based on a 30% Major shareholders (%)
Chan Cheuk Yin 61.7
discount to our end-FY11F NAV estimates of HK$18.99. Risks to our
PT include weaker-than-expected property sales and further Source: Company, Nomura estimates
tightening measures applied to the property sector.
Drilling down
We also expect decent net margin improvement in 2010 -11. Revenue booked in 1H10
was mainly from sales in rather tough markets in FY09, with the ASP for booked
revenue only at RMB8,122psm. Unrecognised revenue as of end-FY09 amounted to
RMB9.5bn, with an ASP of RMB11,585psm, so the margin on those sales not yet
booked should be considerably higher than in 1H10. Also, we expect the next batch of
Hainan sales to be booked in 2H10F (with an estimated ASP of more than
RMB20,000psm) to fetch net margins of ~26%, giving a boost to overall margins. We
estimate around 25% of revenue booked in FY10F will come from Hainan.
Exhibit 162. Agile: NAV discount Exhibit 163. Agile: FY11F NAV forecast
HK$/ % of total
0.6
(RMBmn) share assets
0.4 Dev. prop/under dev’t
Residential 60,711 19.93 86.0
0.2
Commercial 331 0.11 0.5
0.0 Inv. prop/under dev’t
Office 1,345 0.44 1.9
(0.2)
Retail 1,509 0.50 2.1
(0.4) Hotel prop under dev’t 6,659 2.19 9.4
(0.6) Average: -29% Net debt (incl. land premium) (12,714) (4.17)
Total net asset 57,840
(0.8) NAV/share 18.99
(1.0) Source: Nomura research
06 07 08 09 10
Financial statements
Income statement (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Investment properties - - - 153 245
Property development 9,094 13,058 20,490 26,743 35,223
Hotels/serviced apartments 29 40 88 348 578
Other Revenue 203 233 279 335 402
Revenue 9,326 13,331 20,857 27,579 36,448
EBIT contributions
Investment properties - - - 99 159
Property development 2,405 3,582 8,421 9,582 10,734
Hotels/serviced apartments (7) (15) 1 2 2
Other income - - - - -
Management expenses (126) (36) (378) (375) (371)
EBITDA 2,302 3,579 8,092 9,356 10,572
Depreciation and amortisation (31) (48) (48) (48) (48)
EBIT 2,272 3,531 8,044 9,309 10,525
Net interest expense (103) (9) (259) (210) (147)
Associates & JCEs - - - 151 249
Other income 180 4 45 - (0)
Earnings before tax 2,348 3,526 7,830 9,250 10,626
Income tax (1,172) (1,661) (3,759) (4,151) (4,611)
Net profit after tax 1,176 1,865 4,070 5,099 6,016
Minority interests 9 (137) (508) (690) (869)
Other items
Preferred dividends
Normalised NPAT 1,186 1,728 3,562 4,409 5,147
Extraordinary items 4,281 137 2,490 - -
Reported NPAT 5,467 1,865 6,052 4,409 5,147
Dividends (1,089) (560) (1,247) (1,543) (1,801)
Transfer to reserves 4,377 1,306 4,805 2,866 3,345
Growth (%)
Revenue (9.6) 42.9 56.5 32.2 32.2
EBITDA (48.9) 55.4 126.1 15.6 13.0
EBIT (49.4) 55.4 127.8 15.7 13.1
Normalised EPS (43.5) 51.1 109.8 26.1 16.7
Normalised FDEPS (43.5) 51.1 109.8 26.1 16.7
Per share
Reported EPS (RMB) 1.46 0.52 1.71 1.27 1.48
Norm EPS (RMB) 0.32 0.48 1.01 1.27 1.48
Fully diluted norm EPS (RMB) 0.32 0.48 1.01 1.27 1.48
Book value per share (RMB) 3.50 3.90 5.63 6.53 7.57
DPS (RMB) 0.30 0.16 0.36 0.44 0.52
Source: Nomura es timates
Cashflow (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
EBITDA 2,302 3,579 8,092 9,356 10,572
Change in working capital (3,852) 3,171 774 819 (1,933)
Other operating cashflow (1,072) (3,822) (6,902) (4,439) (4,851)
Cashflow from operations (2,622) 2,928 1,964 5,737 3,788
Capital expenditure (157) (354) (5,145) (4,710) (1,000)
Free cashflow (2,779) 2,575 (3,181) 1,027 2,788
Reduction in investments
Net acquisitions 2,771 - - - -
Reduction in other LT assets (1,705) (1,924) (6,168) (5,901) (249)
Addition in other LT liabilities 190 (15) 772 - -
Adjustments 1,851 (1,443) 3,437 3,788 93
Cashflow after investing acts 328 (807) (5,139) (1,086) 2,632
Cash dividends (1,401) (379) (569) (1,272) (1,543)
Equity issue (165) (340) - - -
Debt issue 1,777 1,996 4,091 500 1,500
Convertible debt issue
Others 768 406 1,244 - -
Cashflow from financial acts 979 1,682 4,766 (772) (43)
Net cashflow 1,307 875 (373) (1,858) 2,589
Beginning cash 3,945 5,252 6,128 5,755 3,897
Ending cash 5,252 6,128 5,755 3,897 6,486
Ending net debt 4,816 5,953 10,356 12,714 11,625
Source: Nomura es timates
Leverage
Interest cover 22.0 377.0 31.0 44.3 71.4
Gross debt/property assets (%) 28.8 27.3 24.9 21.8 20.9
Net debt/EBITDA (x) 2.09 1.66 1.28 1.36 1.10
Net debt/equity (%) 37.3 42.3 53.0 56.1 44.2
Dupont decomposition
Net margin (%) 58.6 14.0 29.0 16.0 14.1
Asset utilisation (x) 0.3 0.3 0.4 0.4 0.4
ROA (%) 17.2 4.7 11.1 6.3 6.3
Leverage (Assets/Equity x) 2.9 2.9 3.2 3.3 3.3
ROE (%) 49.9 13.8 36.0 20.9 21.0
Source: Nomura es timates
We reaffirm BUY on ABC, with a price target of HK$4.70. Amid tightening monetary Price target HK$4.70
( set o n 22 Oct 10)
policy and likely lower loan growth next year, we believe ABC, with its focus on
Upside/downside 13.8%
rural business and relatively low LDR ratio, will outperform its peers. Since ABC is Difference from consensus 20.9%
at the forefront of county banking in China, we believe it stands to benefit most from
China’s urbanisation. FY11F net profit (RMBmn) 124,459
Difference from consensus 13.0%
Catalysts Source: Nomura
Rate hikes could serve as a catalyst to expand its NIM.
Nomura vs consensus
Anchor themes
Our net profit forecast is above
The operating environment for Chinese banks should remain favourable in 2011F, consensus estimates, likely owing to
but negative sentiment from uncertainties over policies and asset quality continues our higher NIM and lower credit cost
to weigh on valuations. Better visibility on regulatory policies (capital and assumptions.
provisioning) could trigger a re-rating in the near term.
Nov10
Sep10
Valuation
Our price target of HK$4.70 is based on 2.2x P/BV applied to the average FY10F and
FY11F BVPS. Our sustainable ROE is 16.6%. We use a Gordon Growth model (target
P/BV= (sustainable ROE – long-term growth) / (cost of equity – long-term growth)) to
derive our fair P/BV range, assuming a cost of equity of 12% and terminal growth rate
of 8.3%. We derive our terminal growth rate by applying a 50% payout ratio to our
long-term sustainable ROE assumption.
Investment risks
Being one of the largest banks in China, ABC remains closely tied to the Chinese
economy. We believe that a more severe-than-expected macro tightening could result
in a sharp rise in bad debt costs. The government may implement certain policies
specifically for ABC in county areas which might or might not be of benefit to ABC. A
slowing economy would likely have negative implications for loan growth and asset
quality. The concept of market and operations-related risks has only been introduced
into China’s banking system in recent years, and the system itself is yet to go through
a full credit cycle. Therefore, there is no historical data showing how Chinese banks
may perform under a more testing credit environment.
Financial statements
Profit and Loss (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Interest income 321,855 296,147 382,331 465,804 570,719
Interest expense (121,852) (114,508) (150,188) (180,405) (232,099)
Net interest income 200,003 181,639 232,143 285,398 338,620
Net fees and commissions 23,798 35,640 43,505 53,467 65,975
Trading related profits (571) 271 48 421 611
Other operating revenue (9,214) 6,087 3,001 3,168 4,690
Non-interest income 14,013 41,998 46,553 57,056 71,276
Operating income 214,016 223,637 278,696 342,454 409,897
Depreciation (11,423) (10,775) (11,314) (11,879) (12,473)
Amortisation - - - - -
Operating expenses (98,752) (98,792) (114,970) (132,865) (152,557)
Employee share expense
Op. profit before provisions 103,841 114,070 152,413 197,710 244,866
Provisions for bad debt (39,858) (44,289) (30,843) (35,003) (36,092)
Other provision charges (11,620) 4,147 - - -
Operating profit 52,363 73,928 121,570 162,707 208,774
Other non-operating income (14) - - - -
Associates & JCEs - - - - -
Pre-tax profit 52,349 73,928 121,570 162,707 208,774
Income tax (896) (8,926) (29,177) (38,236) (49,062)
Net profit after tax 51,453 65,002 92,393 124,471 159,712
Minority interests 21 (10) (11) (12) (13)
Other items - - - - -
Preferred dividends - - - - -
Normalised NPAT 51,474 64,992 92,382 124,459 159,699
Extraordinary items - - - - -
Reported NPAT 51,474 64,992 92,382 124,459 159,699
Dividends - (20,000) (20,786) (56,012) (71,871)
Transfer to reserves 51,474 44,992 71,596 68,447 87,829
Growth (%)
Net interest income 21.8 (9.2) 27.8 22.9 18.6
Non-interest income (27.3) 199.7 10.8 22.6 24.9
Non-interest expenses 47.8 0.0 16.4 15.6 14.8
Pre-provision earnings (4.6) 9.9 33.6 29.7 23.9
Net profit 17.6 26.3 42.1 34.7 28.3
Normalised EPS (25.1) (7.3) 26.4 21.3 28.3
Normalised FDEPS (25.1) (7.3) 26.4 21.3 28.3
Source: Nomura estimates
Growth (%)
Loan growth 11.3 33.1 19.2 21.8 22.8
Interest earning assets 33.8 25.0 15.7 17.4 18.2 Asset quality maintained
Interest bearing liabilities 10.8 28.9 15.8 15.5 15.7
Asset growth 32.2 26.6 17.0 15.5 15.5
Deposit growth 15.3 23.0 16.1 16.4 16.4
Per share
Reported EPS (RMB) 0.27 0.25 0.32 0.38 0.49
Norm EPS (RMB) 0.27 0.25 0.32 0.38 0.49
Fully diluted norm EPS (RMB) 0.27 0.25 0.32 0.38 0.49
DPS (RMB) - 0.08 0.06 0.17 0.22
PPOP PS (RMB) 0.54 0.44 0.52 0.61 0.75
BVPS (RMB) 1.12 1.32 1.64 1.96 2.28
ABVPS (RMB) 1.12 1.32 1.64 1.96 2.28
NTAPS (RMB) 1.05 1.24 1.59 1.91 2.23
Source: Nomura estimates
As leader in WTE, CEI will benefit from incineration as the preferred solid waste Price target HK$6.10
(s et on 15 Oct 10)
treatment method in urban China. Together with its strong portfolio in wastewater
Upside/downside 39.9%
treatment, we believe CEI will continue to add new projects in these two high Difference from consensus 41.9%
growth areas. Trading at 21x FY11F EPS, valuation is in line with peers’ 16-21x.
We believe this is undemanding, as we think CEI deserves to trade at a premium FY11F net profit (HK$mn) 760
given its WTE expansion is likely to provide higher returns (10-15%). BUY. Difference from consensus -0.1%
Source: Nomura
Catalysts
Comfortable gearing will allow the company to look for additional WTE, water and Nomura vs consensus
environmental projects. Potential new projects would be share price catalysts.
We believe CEI will continue project
Anchor themes execution in FY11F-12F and have
Water shortages, exacerbated by growing demand and pollution, underscore the need reflected such in our projections for
for conservation. Privatisation, tariff hikes are the solution. We like the tap water model capacity build-out.
but prefer wastewater treatment, WTE, recycled water near term on policy support.
Jan10
Feb10
Mar10
Jun10
Jul10
Aug10
Sep10
Nov10
Apr10
Oct10
ROE spread against peers. New projects would be catalysts, in our view.
Drilling down
As a leader in WTE with high emissions standards, CEI should benefit from growth in
the WTE sector.
China Everbright International (CEI) is a recognised leader in China’s WTE space, with
a focus on developing environmental protection industrial parks, which often comprise
various projects including methane-to-energy, wastewater treatment (WWT) and WTE.
We expect WTE to remain the main revenue driver, contributing 65% of total FY10F
revenue, followed by WWT at 26% of total.
Reiterate BUY
CEI is trading at 21x FY11F EPS vs peers’ 16-21x. We think the valuation is Valuation is undemanding in our
undemanding as we believe WTE expansion should provide higher returns. Its quality view
output in both WWT and WTE should reflect higher ROE-spread against peers as the
government raises the bar for environmental protection, in our view. Also, the
company’s growth momentum remains strong. We believe potential new projects
would be share price catalysts. Hence, we maintain our BUY rating.
Valuation methodology and investment risks: Our price target is derived using DCF,
with a WACC of 10.0% and a 2% terminal growth rate. Our target price is subject to
growth assumptions in treatment volumes (including tap water supply, wastewater
treatment and waste-to-energy), tariffs, capacity and capex. Changes in the macro
landscape and government regulations over the water industry may result in key
changes in our forecasts, and hence our target price.
Financial statements
Income statement (HK$mn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Revenue 1,863 1,766 3,090 4,044 4,310
Cost of goods sold (1,198) (947) (1,981) (2,571) (2,534)
Gross profit 665 819 1,109 1,473 1,776
SG&A (127) (165) (189) (242) (235)
Employee share expense - - - - -
Operating profit 538 654 921 1,231 1,541
Growth (%)
Revenue 38.2 (5.2) 75.0 30.9 6.6
EBITDA 41.0 20.7 40.7 32.0 24.3
EBIT 42.1 21.7 40.7 33.7 25.2
Normalised EPS (3.7) 18.5 50.6 28.1 17.4
Normalised FD EPS (4.2) 19.7 51.9 29.0 17.4
Per share
Reported EPS (HK$) 0.11 0.11 0.16 0.21 0.25
Norm EPS (HK$) 0.09 0.11 0.16 0.21 0.25
Fully diluted norm EPS (HK$) 0.09 0.11 0.16 0.21 0.25
Book value per share (HK$) 0.90 1.26 1.39 1.56 1.75
DPS (HK$) 0.02 0.02 0.03 0.04 0.05
Source: Nomura estimates
Cashflow (HK$mn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
EBITDA 574 693 975 1,288 1,600
Change in working capital (116) (216) (214) (174) (155)
Other operating cashflow (584) (320) 146 (26) (156)
Cashflow from operations (126) 157 907 1,087 1,289
Capital expenditure (1,015) (545) (1,604) (2,067) (1,753)
Free cashflow (1,141) (388) (697) (980) (464)
Reduction in investments 37 1 - - -
Net acquisitions - - - - -
Reduction in other LT assets 9 4 - - -
Addition in other LT liabilities 39 66 0 (0) 0
Adjustments 128 (12) 10 (1) (13)
Cashflow after investing acts (927) (329) (687) (981) (477)
Cash dividends (50) (63) (120) (154) (180)
Equity issue 8 1,445 16 - -
Debt issue 986 518 228 962 744
Convertible debt issue - - - - -
Others 52 (246) (207) (235) (278)
Cashflow from financial acts 995 1,654 (83) 573 286
Net cashflow 68 1,325 (771) (408) (191)
Beginning cash 631 699 2,024 1,253 846
Ending cash 699 2,024 1,253 846 655
Ending net debt 1,912 1,077 2,075 3,445 4,380
Source: Nomura estimates
Liquidity (x)
Current ratio 1.36 2.48 2.39 1.85 1.51
Interest cover 3.7 3.8 4.7 5.2 5.3
Gearing remains healthy,
Leverage positive for expansion
Net debt/EBITDA (x) 3.33 1.55 2.13 2.68 2.74
Net debt/equity (%) 67.8 23.6 41.0 60.8 68.6
Activity (days)
Days receivable 14.9 30.6 22.7 18.6 21.7
Days inventory 2.7 4.8 2.6 2.4 3.4
Days payable 123.1 183.6 97.8 94.9 130.9
Cash cycle (105.5) (148.2) (72.5) (73.9) (105.8)
Source: Nomura estimates
We think China Life is likely to be an outperformer in FY11F on a rising interest rate Price target HK$40.00
(set on 8 Oct 10)
and still relatively high liquidity. Its share price performance has lagged in FY10, but
Upside/downside 18.7%
we expect a rebound in FY11F VoNB growth to support performance. Valuation Difference from consensus 7.4%
looks undemanding at FY11F PEV of 2.1x and NBM of 21x for a stock offering
around 15% VoNB growth, 2.5% ROA and 2-3% dividend yield. FY11F net profit (RMBmn) 38,896
Difference from consensus -5.4%
Catalysts Source: Nomura
Further rounds of rate hikes in 2011 could boost insurers’ earnings together with
any positive sentiment on the A-share market or expectations of more liquidity. Nomura vs consensus
Anchor themes Our lower FY11F earnings forecast
Investor perception of Chinese insurers’ ability to control investment risk is a highly is due to consensus factoring in
valuable intangible asset and should not be taken for granted. Given the Chinese higher investment earnings for
insurance industry remains a growth story and investor focus on VoNB growth, we FY11F.
believe Chinese insurers should continue to trade at higher multiples.
Sep10
Dec09
Jan10
Feb10
Mar10
Apr10
Jun10
Jul10
Aug10
Oct10
Nov10
China Life
In our view, investors interested in China’s urbanisation theme should also consider In our view, investors interested
China Life. According to China Life management, rural business accounts for around in China’s urbanisation theme
half of its total (in terms of premium and agency force). The profitability for the rural should also consider China Life
The key difference between the rural and urban business is that the rural branch and
staff cost could be lower, while health for the rural areas is poorer, leading to higher
mortality generally. These two factors tend to even out each other. Premium growth
rates have also been roughly equal for its urban and rural business during 2010,
according to management.
From a life insurance perspective, China Life is probably the only real rural
urbanisation play as other life insurers focus more on the cities while high initial
investments also mean they are unlikely to invest significantly in their rural business.
Exhibit 164. Rolling forward PEV Exhibit 165. Rolling forward NB Multiple
6.0 90
80
5.0
70
4.0 60
50
3.0
40
2.0 30
20
1.0
10
0.0 0
Jan-04
Apr-04
Jul-04
Oct-04
Jan-05
Apr-05
Jul-05
Oct-05
Jan-06
Apr-06
Jul-06
Oct-06
Jan-07
Apr-07
Jul-07
Oct-07
Jan-08
Apr-08
Jul-08
Oct-08
Jan-09
Apr-09
Jul-09
Oct-09
Jan-10
Apr-10
Jul-10
Oct-10
Jan-04
Jul-04
Jan-05
Jul-05
Jan-06
Jul-06
Jan-07
Jul-07
Jan-08
Jul-08
Jan-09
Jul-09
Jan-10
Jul-10
Source: Bloomberg, Nomura Source : Bloomberg, Nomura
Valuation
Our PT of HK$40.00 is premised on an NB multiple of 25.0x, derived by a risk discount
rate (RDR) of 11%, according to China Life’s EV assumptions. We use our explicit
VoNB growth forecasts for FY10-13F, an assumed 15% VoNB growth over the next
seven years (FY14-20F), levelling off to 10% in FY21-25F. The valuation is based on a
15-year basis and assumes no perpetuity growth, an approach similar to standard
actuarial practice, as long-term growth is deemed too uncertain and therefore has
close to zero value.
We apply the target NB multiple to China Life’s FY12F new business value and add
FY11F embedded value.
Financial statements
Profit and Loss (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Gross premiums 265,656 275,970 312,059 365,154 432,076
Government charges - - - - -
Reinsurance ceded (156) (158) (179) (209) (247)
Net written premium 265,500 275,812 311,881 364,945 431,828
Change in unearned premium reserves (323) (735) (831) (973) (1,151)
Net earned premium 265,177 275,077 311,049 363,972 430,677
Claims and benefit payments (134,649) (154,372) (178,983) (201,901) (237,944)
Change in reserves - - - - -
Commission and DAC expenses - - - - - Potential earnings upside
Other expenses (145,721) (143,877) (145,902) (185,798) (221,322) from investment gains
Underwriting surplus (15,193) (23,172) (13,835) (23,728) (28,589)
Recurrent investment income 44,946 38,890 48,476 68,996 81,031
Realised and unrealised gains (13,158) 22,693 5,897 - -
Investment income 31,788 61,583 54,373 68,996 81,031
Other income - - - - -
Employee share expense - - - - -
Operating profit 16,595 38,411 40,538 45,268 52,442
Amortisation - - - - -
Other non-operating income 3,420 2,630 2,893 3,182 3,501
Associates and JCEs (56) 704 810 931 1,071
Pre-tax profit 19,959 41,745 44,240 49,381 57,013
Income tax (685) (8,709) (9,230) (10,302) (11,894)
Net profit after tax 19,274 33,036 35,011 39,079 45,119
Minority interests (137) (155) (164) (183) (212)
Other items
Preferred dividends
Normalised NPAT 19,137 32,881 34,847 38,896 44,907
Extraordinary items
Reported NPAT 19,137 32,881 34,847 38,896 44,907
Dividends
Transfer to retained earnings 19,137 32,881 34,847 38,896 44,907
Growth (%)
Life premiums 173.5 3.7 13.2 17.3 18.7
Non life premiums (32.7) 6.7 10.4 10.7 10.9
Net profit (50.8) 71.8 6.0 11.6 15.5
Normalised EPS (50.8) 71.8 6.0 11.6 15.5
Normalised FDEPS (50.8) 71.8 6.0 11.6 15.5
Source: Nomura estimates
Per share
Reported EPS (RMB) 0.68 1.16 1.23 1.38 1.59
Norm EPS (RMB) 0.68 1.16 1.23 1.38 1.59
Fully diluted norm EPS (RMB) 0.68 1.16 1.23 1.38 1.59
DPS (RMB) 0.23 0.70 0.74 0.83 0.96
BVPS (RMB) 6.15 7.47 7.62 8.53 9.61
Life/LT EVPS (RMB) 8.49 10.09 11.13 12.89 15.01
Life/LT VNBPS (RMB) 0.49 0.63 0.71 0.87 1.04
Value of non-life bus. PS (RMB) - - - - -
Source: Nomura estimates
Mengniu shares have underperformed the MSCI China by 16% in the past six Price target HK$32.00
(s et on 19 Nov 10)
months, mainly due to cost pressure concerns, we think. We see a potential
Upside/downside 41.0%
earnings turnaround for 2H FY10F and FY11F given product upgrades, pricing Difference from consensus 23.1%
power and positive operating leverage. Management indicates that it will focus
more on profitability rather than market share gain, given its leading position FY11F net profit (RMBmn) 1,784
(already 40% share in the liquid milk segment). Difference from consensus 7.1%
Source: Nomura
Catalysts
EPS upgrades by the street, product price hikes and M&A. Nomura vs consensus
Anchor themes Our numbers are higher than the
Street mainly because we expect
We are positive on China’s long-term consumption outlook. China’s GDP per capita
Mengniu to pass on cost pressure.
(about US$3,700 in 2009) is close to seeing consumption pick up, based on the
experience of developed markets.
Earnings turnaround
Key financials & valuations
31 Dec (RMBmn) FY09 FY10F FY11F FY12F
Revenue 25,710 30,536 36,231 43,289
Time to pass on cost pressure Reported net profit 1,116 1,217 1,784 2,347
Normalised net profit 1,116 1,217 1,784 2,347
In our view, Mengniu could pass on its raw milk cost pressures Normalised EPS (RMB) 0.68 0.70 1.03 1.35
through product upgrades and ASP hikes in FY11F. We forecast a 7% Norm. EPS growth (%) na 2.9 46.6 31.6
Norm. P/E (x) 29.2 27.9 18.1 13.0
y-y increase in raw milk cost for FY11F following an estimated 13%
EV/EBITDA (x) 14.4 13.8 8.1 5.1
y-y increase in FY10F. Management indicates that its high-end Price/book (x) 4.0 3.5 2.9 2.3
products (with GPM of 28% to 40%) will increase by 2-3pp pa as a Dividend yield (%) 0.7 0.8 1.2 1.7
percentage of total sales from 18% currently. Moreover, according to ROE (%) 17.1 13.4 17.5 19.8
Net debt/equity (%) net cash net cash net cash net cash
management, the company has raised selling prices by 4% on Earnings revisions
average recently. On our estimate, its 5% ASP increase (1pp from Previous norm. net profit 1,217 1,784 2,347
product upgrade and 4pp from direct price hike) could help it to fully Change from previous (%) - - -
Previous norm. EPS (RMB) 0.70 1.03 1.35
pass on cost pressure for FY11F. Compared with an estimated 26.1%
Source: Company, Nomura estimates
GPM for FY10F, we expect a GPM of 26.6% for FY11F on a 5% y-y
ASP increase. Share price relative to MSCI China
(HK$) Price
May10
Dec09
Jan10
Mar10
Apr10
Jun10
Jul10
Aug10
Oct10
Nov10
Sep10
25
20
15
10
(5)
FY08 FY09 FY10F FY11F FY12F
Financial statements
Income statement (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Revenue 23,865 25,710 30,536 36,231 43,289
Cost of goods sold (19,196) (18,858) (22,574) (26,578) (31,751)
Gross profit 4,669 6,852 7,962 9,653 11,539
SG&A (5,050) (5,517) (6,620) (7,473) (8,601)
Employee share expense
Operating profit (381) 1,335 1,342 2,180 2,938
Growth (%)
Revenue 11.9 7.7 18.8 18.7 19.5
EBITDA (84.0) 701.9 (2.9) 42.6 27.2
EBIT (136.6) na 0.5 62.4 34.8
Normalised EPS (196.1) na 2.9 46.6 31.6
Normalised FD EPS (196.2) na 2.9 46.6 31.6
Per share
Reported EPS (RMB) (0.64) 0.68 0.70 1.03 1.35
Norm EPS (RMB) (0.64) 0.68 0.70 1.03 1.35
Fully diluted norm EPS (RMB) (0.64) 0.68 0.70 1.03 1.35
Book value per share (RMB) 2.86 4.94 5.49 6.29 7.35
DPS (RMB) - 0.14 0.15 0.23 0.30
Source: Nomura estimates
Cashflow (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
EBITDA 249 1,999 1,942 2,770 3,522
Change in working capital 833 (166) 231 1,197 691
Other operating cashflow 189 (77) (41) (133) (228)
Cashflow from operations 1,272 1,756 2,132 3,833 3,986
Capital expenditure (788) (613) (650) (700) (700)
Free cashflow 483 1,143 1,482 3,133 3,286
Reduction in investments 17 (27) - - -
Net acquisitions - - - - -
Reduction in other LT assets (206) (58) - - -
Addition in other LT liabilities (112) (11) - - -
Adjustments - - - - -
Cashflow after investing acts 183 1,048 1,482 3,133 3,286
Cash dividends (188) - (245) (268) (392)
Equity issue (2) 2,694 - - -
Debt issue 1,502 (1,021) - - -
Convertible debt issue - - - - -
Others (664) 387 124 (185) (282)
Cashflow from financial acts 648 2,060 (122) (453) (674)
Net cashflow 831 3,108 1,360 2,680 2,612
Beginning cash 2,211 3,042 6,150 7,510 10,190
Ending cash 3,042 6,150 7,510 10,190 12,801
Ending net debt (1,240) (5,369) (6,729) (9,409) (12,021)
Source: Nomura estimates
Liquidity (x)
Current ratio 0.88 1.76 1.76 1.89 1.89
Interest cover na na na na na
Leverage
Net debt/EBITDA (x) net cash net cash net cash net cash net cash
Net debt/equity (%) net cash net cash net cash net cash net cash
Activity (days)
Days receivable 5.6 6.6 6.6 6.6 6.6
Days inventory 16.2 14.9 22.0 22.0 22.1
Days payable 37.8 45.8 45.8 45.8 45.9
Cash cycle (16.1) (24.3) (17.2) (17.2) (17.3)
Source: Nomura estimates
We maintain BUY on CRCC after the market reacted strongly towards the negative Price target HK$11.80
(s et on 18 Nov 10)
news from Saudi Arabia, as, in our view: 1) its losses are one-off and should not
Upside/downside 25.3%
affect FY11F EPS; 2) compensation from Saudi Arabia is possible; 3) its domestic Difference from consensus 3.3%
business remains solid and is likely to surprise on the upside in 4Q and 4) its
valuation looks attractive, especially considering its net cash position. Our PT is FY11F net profit (RMBmn) 10,113
unchanged at HK$11.8, which is based on 12x FY11F EPS of RMB0.82. Difference from consensus 6.3%
Source: Nomura
Catalysts
Upward revisions to railway plans in China’s 12th Five-Year Plan and Nomura vs consensus
compensation received for the Saudi metro project may serve as positive catalysts.
We believe its domestic business
Anchor themes remains solid and CRCC will
While China’s railway construction is still the most significant revenue contributor to continue to benefit from China’s
Chinese E&C companies, the risks on their overseas projects may be an overhang railway boom.
for their stock performance.
May10
Dec09
Jan10
Mar10
Apr10
Jun10
Jul10
Aug10
Oct10
Nov10
Sep10
Drilling down
Valuation methodology
Our 12-month price target of HK$11.8 is derived by applying a 12x target multiple to its
FY11F EPS of RMB0.82 (forex assumption RMB1:HKD1.2). We believe the target
multiple of 12x is justified as global engineering and construction companies, on
average, are trading at similar levels, based on Bloomberg consensus. With
continuous investment in China’s railway networks, we believe this target multiple is
not aggressive.
Exhibit 168. Historical price (18 Jul 10: 100) Exhibit 169. Historical prices (18 Jul 10: 100)
150 125
Construction CRG
HSI CCCC
115
130 HSI
110
120
105
110
100
100
95
90 90
Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10
Financial statements
Income statement (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Revenue 219,410 344,976 414,653 497,641 595,206
Cost of goods sold (203,607) (322,428) (389,651) (462,938) (554,022)
Gross profit 15,803 22,548 25,002 34,702 41,184
SG&A (10,233) (14,913) (16,918) (19,756) (23,630)
Employee share expense (1,460) (118) (1,567) (1,000) (1,000) Domestic revenue remains
Operating profit 4,110 7,517 6,517 13,946 16,555 solid
Growth (%)
Revenue 27.6 57.2 20.2 20.0 19.6
EBITDA 22.9 67.4 (0.6) 67.1 19.3
EBIT 9.4 82.9 (13.3) 114.0 18.7
Normalised EPS 12.7 65.0 (31.3) 123.0 18.9
Normalised FD EPS 12.7 65.0 (31.3) 123.0 18.9
Per share
Reported EPS (RMB) 0.32 0.53 0.37 0.82 0.97
Norm EPS (RMB) 0.32 0.53 0.37 0.82 0.97
Fully diluted norm EPS (RMB) 0.32 0.53 0.37 0.82 0.97
Book value per share (RMB) 4.25 4.32 4.59 5.19 5.92
DPS (RMB) 0.11 0.16 0.09 0.20 0.24
Source: Nomura estimates
Cashflow (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
EBITDA 8,302 13,893 13,815 23,084 27,549
Change in working capital (2,851) 7,461 395 2,991 5,795
Other operating cashflow 1,849 (3,879) (1,699) (2,970) (3,446)
Cashflow from operations 7,300 17,475 12,511 23,104 29,898
Capital expenditure (12,103) (15,571) (15,000) (15,000) (15,000)
Free cashflow (4,803) 1,904 (2,489) 8,104 14,898
Reduction in investments (632) (980) (54) (121) (144)
Net acquisitions - - - - -
Reduction in other LT assets (1,200) (38) (130) (130) (130)
Addition in other LT liabilities (255) (830) 336 758 903
Adjustments 1,121 3,789 2,968 2,587 2,561
FCF expected to come
Cashflow after investing acts (5,768) 3,845 631 11,198 18,088
Cash dividends (1,234) (1,974) (1,134) (2,528) (3,005)
Equity issue
Debt issue
Convertible debt issue
Others 35,818 5,492 (414) 1,591 2,050
Cashflow from financial acts 34,584 3,518 (1,547) (937) (955)
Net cashflow 28,816 7,364 (916) 10,261 17,133
Beginning cash 26,190 55,006 62,370 61,454 71,715
Ending cash 55,006 62,370 61,454 71,715 88,848
Ending net debt (32,874) (35,656) (33,054) (39,506) (52,104)
Source: Nomura estimates
Liquidity (x)
Current ratio 1.17 1.15 1.14 1.14 1.14
Interest cover na 23.2 6.0 11.5 12.5
Leverage
Net debt/EBITDA (x) net cash net cash net cash net cash net cash
Net debt/equity (%) net cash net cash net cash net cash net cash
Activity (days)
Days receivable 52.6 41.1 40.3 37.6 37.7
Days inventory 18.9 18.2 18.0 16.6 16.6
Days payable 98.1 94.1 95.1 86.3 86.2
Cash cycle (26.5) (34.8) (36.8) (32.2) (31.8)
Source: Nomura estimates
We lift our price target from HK$4.1 to HK$4.3 as we roll our valuations to FY11 Price target HK$4.30
(from HK$4.10)
and upgrade our earnings estimates due to better-than-expected sales and margin.
Upside/downside 36.5%
We expect margins to continue to improve in the next 12 months, given Gome’s Difference from consensus 33.5%
product mix upgrade and sales efficiency improvement. We expect store expansion
and SSS to drive earning growth beyond FY12F, as part of the company’s five-year FY11 net profit (RMBmn) 2,320
plan. Maintain BUY. Difference from consensus 8.8%
Source: Nomura
Catalysts
Better-than-expected results, accelerating SSS and more favourable macro policies Nomura vs consensus
stand as positive catalysts.
We are above the market, as we are
Anchor themes more upbeat on Gome’s growth
With China’s GDP likely to remain strong at 9.8% in 2011F, we are positive on the outlook.
growth outlook for retail stocks. The transformation of China’s economic growth
appears to be under way, with consumption becoming increasingly important.
already saw better SSS in lower-tier cities compared with those of 3.4 Rel MSCI China 120
3.2
first-tier cities. Gome may raise its store number in tier-2 markets as a 3.0 110
2.8 100
percentage of the total to 55% in 2014 from 36% in end-3Q10. Store 2.6
expansion and SSS will be key potential earnings drivers from FY12F. 2.4 90
2.2 80
2.0
Margin wise, we expect margins to continue to improve in the next 12 1.8 70
months, given its product mix upgrade and sales efficiency
May10
Dec09
Jan10
Feb10
Mar10
Jun10
Jul10
Aug10
Sep10
Nov10
Apr10
Oct10
in the home appliance market with the help of the online shop.
Exhibit 170. Same store sales Exhibit 171. Sales per sqm
(%) (RMB)
30 25.7 23.9 25.7 6,000
20 4,809
14.1 5,000 4,418 4,582
3,799 3,993
10 4,000 3,658
2.1 3,183
0 3,000
(10) 2,000
(8.3)
(20) 1,000
(20.8)
(30) 0
1Q09 2Q09 3Q09 4Q09 1Q10 2Q10 3Q10 1Q09 2Q09 3Q09 4Q09 1Q10 2Q10 3Q10
Source: Company data, Nomura research Source: Company data, Nomura research
15.5 2
15.0
1
14.5
14.0 0
1Q09 2Q09 3Q09 4Q09 1Q10 2Q10 3Q10 1Q09 2Q09 3Q09 4Q09 1Q10 2Q10 3Q10
Source: Company data, Nomura research Source: Company data, Nomura research
Financial statements
Income statement (RMBmn)
Year-end 31 Dec FY08 FY09 FY10 FY11 FY12
Revenue 45,889 42,668 50,243 59,317 70,749
Cost of goods sold (41,381) (38,408) (44,724) (52,624) (62,625)
Gross profit 4,508 4,260 5,518 6,693 8,124
SG&A (2,564) (2,563) (2,981) (3,601) (4,473) Revenue driven by store
Employee share expense openings
Operating profit 1,944 1,696 2,538 3,091 3,651
Growth (%)
Revenue 8.0 (7.0) 17.8 18.1 19.3
EBITDA 8.8 (8.8) 42.4 21.1 17.6
EBIT 7.8 (12.7) 49.6 21.8 18.1
Normalised EPS 7.9 (35.2) 45.1 19.9 16.1
Normalised FD EPS 7.9 (35.2) 45.1 19.9 16.1
Per share
Reported EPS (RMB) 0.08 0.08 0.11 0.13 0.16
Norm EPS (RMB) 0.14 0.09 0.13 0.16 0.18
Fully diluted norm EPS (RMB) 0.14 0.09 0.13 0.16 0.18
Book value per share (RMB) 0.67 0.78 0.89 1.00 1.13
DPS (RMB) 0.03 - 0.04 0.05 0.06
Source: Nomura estimates
Cashflow (RMBmn)
Year-end 31 Dec FY08 FY09 FY10 FY11 FY12
EBITDA 2,250 2,051 2,920 3,536 4,159
Change in working capital (267) 1,363 1,711 (327) (534)
Other operating cashflow 238 (3,588) (2,504) (779) (852)
Cashflow from operations 2,220 (175) 2,126 2,430 2,772
Capital expenditure (1,180) (330) (800) (800) (800)
Free cashflow 1,041 (504) 1,326 1,630 1,972
Reduction in investments - - - - -
Net acquisitions (3,350) (3) - - -
Reduction in other LT assets (927) (3,163) - (0) (0)
Addition in other LT liabilities (2) 25 - - -
Adjustments 2,979 3,176 1,814 17 (2)
Cashflow after investing acts (259) (469) 3,140 1,647 1,970
Cash dividends (661) - (276) (624) (766)
Equity issue (2,068) 1,266 - - -
Debt issue (130) 180 - - -
Convertible debt issue - 2,037 - - -
Others (101) (37) - - -
Cashflow from financial acts (2,960) 3,447 (276) (624) (766)
Net cashflow (3,219) 2,978 2,865 1,023 1,204
Beginning cash 6,270 3,051 6,029 8,894 9,917
Ending cash 3,051 6,029 8,894 9,917 11,121
Ending net debt 688 (324) (3,188) (4,211) (5,415)
Source: Nomura estimates
Liquidity (x)
Current ratio 1.22 1.13 1.17 1.21 1.26
Interest cover na na na na na
Leverage
Net debt/EBITDA (x) 0.31 net cash net cash net cash net cash
Net debt/equity (%) 8.0 net cash net cash net cash net cash
Activity (days)
Days receivable 0.6 0.4 0.4 0.4 0.4
Days inventory 48.0 57.0 58.3 59.2 60.2
Days payable 117.1 136.5 134.2 123.6 113.5
Cash cycle (68.5) (79.1) (75.5) (64.0) (52.8)
Source: Nomura estimates
Perfect World’s stock has pulled back significantly after failing to beat estimates in Price target US$37.00
(s et on 16 Nov 10)
the core business in 3Q10. We estimate that 3Q will mark the bottom for non-GAAP
Upside/downside 56.1%
operating margin and we believe that investors should look beyond current results Difference from consensus 9.7%
and look to the new game launches and strong pipeline. We reaffirm our BUY
rating and our 12-month PT of US$37, equivalent to 10.3x FY11F P/E. FY11F net profit (US$mn) 167.3
Difference from consensus na
Catalysts Source: Nomura
New games in the pipeline and increasing traction in current games should
continue to drive growth in FY11F and serve as potential catalysts. Nomura vs consensus
Anchor themes We believe consensus is in the
Shielded from the slowing world economy (minimal revenue outside China) and process of adjustment for the latest
with a low Internet penetration rate, Chinese online-gaming stocks offer good announced results.
defensive and growth components for a China portfolio, in our view, given their
counter-cyclical business model and high cashflow generation.
growth
Revenue 314.0 367.8 442.4 499.2
Reported net profit 151.9 134.5 167.3 193.2
Normalised net profit 163.3 148.5 182.8 210.7
Normalised EPS (US$) 3.06 2.81 3.58 4.13
New games kicking in Norm. EPS growth (%) 59.3 (8.2) 27.4 15.3
Perfect World launched two new games, Forsaken World and Dragon Norm. P/E (x) 7.7 8.4 6.6 5.7
EV/EBITDA (x) 5.7 5.4 3.4 2.1
Excalibur, in October. In addition, the company plans to launch two
Price/book (x) 3.6 2.4 1.8 1.4
major expansion packs for Perfect World II and Zhu Xian in 4Q10F. Dividend yield (%) 0.0 0.0 0.0 0.0
Another expansion pack for BOI is also slated for the coming months. ROE (%) 52.3 32.8 29.1 25.0
As a result, we believe that aggregate APUs and ACUs will improve Net debt/equity (%) net cash net cash net cash net cash
Earnings revisions
going forward. We believe that investors should look beyond current Previous norm. net profit 148.5 182.8 210.7
results and look to the pipeline. There are another four games in the Change from previous (%) - - -
pipeline that the company plans to launch in 2011, starting with Previous norm. EPS (US$) 2.81 3.58 4.13
Sourc e: Company, Nom ura estimates
Empire of Immortals (EOI) in 1Q11. Xiao Ao Jiang Hu (XAJH) is
tentatively scheduled for launch in 2H11, according to management. Share price relative to MSCI China
(US$) Price
Operating margins hitting the bottom 48 Rel MSCI China 110
43 100
We estimate that 3Q will mark the bottom for non-GAAP operating 90
38
margin at Perfect World. Although the margins for the online gaming 33
80
70
industry in China will likely remain under pressure as R&D and S&M 28 60
expenses are not likely to decrease in the near future due to 23 50
18 40
intensified competition, we expect gradual improvement on Perfect
Feb10
Dec09
Apr10
Jun10
Aug10
Oct10
Hitting the bottom. We estimate that 3Q will mark the bottom for non-GAAP
operating margin at Perfect World. While operating margins at 36.1% came in
above our expectations, we expect gradual improvement going forward, hitting
42.3% in 3Q11F, largely owing to top-line leverage. We also believe that 3Q will be
the trough for several key performing metrics such as APCs and APUs, as we
expect contributions from the new games to drive traffic and momentum back to the
company. We expect APCs and APUs to improve 5% and 7%, respectively, on a q-
q basis, driven by new games such as Dragon Excalibur and Forsaken World. We
do not expect significant contributions from declining legacy games; much of the
incremental growth should come from the new games and expansion packs.
However we believe that margins will likely remain under pressure, as R&D and
S&M expenses are not likely to decrease in the near future.
We use P/E valuation to determine our price target rather than using a discounted PT now implies 10.3x FY11F P/E,
cashflow (DCF) basis, because we believe this is the most suitable metric to determine largely in line with our adjusted
the value of Chinese Internet companies given the business cyclicality, the lack of peer group average
earnings visibility and the short history of China’s internet industry. We reaffirm our
BUY rating and our 12-month price target of US$37, equivalent to 10.3x FY11F P/E,
largely in line with our adjusted peer group average of 9.7x FY11F P/E applied to our
fully diluted FY11 EPS estimate (excluding share-based compensation) of US$3.58.
This implies potential upside of 56.1%. The valuation methodology is unchanged.
Investment risks. Company-specific risks to our price target and estimates include:
1) any delays in future gaming releases; 2) new games failing to generate material
revenue; 3) declining performance of existing games, including the newly launched
Fantasy Zhu Xian; and 4) minimal penetration in tier-3 and tier-4 cities in China.
Financial statements
Income statement (US$mn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Revenue 211 314 368 442 499
Cost of goods sold (25) (43) (64) (69) (77)
Gross profit 185 271 304 374 422
SG&A (67) (101) (148) (179) (194) New games and expansion
Employee share expense packs drive revenue growth
Operating profit 118 170 156 195 228
Growth (%)
Revenue 123.0 49.1 17.1 20.3 12.8
EBITDA 165.7 34.9 (7.5) 24.4 16.6
EBIT 141.0 43.6 (8.3) 25.2 16.8
Normalised EPS 102.1 59.3 (8.2) 27.4 15.3
Normalised FDEPS 102.1 59.3 (8.2) 27.4 15.3
Per share
Reported EPS (US$) 1.60 2.85 2.55 3.28 3.79
Norm EPS (US$) 1.92 3.06 2.81 3.58 4.13
Fully diluted norm EPS (US$) 1.92 3.06 2.81 3.58 4.13
Book value per share (US$) 4.34 6.67 9.68 13.32 17.52
DPS (US$) - - - - -
Source: Nomura estimates
Cashflow (US$mn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
EBITDA 133 180 166 207 241
Change in working capital 61 (14) 13 18 14
Other operating cashflow (51) 22 (8) (53) (83)
Cashflow from operations 142 187 171 171 171
Capital expenditure (112) (25) (28) (28) (28)
Free cashflow 31 163 143 143 143
Reduction in investments (11) 2 (1) (1) (1)
Net acquisitions (22)
Reduction in other LT assets (3) (4) (1) (2) (1)
Addition in other LT liabilities 8 (5) 1 1 1
Adjustments (20) 5 (2) (2) (2)
Cashflow after investing acts (17) 161 140 140 140
Cash dividends
Equity issue 1 2 - - -
Debt issue - - - - -
Convertible debt issue
Others 7 (129) - 37 58
Cashflow from financial acts 7 (127) - 37 58
Net cashflow (10) 34 140 177 198
Beginning cash 205 195 230 369 546
Ending cash 195 230 369 546 743
Ending net debt (195) (230) (369) (546) (743)
Source: Nomura estimates
Liquidity (x)
Current ratio 1.93 2.63 3.51 4.25 5.08
Interest cover na na na na na
Leverage
Net debt/EBITDA (x) net cash net cash net cash net cash net cash
Net debt/equity (%) net cash net cash net cash net cash net cash
Activity (days)
Days receivable 6.9 11.0 14.3 14.1 14.6
Days inventory - - - - -
Days payable 37.8 65.5 84.1 92.7 95.7
Cash cycle (30.8) (54.5) (69.8) (78.6) (81.2)
Source: Nomura estimates
Sinopec is our near-term top pick in the China oil and gas sector due to its P ri ce target HK$9.60
(set on 25 Nov 10)
attractive valuations, potential upside in petrochem earnings and a likely rerating of
Upside/downside 31.9%
the stock in line with its improving returns despite assuming low refining margins. Difference from consensus 11.0%
We maintain our BUY rating and target price of HK$9.60, based on ROACE/WACC
(14.3%/10.3%). FY11F net profit (RMBmn) 86,837
Difference from consensus 17.8%
Catalysts Source: Nomura
The next catalyst could be when the government improves the oil product pricing
mechanism or VAT on oil products, which we believe could be towards end-2010 or Nomura vs consensus
early 2011.
Our FY11F earnings estimates are
Anchor themes above consensus due to factoring in
We believe the chemical sector is poised to enter a golden age, benefiting from the Angola oilfield.
rising demand and restrained capacity additions over the next two years. This
should result in improved margins and petrochem sector earnings.
Waiting for an improved pricing mechanism 8.5 Rel MSCI China 115
8.0 110
Sinopec thinks that the market is overly concerned about its refining 7.5 105
business due to losses during 2005-08. The company believes that 7.0
100
6.5
the current pricing mechanism should ensure profits while an 95
6.0
upcoming improved version should further benefit margins. 5.5 90
Jul10
Aug10
Sep10
Dec09
Jan10
Feb10
Mar10
Apr10
May10
Jun10
Oct10
Nov10
Valuation
1m 3m 6m
We think Sinopec is trading at a compelling valuation at 6.4x FY11F Absolute (HK$) (2.8) 17.6 19.7
PE, 3.9x EV/EBITDA and 1.1x P/B while ROACE is 14.3%. Absolute (US$) (3.0) 17.7 20.1
Relative to Index 0.7 7.5 3.9
Regulatory risks – remain cautious on refining Market cap (US$mn)
Estimated free float (%)
81,259
22.6
Even though we think that it is unlikely that the government will allow 52-week range (HK$) 7.94/5.75
losses, we think that a high inflationary environment could put 3-mth avg daily turnover (US$mn) 90.2
Stock borrowability Easy
pressure on the NDRC to limit product price increases. Major shareholders (%)
Sinopec Group 71.2
Drilling down
Refining
Sinopec believes that the NDRC will likely continue to follow the mechanism until oil
prices exceed US$130/bbl since the government said that oil prices have little indirect
impact on CPI. The government is likely to modify the mechanism by shortening the
number of days (currently 22 working days) and by narrowing the trigger (currently 4%
of oil price fluctuation) which should be positive for the refining sector. While the
government has not given a specific timing for the change, it is possible that the new
measures will be announced at the end of 2010, we believe.
We think the government is unlikely to let the refiners suffer losses since losses will
deter future investments in the sector which will cause shortages in the system.
However, it is also unlikely that the government will allow windfall profits like in 1H09
especially in light of the inflationary environment. We think that the government will
probably lower the VAT burden on the refiners and allow a narrow margin that moves
more in line with international prices. Over the next two years, we are forecasting
refining EBIT of around RMB4bn per quarter or RMB16bn per year indicating a
marginal operating margin of 1.1%-1.3%.
Marketing
We continue to think that the marketing sector will remain stable, growing in line with
volume growth. If the government improves the pricing mechanism to discourage
hoarding and demand swings, margins will likely remain stable.
Petrochem
Sinopec has added 2.8 mn tonnes of ethylene capacity or around +50% over the past
two years to around 9mn tonnes. However, there will be no more additions until 2013
when its 800kMt plant in Wuhan comes onstream. Since bottoming out in 2Q and
3Q10, product prices and margins have picked up strongly and the outlook for 4Q and
2011 is looking good. We believe there is significant upside to its chemical earnings
over the next few years.
E+P
Sinopec has injected its parent's Block 18 Angola asset to enhance its upstream
business. The asset produces around 4mntonnes of crude oil per year or around 9% of
its domestic production. Further injections are likely even though there is no time line.
For future injections, Sinopec will select currently producing assets from "friendly"
countries in our view. For domestic assets, oil production growth target is around 1-2%
per year while targeting RRR of 1x. For natural gas, 2010 volume will likely jump 40%
due to the new Puguang field. It will further contribute another 20% production growth
in 2011F. The wellhead price in Puguang is RMB1.51/m3 while the transportation tariff
was set at RMB0.86/m3, indicating a city gate price of RMB2.37/m3.
Earnings
We are forecasting a 22% earnings increase in 2010F, 15% in 2011F and 13% in
2012F and believe that there could be potential upside to our forecast mainly on the
back of a petrochemical upturn. Our 12-M target price of HK$9.60 is based on 2011F
ROACE/WACC (14.3%/10.3%). In our view, Sinopec is trading at a compelling
valuation of 6.4x FY11F PE, 3.9x EV/EBITDA and 1.1x P/B while ROACE is 14.3%.
Downside risks to our view include: 1) rising inflation; 2) chemical downcycle and
3) resources tax. Upside risks: 1) potential change in oil product pricing mechanism
and 2) lifting of the windfall tax hurdle rate.
Financial statements
Income statement (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Revenue 1,452,101 1,345,052 1,851,797 2,212,356 2,531,569
Cost of goods sold (1,379,078) (1,220,121) (1,696,535) (2,032,256) (2,328,497)
Gross profit 73,023 124,931 155,262 180,100 203,072
S G&A (39,392) (40,500) (49,999) (59,734) (68,352)
E mployee share expense
Operating profit 33,631 84,431 105,264 120,367 134,719
Growth (%)
Revenue 20.5 (7.4) 37.7 19.5 14.4
E BITDA (38.1) 68.7 20.7 13.2 11.3
E BIT (60.8) 151.1 24.7 14.3 11.9
Normalised EPS (36.6) 72.4 22.0 15.3 12.7
Normalised FDEPS (36.6) 72.4 22.0 15.3 12.7
P er share
Reported EPS (RMB) 0.41 0.71 0.87 1.00 1.13
Norm EPS (RMB) 0.41 0.71 0.87 1.00 1.13
Fully diluted norm EPS (RMB) 0.41 0.71 0.87 1.00 1.13
B ook value per share (RMB) 3.78 4.33 5.00 5.75 6.60
DPS (RMB) 0.12 0.18 0.23 0.27 0.30
Source: Nomura est imates
Cashflow (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
E BITDA 79,952 134,918 162,871 184,313 205,165
Change i n working capital (8,101) 29,008 (7,252) (14,997) (24,150)
Other operating cashfl ow (5,334) (11,851) (28,822) (34,369) (37,921)
Cashflow from operations 66,517 152,075 126,797 134,947 143,094
Capital expenditure (100,544) (104,761) (112,000) (113,066) (114,153)
Free cashflow (34,027) 47,314 14,797 21,881 28,941
Reduction in investments 3,923 (5,405)
Net acquisitions (1,292) (2,680) - - -
Reduction in other LT assets (7,831) (6,640)
A ddition in other LT liabilities 2,532 2,912 - - -
A djustments (6,813) 535 Positive free cashflow
Cashflow after investing acts (43,508) 36,036 14,797 21,881 28,941
Cash dividends (12,572) (13,559) (17,448) (21,549) (24,602)
E quity issue - - - - -
Debt issue 28,587 (19,116) 5,221 - -
Convertible debt issue 29,850 - - - -
Others (3,045) (1,619) - - -
Cashflow from financial acts 42,820 (34,294) (12,227) (21,549) (24,602)
Net cashflow (688) 1,742 2,570 332 4,338
B eginning cash 7,696 7,008 8,750 11,320 11,652
E nding cash 7,008 8,750 11,320 11,652 15,990
E nding net debt 229,062 209,619 212,270 211,938 207,600
Source: Nomura est imates
Liquidity (x)
Current ratio 0.58 0.64 0.69 0.75 0.84
Interest cover 4.5 11.5 15.4 17.5 19.9
Leverage
Net debt/EBITDA (x) 2.86 1.55 1.30 1.15 1.01
Net debt/equity (%) 69.9 55.8 49.0 42.5 36.3
Activity (days)
Days receivable 6.6 6.2 5.8 5.0 4.6
Days inventory 28.1 35.5 33.4 33.7 36.2
Days payable 23.9 29.3 27.3 25.1 24.1
Cash cycle 10.8 12.4 11.9 13.6 16.6
Source: Nomura est imates
Looking to 2011F, we believe the network convergence policy in China, 3G network Price target HK$36.00
(set on 1 Dec 10)
rollout in India and emergence of entry-level smartphones will drive ZTE’s revenue
Upside/downside 22.4%
and earnings growth to offset weakening 3G equipment demand in China. Revenue Difference from consensus 16.8%
from TD-LTE remains small in FY11F, but is important to its long-term growth.
Reaffirming BUY and price target of HK$36. FY11F net profit (RMBmn) 3,700
Difference from consensus -2.2%
Catalysts Source: Nomura
Positive catalyst: further consolidation in the telecom equipment industry. Negative:
any regulatory policy change that is unfavourable to Chinese vendors. Nomura vs consensus
Anchor themes FY11F earnings are -2% but rev. is
The convergence of the telecom, Internet and television networks is an element of +3% vs consensus. This reflects
China’s 12th Five-Year Plan. We believe this will spur both telecom and cable TV our view that low-margin
operators to accelerate optical-fibre network development, and benefit the whole smartphone business will grow
optical network supplier chain in China. faster than the market expects.
Feb10
Mar10
May10
Jun10
Sep10
Oct10
N ov10
Dec09
Apr10
Jul10
Aug10
Drilling down
ZTE has a strong product portfolio in access network-related products such in EPON Leading supplier of EPON/GPON
(Ethernet-based Passive Optical network)/GPON (Gigabit PON). Since network
convergence capex is mainly spent on access network to deploy the last mile between
operator and subscribers’ homes, we believe ZTE’s strong product portfolio in
EPON/GPON is a key strength to drive revenue growth in 2011F.
In the emerging entry-level smartphone (US$150) space, ZTE has launched more than Entry-level smartphone: ZTE to
10 Android based smartphones since early 2010 for three Chinese operators and ship 4-5mn smartphones in 2011F
several European operators including Vodafone and Orange. The company expects from 1.5mn in 2010F
1.5mn smartphone shipments in 2010. We expect ZTE will ship 4-5mn smartphones in
2011F, with the revenue contribution from smartphones within handset and data card
(terminal) segment rising to 15% in FY11F, from less than 5% in 2010.
Exhibit 175. ZTE's entry-level smartphone Exhibit 176. India capex trend
Model ZTE Blade ZTE X850 Bharti (LHS) IDEA (LHS)
/Orange San Francisco (US$mn) RCOM (LHS) Vodafone India (LHS) (%)
Photo 6,000 y-y change (RHS) 20
10
5,000
0
4,000
(10)
3,000 (20)
(30)
Screen 3.5inch QVGA 2.8inch QVGA 2,000
Capacitive touch Resistive touch (40)
Communication GSM/HSPA GSM/HSPA 1,000
(50)
standard
0 (60)
OS Android 2.2 Android 2.1
2010 2011F 2012F 2013F 2014F
CPU Qualcomm MSM 7227 Qualcomm MSM 7227
Market France, China UK, France, China Source: Company data, Nomura estimates
Retail price ~US$150 ~US$150
Launch date Q3 2010 Q1 2010
Source: Company Data, Nomura research
The India 3G network rollout will be the next big capex for global telecom equipment India 3G: key supplier already and
vendors. Our global telecom team forecasts total telecom capex from major four India gaining market share
telecom operators will grow 10% y-y in FY11 (ending March 2011). ZTE is already the
key equipment supplier for RCOM and Bharti and is actively participating with other
operators. We expect ZTE’s sales in India will grow more than 50% y-y, and the sales
contribution from India will account for ~8% in FY11 from ~6% in FY10 driven by the
3G rollout in FY11 and weak sales in FY10 due to the India government’s ban on
Chinese equipment from April until Autumn.
ZTE is the front runner in TD-LTE technology development and major LTE network LTE: front-runner
equipment vendor globally. In addition to China Mobile’s TD-LTE projects, ZTE has
already signed several commercial LTE contracts globally, and will help CSL to launch
the first commercial LTE service in Asia-ex-Japan. Although the revenue contribution
from LTE is still small in FY11, we expect ZTE to leverage its technology leadership in
LTE to gain market share in the global telecom equipment market.
Financial statements
Income statement (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
Revenue 44,293 60,273 70,500 86,500 107,300
Cost of goods sold (29,493) (40,623) (47,300) (58,500) (73,000)
Gross profit 14,801 19,649 23,200 28,000 34,300
SG&A (13,114) (17,179) (20,300) (24,500) (30,000)
Employee share expense
Margin declines due to growth
Operating profit 1,687 2,470 2,900 3,500 4,300
in low-margin smartphone
sales
EBITDA 2,387 3,233 3,800 4,500 5,400
Depreciation (700) (763) (900) (1,000) (1,100)
Amortisation - - - - -
EBIT 1,687 2,470 2,900 3,500 4,300
Net interest expense (442) (406) (500) (500) (600)
Associates & JCEs - - - - -
Other income 1,017 1,261 1,600 2,000 2,500
Earnings before tax 2,263 3,325 4,000 5,000 6,200
Income tax (351) (629) (800) (900) (1,200)
Net profit after tax 1,912 2,696 3,200 4,100 5,000
Minority interests (252) (238) (300) (400) (400)
Other items
Preferred dividends
Normalised NPAT 1,660 2,458 2,900 3,700 4,600
Extraordinary items
Reported NPAT 1,660 2,458 2,900 3,700 4,600
Dividends (403) (552) (652) (832) (1,034)
Transfer to reserves 1,257 1,906 2,248 2,868 3,566
Growth (%)
Revenue 27.4 36.1 17.0 22.7 24.0
EBITDA 30.8 35.4 17.5 18.4 20.0
EBIT 38.9 46.4 17.4 20.7 22.9
Normalised EPS 32.6 41.2 13.0 27.6 24.3
Normalised FDEPS 32.6 41.2 13.0 27.6 24.3
Per share
Reported EPS (RMB) 0.63 0.89 1.01 1.29 1.60
Norm EPS (RMB) 0.63 0.89 1.01 1.29 1.60
Fully diluted norm EPS (RMB) 0.63 0.89 1.01 1.29 1.60
Book value per share (RMB) 10.61 9.19 6.66 7.67 8.93
DPS (RMB) 0.30 0.30 0.23 0.29 0.36
Source: Nomura es timates
Cashflow (RMBmn)
Year-end 31 Dec FY08 FY09 FY10F FY11F FY12F
EBITDA 2,387 3,233 3,800 4,500 5,400
Change in working capital 1,365 (629) (1,491) (2,200) (2,800)
Other operating cashflow (104) 1,126 1,391 1,100 800
Cashflow from operations 3,648 3,729 3,700 3,400 3,400
Capital expenditure (1,912) (2,054) (2,200) (2,300) (2,400)
Free cashflow 1,736 1,675 1,500 1,100 1,000
Reduction in investments (115) (274) (6) - -
Net acquisitions Trend of positive operating
Reduction in other LT assets cash will continue, in our view
Addition in other LT liabilities
Adjustments 40 27 6 (1,000) (600)
Cashflow after investing acts 1,660 1,428 1,500 100 400
Cash dividends (830) (1,045) (552) (652) (832)
Equity issue 43 46 - - -
Debt issue 468 2,286 1,260 250 285
Convertible debt issue 3,961 - - - -
Others (306) 301 (4) 2 46
Cashflow from financial acts 3,337 1,588 704 (400) (500)
Net cashflow 4,997 3,017 2,204 (300) (100)
Beginning cash 6,483 11,480 14,497 16,700 16,400
Ending cash 11,481 14,497 16,700 16,400 16,300
Ending net debt (1,009) (1,621) (1,300) (800) (400)
Source: Nomura es timates
Liquidity (x)
Current ratio 1.44 1.36 1.47 1.45 1.45
Interest cover 3.8 6.1 5.8 7.0 7.2
Leverage
Net debt/EBITDA (x) net cash net cash net cash net cash net cash
Net debt/equity (%) net cash net cash net cash net cash net cash
Activity (days)
Days receivable 163.3 152.8 152.2 133.6 124.0
Days inventory 101.8 82.2 79.6 78.9 78.7
Days payable 252.0 243.4 241.9 212.8 197.3
Cash cycle 13.1 (8.4) (10.2) (0.3) 5.4
Source: Nomura es timates
Appendix
1 Dec
closing Nomura Price
Company Ticker price rating target Valuation basis Investment risks
CCCC 1800 HK 6.83 NEUTRAL 7.5 Our price target of HK$7.50 is based on 11x FY10- Any major shift in government policies in terms
11F average EPS of RMB0.55, with the target of infrastructure investments in China may affect
multiple at a discount to the 13x target multiple we the outlook of leading Chinese construction
have applied to its railway peers. companies. Rapid increases in critical raw
material costs, such as steel and cement, may
affect Chinese construction companies’ gross
margins and earnings. Any potential shortage in
funding in other emerging economies outside
China may result in lower sales and higher
receivable write-offs for Chinese construction
companies with meaningful exposure to projects
outside China. On the other hand, any better-
than expected recovery in the port machinery
segment may mean our estimates prove to be
too conservative.
Changyou CYOU US 29.41 BUY 39 Our price target of US$39.00 implies 9.8x FY11F Downside risks to our price target include: 1) a
P/E, largely in line with the adjusted peer group faster-than-expected slowdown in TLBB; 2)
average of 10.0x FY11F P/E, applied to our fully further delays in new game launches; and 3)
diluted EPS estimate (excluding share-based costs increasing faster than sales.
compensation) of US$3.97.
China Agri 606 HK 9.27 BUY 13.5 14x 12-month forward EPS. Investment risks: a significant loss in its hedging
and a significant drop in soybean prices.
China Merchants Bank 3968 HK 20.5 BUY 26.36 Our price target of HK$26.36 is based on 3.5x We believe that any more-severe-than-expected
P/BV applied to our FY10F BVPS forecast. Our macro tightening could result in a sharp rise in
sustainable ROE is 17.8%. We use the Gordon bad debt costs. In addition, a slowing economy
Growth Model [target P/BV = (sustainable ROE – would have negative implications for loan
long-term growth) / (cost of equity – long-term growth.
growth)] to derive our fair P/BV range, assuming a
cost of equity of 11.5% and a terminal growth rate
of 8.9%. We derive our terminal growth rate by
applying a 50% payout ratio to our long-term
sustainable ROE.
China Construction 939 HK 7.03 BUY 8.5 Our price target of HK$8.50 is based on 2.4x P/BV Downside risks to our price target: we believe
Bank (H-share) applied to FY10F BVPS. Our sustainable ROE that a more severe-than-expected macro
assumption is 16.94%. We use the Gordon Growth tightening could result in a sharp rise in bad debt
Model [target P/BV = (sustainable ROE – long-term costs. In addition, a slowing economy would
growth)/(cost of equity – long-term growth)] to have negative implications for loan growth and
derive our fair P/BV range, assuming a cost of could lead to a significant rise in NPLs, in our
equity of 12% and a terminal growth rate of 8.5%. view.
We derive our terminal growth figure by applying a
50%payout ratio to our long-term sustainable ROE.
China CNR 601299 CH 6.23 BUY 8.2 Our 12-month PT of RMB8.2 is based on a 22x Risks to our call include any shift in government
target multiple applied to our FY11F EPS estimate policy on railway development.
of RMB0.38.
China Cosco 1919 HK 8.46 BUY 12.1 Our PT of HK$12.10 is based on the mid-cycle Key risks include declining freight rates (both
P/BV of 2.0x. container and drybulk) and weaker global
economic growth.
China Eastern Airlines 670 HK 4.54 BUY 5.9 Our price target of HK$5.90 is based on 2.1x The main risks to our price targets for Chinese
2011F P/BV after assuming strategic investors take airlines: passenger throughput growth may not
a 25% stake in CEA at HK$3.80/shr. meet our assumptions, passenger yield growth
may be lower than we expect, currency
movements and oil prices. Particularly for CEA,
the main risk may come from the introduction of
a strategic partner.
China Everbright 257 HK 4.36 BUY 6.1 Our price target is derived using DCF, with a Our price target is subject to growth assumptions
International WACC of 10.0% and a 2% terminal growth rate. in treatment volumes (including tap water supply,
wastewater treatment and waste-to-energy),
tariffs, capacity and capex. Changes in the
macro landscape and government regulations
over the water industry may result in key
changes in our forecasts, and hence our price
target.
China Foods 506 HK 5.44 REDUCE 4.2 We value China Foods at 18x 12-month forward Upside investment risks include faster-than-
EPS for our PT of HK$4.20. expected progress of the distribution channel
reform in wine and any product price hikes in
beverages.
China High Speed 658 HK 14.24 BUY 22 Our DCF-based price target of HK$22.0 assumes a Company-specific risks: uncertainty of
WACC of 9.5% and terminal growth of 1% after government policies for wind power; tightening
FY20F. global credit market; development of direct-drive
wind turbine technology; the company's failure to
improve technology to compete with foreign
competitors; severe shortage of raw materials;
and delays in capacity expansions.
China Life Insurance 2628 HK 33.7 BUY 40 Our price target of HK$40 is premised on an NB The key downside risks include poor returns
multiple of 25.0x derived by a risk discount rate from the A-share market, which would affect
(RDR) of 11% according to China Life’s EV sentiment to insurers in general. Intense
assumptions. We use our explicit VoNB growth competition leading to a continued squeeze in
forecasts for FY10-12F, assuming 17% VoNB NB margins for life insurers, especially China
growth over the next thirteen years (FY13-25F). Life, which hopes to recapture market share.
The valuation is based on a 15-year basis and
assumes no perpetuity growth, an approach similar
to standard actuarial practice, as long-term growth
is deemed too uncertain and therefore has close to
zero value.
China Mengniu Dairy 2319 HK 22.7 BUY 32 Based on 23x 12-month forward EPS (excluding Downside investment risks: higher-than-
stock option expense), we have a price target of expected raw milk prices, higher-than-expected
HK$32.00, which implies 50% potential upside. A&P expenses and food safety concerns.
1 Dec
closing Nomura Price
Company Ticker price rating target Valuation basis Investment risks
China Mobile 941 HK 78.20 BUY 95 Our price target of HK$95 is based on DCF. We Risks to our investment view include: 1) irrational
assume a WACC of 11.7% and a long-term tariff competition; 2) the regulatory environment;
growth-to-perpetuity rate of 1.5%. and 3) new technologies may disrupt the industry
landscape.
China Railway 1186 HK 9.42 BUY 11.8 Our price target of HK$11.8 is based on FY11F Risks to our view include any changes in
Construction Corp EPS of RMB0.82 (forex assumption government policy on railway development as
RMB1:HK$1.2) and a multiple of 12x. well as country risk from its overseas projects.
China Res. Gas 1193 HK 10.72 BUY 14.8 Our price target of HK$14.8 is based on a sum-of- Upside investment risks include faster-than-
the-parts (SOTP) valuation, of which HK$12.29 expected progress of the distribution channel
comes from the existing 41 projects and HK$2.50 reform in wine and any product price hikes in
from to-be-injected projects. beverages.
China Shineway 2877 HK 26.5 BUY 32.3 We value Shineway at HK$32.3, based on 23x Despite the long-term effects from the expansion
FY11F P/E, or 1x PEG, which we believe is of EDL drugs sales amid support from new
conservative for a firm that operates on a superior healthcare reforms, its product price and profit
scale and is the cost leader with net cash of margin could expose the firm to downside risk if
HK$2.5bn. Stripping out its net cash position, the the Chinese government decides to impose
ex-cash P/E target is c. 21x. deeper-than-expected price cuts for drugs listed
in the EDL.
China Steel 2002 TT 31.35 BUY 37 Our price target is based on 1.8x FY11F P/BV, the Risks include a delay in price recovery,
mid-cycle multiple. disappointing supply-demand balance, disposal
gains and the impact from Dragon Steel.
China Telecom 728 HK 3.98 NEUTRAL 4.8 Our DCF-based price target of HK$4.80 assumes a Risks to our investment view include: 1) irrational
WACC of 10.3% and a long-term growth-to tariff competition; 2) the regulatory environment;
perpetuity rate of 0.5%. and 3) new technologies may disrupt the industry
landscape.
China Unicom 762 HK 10.68 BUY 13.5 Our DCF-based price target of HK$13.50 assumes Risks to our investment view include: 1) irrational
a WACC of 11.2% and a long-term growth-to- tariff competition; 2) the regulatory environment;
perpetuity rate of 1.0%. and 3) new technologies may disrupt the industry
landscape.
China Yurun 1068 HK 26.85 BUY 39 Our PT of HK$39 is SOTP based. Downside investment risks: an unexpected
outbreak of pig disease across the country and
potential food safety scandals within the food
processing sector or at Yurun could have a
negative impact on our earnings estimates.
CIMC 000039 CH 18.66 BUY 21 Based on discounted cashflow (DCF) valuation, Investment risks: global economic slowdown,
our price target for CIMC of RMB21.00 is based on failure to pass higher costs to customers, and
a WACC of 6.8% and 2% terminal growth. operational risks from offshore business.
CITIC Bank 998 HK 5.46 BUY 6.6 Our price target of HK$6.60 is based on 1.8x P/BV We believe that any more-severe-than-expected
applied to our FY10F BVPS forecast and is on the macro tightening could result in a sharp rise in
back of a sustainable ROE of 15.3%. We use the bad debt costs. In addition, a slowing economy
Gordon Growth Model [target P/BV = (sustainable would have negative implications for loan
ROE – long-term growth)/(cost of equity – long- growth.
term growth)] to derive our fair P/BV, assuming a
cost of equity of 12% and a terminal growth rate of
7.6%. We derive our terminal growth rate by
applying a 50% payout ratio to our long-term
sustainable ROE.
CKI 1038 HK 34.75 BUY 36.6^ SOTP valuation based on 8.5% cost of equity for Risks include strengthening of US dollar and the
assets in Australia, Canada, New Zealand and the Japanese yen, lower-than-expected SOC capex
UK, and a 10% cost of equity for its China and HK spent during FY08- 13F, poor operating
materials businesses. performance at overseas projects.
CNBM 3323 HK 18.26 BUY 22 Our price target of HK$22.00 is based on SOTP Investment risks include 1) exposure to risk of
valuation. We use the same target multiples for its slowing economic growth; 2) high financial
cement (11x EV/EBITDA) and non-cement leverage; 3) seasonality impact.
business (14.8x of FY10F P/E).
CNOOC 883 HK 17 BUY 19.5 Our price target of HK$19.50 is based on our Downside risks include: 1) rising operating costs;
FY11F ROACE and WACC of 29% and 10%, 2) lower-than- budgeted production; 3)
respectively. acquisition risks; and 4) weather-related risks —
offshore China often experiences a large number
of typhoons, which can affect the development
and production of natural gas.
COLI 688 HK 15.36 BUY 21 Our price target of HK$21.0 is based on a historical Investment risks include: 1) lower-thanexpected
average of 14x 2011F P/E and implies a 19% sales; 2) tighter-than-expected property
premium to our end-11 NAV of HK$17.64. We measures.
adopt a target P/E to derive our PT as we believe
our NAV estimate does not capture any growth
potential through land acquisitions. COLI’s current
landbank is only sufficient for 4-5 years
development and it will likely buy more land to
sustain future growth.
Cosco Pacific 1199 HK 12.34 BUY 15.5 Our price target for COSCO Pac of HK$15.50 is We see risk to our price target for COSCO Pac if
benchmarked off a half standard deviation above container throughput growth and/or cargo mix
the group's historical mid-cycle P/E of 12.6x. differ substantially from our estimates, given an
uncertain macroeconomic picture. Further,
changing market perceptions of the speed of a
global trade recovery would affect the valuation
multiples that the market is willing to assign the
port stocks even if earnings estimates are
unchanged.
Country Gdn 2007 HK 2.91 NEUTRAL 2.78 Our price target of HK$2.78 is based on 30% Upside risks to our view include faster than
discount to our end-11F NAV of HK$3.97. Our NAV expected ramp up in production volume and
is based on sum-of-the-parts, where development higher than expected margins. Downside risks
properties are valued based on DCF and hotels are include stringent tightening policies that hit end-
valued using the income-capitalization method. Our user demand, and the inability to acquire large
PT implies 15x/10x FY10F/FY11F P/E. enough sites to sustain their large community
development business model.
1 Dec
closing Nomura Price
Company Ticker price rating target Valuation basis Investment risks
CPIC 2601 HK 30.7 REDUCE 28 Our TP of HKD28 is premised on a sum of the The key upside risks: sales of bancassurance
parts (SOTP) valuation. For the life business, our products supporting higher VoNB growth,
target NB Multiple of 9.5x is derived by a risk stronger-than-expected returns from the A-share
discount rate (RDR) of 11.5%, according to CPIC’s market which would affect sentiment toward
EV assumptions. We use our explicit VoNB growth insurers in general and Carlyle doing a share
forecasts for FY10-12F, and assumed 8.0% VoNB placement at a low discount to the market price.
growth over the next 8 years (FY13-20F). The
valuation is based on a 10-year basis and assumes
no perpetuity growth, an approach similar to
standard actuarial practice, as long-term growth is
deemed too uncertain and therefore has close to
zero value.
We apply the target New Business (NB) multiple to
the FY11F New Business Value and then add the
FY10F Embedded Value. We value CPIC’s P&C
business using a present value of the net profit
after tax and cost of capital approach. We
assumed a sustainable combined ratio of 95%, a
required cost of capital of 17.8%, which is derived
from CPIC P&C’s minimum capital
requirement to net earned premium; a sustainable
investment yield of 4.6%, a terminal growth rate of
2.5% and a RDR of 11.5%. For the other business,
we use a present
value of NPAT approach assuming 2% and 14% in
terminal growth rates and RDR respectively.
CRCC 1186 HK 9.42 BUY 11.8 Our price target of HK$11.8 is based on FY11F Risks to our view include any changes in
EPS of RMB0.82 (forex assumption government policy on railway development as
RMB1:HK$1.2) and a multiple of 12x. well as country risk from its overseas projects.
CRG 390 HK 5.5 NEUTRAL 6.6 Our TP of HK$ 6.6 is derived by applying a 12x Any major shift in government policies in terms
multiple to its FY11F EPS of RMB46 cents (FX of infrastructure investments in China may
assumption RMB1=HK$1.2). impact the outlook for leading Chinese
construction companies. Potential shortage in
funding in emerging economies outside China
may result in lower sales and higher receivable
write-offs for Chinese construction companies
that have meaningful exposure to projects
outside China. However, if the government
announces a larger package of infrastructure
investments in the 12th five-year plan, our
estimates may be proven too conservative. Any
country risk incurred by its overseas projects
may significantly impact its earnings.
CRL 1109 HK 14.18 REDUCE 14.87 Our price target of HK$14.87 is based on a 20% Investment risks include 1) better-than-expected
discount to our end-11 NAV estimate of HK$18.59. sales in BJ & SH and 2) no further tightening
measures in the China property market.
CSCL (2866 HK) 2866 HK 3.13 REDUCE 2.05 For China Shipping Container Lines, we value the Risks include further asset injections and
stock using the sum-of-the parts valuation, which is domestic China route returning to profitability.
based on 0.6x 2010 P/B (which is the mid-point of
trough and mid-cycle valuation) and 1.5x multiple
to port business.
CSD (1138 HK) 1138 HK 11.02 BUY 15.6 For China Shipping Development, our price target Key risks for the bulk sector include decline in
of HK$15.60 is based on mid-cycle P/B of 2.0x in freight rates due to less-than-expected
2010, which is equivalent to a target EV/fleet of newbuilding cancellations/delays, and slower
1.9x, as we maintain our positive view on the bulk demand growth. Company-specific risks include
shipping industry. a slowdown in oil and domestic coal demand.
CSR Corp 1766 HK 9.27 BUY 10.5 Our 12-month PT of HK$10.50 is derived by Risks to our call include any shift in government
applying a target P/E of 22x to FY11F EPS of policy on the railway development plan, as well
RMB0.39 (assuming RMB1:HK$1.2). as future orders on low margin products by The
Ministry of Railways.
1 Dec
closing Nomura Price
Company Ticker price rating target Valuation basis Investment risks
CTIH 966 HK 26 BUY 35 Our PT of HK$35 is premised on a sum of the parts The key downside risks include poor returns
(SOTP) valuation. For the life business, our target from the A-share market, which would affect
NB Multiple of 28.1x is derived by a risk discount sentiment toward insurers in general, and
rate (RDR) of 11.5% according to Taiping Life’s EV Taiping Life’s inability to deliver the expected
assumptions. We use our explicit VoNB growth high VoNB growth under market pressure.
forecasts for FY10-12F and assume 30% VoNB
growth over the next 7 years (FY14-20F). The
valuation is based on a 10-year basis and assumes
no perpetuity growth, an approach similar to
standard actuarial practice, as long-term growth is
deemed too uncertain and therefore has close to
zero value. We apply the target New Business
(NB) multiple to the FY11F New Business Value
and then add the FY10F Embedded Value. We
value TPRe using a present value of the net profit
after tax and cost of capital approach. We
assumed a sustainable combined ratio of 95.5%, a
required cost of capital of 25%, which is derived
from TPRe’s minimum capital requirement to net
earned premium; a sustainable investment yield of
5.3%, a terminal growth rate of 2.5% and a RDR of
11%. We value Taiping Insurance and CTPI (HK)
using a present value of the net profit after tax and
cost of capital approach. We assumed sustainable
combined ratios of 100.0% and 99.6%,
respectively, required cost of capital of 13.7% and
24.4%, respectively,
which is derived from their minimum capital
requirement to net earned premium; sustainable
investment yields of 4.1% and 5.0%, respectively,
and terminal growth
rates of 2.5% and a RDR of 11% for both.
Ctrip CTRP US 43.78 BUY 60.0 Our price target of US$60 is based on 37x FY11 Downside risks include lower-than-expected
P/E (EPS: RMB10.09), in line with its historical 12- volume sales in the air ticket segment and hotel
month forward P/E. rooms, further price corrections, a commission
decline and rising competition.
Dongfeng Motor 489 HK 15.48 BUY 19.5 Our PT for Dongfeng, of HK$19.5, is based on 12x Downside risks to our price target include
FY11F EPS of RMB1.41 (FX assumption: widening losses in the company’s independent
1RMB=1.15HK$). brand operations.
Focus Media FMCN US 23.33 NEUTRAL 24 Our DCF valuation assumes a WACC of 11.3% Downside risks: 1) Recovery may be slower than
and terminal growth of 2%. Our price target implies expected, and; 2) new entrants, if any, could
17.2x FY11F P/E. constitute competition. Upside risks: faster-than-
expected penetration in tier 2 and tier 3 cities
that may drive revenue even higher.
Geely Automobile 175 HK 4.29 BUY 5.5 Our price target is based on 16x FY11F fully- Downside risks to our call include disappointing
diluted EPS of RMB0.282 (FX assumption: RMB1 new model sales and accelerating competition
= HK$1.15). among domestic brands, which could hurt pricing
and margin.
Gome Electrical 493 HK 3.15 BUY 4.3 Our price target of HK$4.3 is based on 22x FY11F Downside risks: lower-than-expected SSS and
Appliances P/E (EPS: RMB0.155), in line with its historical 12- margins.
month forward P/E. We estimate Gome will witness
strong earnings growth of 45.1% in FY10F. While
we think this remarkable growth is unlikely to be
sustainable, we expect it to post strong growth of
19.9% in FY11F and 16.1% in FY12F. We foresee
upside revisions due to better-than-expected store
efficiency and store number.
Great Wall Motor 2333 HK 28.55 BUY 32 Our TP of HK$32 is based on 13x our FY11F EPS Investment risks include diesel shortage, which
of RMB2.17 (FX assumption: RMB1= HK$1.15). could bring downside risks to the company’s
diesel SUV sales.
GZ R&F 2777 HK 10.88 REDUCE 9.98 Our price target of HK$9.98 is based on a 40% Investment risks include better-than-expected
discount on our end-11 NAV estimate of HK$16.64. sales in 2H10-11 and significant improvement in
financial position.
Huabao 336 HK 12.32 BUY 14.8 We value Huabao at 23x 12-month forward EPS, at Downside risk: government policy changes for
par to the F&B sector average. the tobacco industry and any share placement of
old share by the chairwoman.
Jiangsu Expressway 177 HK 8.57 BUY 11.95 Our price target for Jiangsu Exp is HK$11.95/shr, The main risk to our price target is if the
based on one standard deviation above the stock's diversion impact (from new competition and/or
historical mid-cycle PE of 15.7x. This is equivalent maintenance works) varies substantially from our
to an estimated 2011 PE of 17.5x and 2012 PE of estimates.
14.6x.
Kunlun Energy 135 HK 11.54 BUY 13.5 Our price target of HK$13.50/share is based on Risks: (i) government regulatory risks; (ii)
FY11F ROACE of 17.7% and WACC of 7.1% with uncertain of Kunlun Gas and Kunlun Natural
a LT growth rate of 3%. Gas, Petrochina’s subsidiary, injection; (iii) LNG
earnings contributions uncertainty in FY12F; (iv)
crude oil price and production risks; and (v)
share issuance leading to earnings dilution.
KWG 1813 HK 6.1 BUY 7.52 Our price target of HK$7.52 is based on 30% Investment risks include: 1) over-aggressive
discount to our end-11F NAV of HK$10.75. landbank replenishment; and 2) tighter-than-
expected property measures.
1 Dec
closing Nomura Price
Company Ticker price rating target Valuation basis Investment risks
Lijun Int'l 2005 HK 2.51 REDUCE 2.45 Our price target of HK$2.45 is based on 18x Lijun has signed an agreement to set up an IV
Pharmaceutical FY11F P/E, equivalent to 0.92x PEG. Our target infusion joint venture (JV) in Jilin. In our view, the
FY11 P/E is slightly lower than the sector average stock should react positively to this JV, which
of c.19x for the HK-listed healthcare stocks. could also encourage Lijun to seek other
external growth opportunities in the future. News
of winning bids in more new provinces could be
positive in terms of further consolidating its
market share. Expansion in soft-packaged IV
infusion capacity and its long-term development
strategy for new finished drugs could drive solid
revenue growth and improve profit margins.
Increased local procurement could be an upside
risk.
Longyuan 916 HK 7.28 REDUCE 7.6** Our price target of HK$7.60 (under review) is CER VER registration risks; resolution of grid
based on DCF, with a WACC of 11.8% and connection bottlenecks in China; uncertainty
terminal growth after FY20F of 1%. regarding wind subsidies and policies.
Minsheng 1988 HK 6.91 NEUTRAL 7.4 Our price target of HK$7.4 is based on 1.70x P/BV We believe that any more-severe-than-expected
applied to our FY10F BVPS forecast as well as a macro tightening could result in a sharp rise in
sustainable ROE of 15.74%. We use the Gordon bad debt costs. In addition, a slowing economy
Growth Model [target P/BV = (sustainable ROE – would have negative implications for loan
long-term growth)/(cost of equity – long-term growth. If these risks were to exceed our
growth)] to derive our fair P/BV, assuming a cost of expectations, it could affect our estimates and
equity of 12.5% and a terminal growth rate of 7.9%. the achievement of our price target.
We derive our terminal growth rate by applying a
50% payout ratio to our long-term sustainable
ROE.
NetEase NTES US 38.18 NEUTRAL 43 Our 12-month price target of US$43.00 is based on Company-specific downside risks to our price
the adjusted peer average of 14.1x FY11F P/E, target and our estimates include: 1)
applied to our fully diluted EPS estimate (excluding disappointing performance of WoW and WLK; 2)
share-based compensation) of US$3.06. a slide in FWJ performance from current levels;
and 3) the advertising business losing upside
momentum and market share. Upside risks
include: Earlier-than-expected introduction of
Cataclysm and Starcraft II in China.
NWDS 825 HK 7.09 BUY 9.2 Our PT of HK$9.20 is pegged to 22x calendarised Downside risks could come from weaker-than-
FY11F P/E (EPS: HK$0.417), in line with the expected margins and SSS growth, and failure to
stock’s historical 12-month forward P/E. proceed with acquisitions from the parent.
O-Net 877 HK 5.85 BUY 7.0 To reflect robust earnings growth underpinned by Margins may be negatively affected if any major
the network convergence story, we apply a target technological breakthroughs are achieved by its
multiple of 22x to 2011F EPS, slightly lower than competitors. However, we do not see this having
the 24x we apply to peer ZTE. We believe the an effect on the company’s short term earnings,
relatively higher P/E multiples for O-Net reflect as system vendors tend to have long certification
market expectations of higher-than-industry- processes. A sudden slowdown in optical
average EPS growth for these vendors given network demand due to a change in the macro
considerable exposure to the fast-growing Chinese environment in, say, North America may also
market and network convergence story. have a negative impact on company earnings.
OOIL 316 HK 76.9 NEUTRAL 61.8 Our price target of HK$61.80 is based on sum-of- Upside risk includes continuing to control
the-parts valuation. We value the shipping capacity through reducing chartered fleet.
business using a FY11F midpoint between trough Downside risk includes aggressive fleet
and mid-cycle P/BV of 0.8x and value its expansion.
investment property at fair value.
Pacific Basin 2343 HK 5.3 BUY 8.5 Our price target of HK$8.50 is based on mid-cycle Upside risk includes continuing to control
P/B of 1.4x in 2010, which is equivalent to a target capacity through reducing chartered fleet.
EV/fleet of 1.5x, as we maintain our positive view Downside risk includes aggressive fleet
on the bulk shipping industry. expansion.
Parkson 3368 HK 13.1 BUY 17.5 Our PT of HK$17.5 is based on 30x FY11F P/E Downside risks: lower than expected SSS and
(EPS: RMB0.47), unchanged, and in line with its margin compression.
historical trading average.
PCD 331 HK 2.43 BUY 3.1 Our PT of HK$3.1 is based on 24x FY11 P/E (EPS: Downside risk: delay of Beijing store injection,
RMB0.103), in line with the China department store competition of outlets business to intensify.
average.
Perfect World PWRD US 23.7 BUY 37 Our 12-month PT of US$37 is equivalent to 10.3x Company-specific risks to our price target and
FY11F P/E – in line with our adjusted peer group estimates include: 1) any delays in future gaming
average – applied to our fully diluted FY11F EPS releases; 2) new games failing to generate
estimate (excluding sbc) of US$3.58. material revenue; 3) declining performance of
existing games, including the newly launched
Fantasy Zhu Xian; and 4) minimal penetration in
tier-3 and tier-4 cities in China.
Petrochina 857 HK 9.74 BUY 13 Our 12-month price target of HK$13.00 is based on Risks to our view include: 1) lower-than-
FY11F ROACE/WACC (13.2%/7.9%). expected oil product prices; 2) international
crude oil price volatility; and 3) government
regulatory risks.
PICC 2328 HK 11.64 NEUTRAL 12 We value PICC using a present value of the net Key downside risks include a worse-than-
profit after tax and cost of capital approach. We expected combined ratio in 2H10 from
assume a sustainable combined ratio of 98.6%, a intensifying competition and poor returns from
required cost of capital of 16.0%, which is derived the A-share market, which would affect
from PICC’s minimum capital requirement to net sentiment toward insurers in general. Key upside
earned premium, a sustainable investment yield of risks include a better-than-expected and
3.8%, a terminal growth rate of 2.5% and a RDR of sustained combined ratio from 2011 through a
11.5%. lower loss ratio and better-than-expected returns
from the A-share market, which would affect
sentiment of insurers in general.
1 Dec
closing Nomura Price
Company Ticker price rating target Valuation basis Investment risks
Ping An 2318 HK 91 NEUTRAL 90 Our price target is based on a sum-of-the-parts The key downside risks include poorer-than-
(SOTP) valuation. For the life business, our target expected: execution of the financial
New Business (NB) multiple of 13.9x is derived by conglomerate model, integration with SZDB and
a risk discount rate (RDR) of 11%, based on Ping returns from the A-share market. These would
An’s EV assumptions. We use our explicit VoNB affect sentiment toward insurers in general, in
growth forecasts for FY10-12F, assuming 15.5% our view. The key upside risks include better-
VoNB growth over the next eight years (FY13- and earlier-than-expected synergies from the
20F). Our valuation is on a 10-year basis and integration of SZDB and continued strong growth
assumes no perpetuity growth, an approach similar in VoNB in 2H10.
to standard actuarial practice; long-term growth is
deemed too uncertain and is thus assumed to have
close to zero value. We apply the target new
business (NB) multiple to the FY11F new business
value and then add FY10F embedded value. We
value Ping An’s P&C business using a present
value of net profit after tax and cost of capital
approach. We assume a sustainable combined
ratio of 99.3%, a required cost of capital of 17.8%
(derived from Ping An P&C’s minimum capital
requirement to net earned premium), a sustainable
investment yield of 3.6%, a terminal growth rate of
2.5% and a RDR of 11%. We have incorporated
SZDB into our valuation of Ping An by applying our
banking team’s target P/BV multiple of 1.86x to our
FY11F BV forecast. For the securities and other
businesses, we use present value base on the
NPAT approach, assuming terminal growth rates of
2.5% and 2.0% and RDR of 13% and 14%,
respectively.
Poly (HK) 119 HK 7.36 BUY 9.98 Our price target of HK$9.98 is based on a 20% Investment risks include 1) Poly (HK)’s lack of a
discount to our end-11 NAV estimate of HK$12.5. track record; and 2) tighter-than-expected policy
measures in China.
Sands China 1928 HK 17.40 BUY 20 SOTP methodology. Regulatory risks, especially regarding China;
substantial delays from its Cotai project; and
more market share losses from competition.
Shanda Game GAME US 5.6 BUY 8 Our 12-month price target of US$8.00 represents Company-specific downside risks to our PT and
9.6x FY11F P/E, largely in line with the adjusted estimates are: 1) a continued steep drop in
peer average. revenue from cash cows including Mir II and
WoooL; and 2) delay in new game launches.
Shanghai Petrochem 338 HK 3.91 BUY 4.2 Our price target of HK$4.20 is based on FY11F Downside risks to our price target: 1) lower-than-
ROACE/WACC of 11%/8.6% (was 10.9%/8.7%). expected oil product price hikes;
2) government regulatory risks; and 3)
petrochemicals downcycle.
Shenhua 1088 HK 33.3 BUY 44.6 Our sum-of-the-parts-based price target of 1) higher-than-expected coal prices; 2) weaker-
HK$44.6 is equal to 13.5x FY10F P/E, in line with than- expected recovery in China’s economy; 3)
its peers and looks undemanding against a higher higher-than-expected cost hikes; 4) higher coal
ROE. imports boosted by a strengthening RMB; and 5)
overall market weakness given the stock’s high
correlation to the market index (Hang Seng
Index).
Shimao 813 HK 12.06 BUY 15.39 13.5x FY10F P/E, in line with its peers’ and looks Investment risks include lower-than-expected
undemanding. sales in 2H10-2011 and tighter-than-expected
property policy in China.
Singamas 716 HK 2.41 BUY 2.22 Based on discounted cashflow (DCF) valuation, Key risks for the container manufacturing sector
our price target for Singamas of HK$2.22 is based include a global economic slowdown and failure
on a WACC of 8.6% and 2% terminal growth. to pass higher material costs on to customers.
Company-specific risks diversifying product mix
to non-dry container products.
Sino Biopharmaceutical 1177 HK 3.02 BUY 3.75 We value SBP at HK$3.75, based on 30x FY11F Risk factors will come from drug pricing pressure
P/E, or 25x ex-cash, which is a premium to the and slowdown in some mature products.
sector’s average 19x P/E.
Sinoma 1893 HK 7.19 BUY 8.7 Our SOTP-derived PT of HK$8.70, based on a Investment risks include: 1) foreign exchange
10% discount to fair value of RMB8.72 per share risk; 2) political risk; 3) raw material cost
(HK$9.70), implies an FY10F P/E of 21x and a increase.
P/BV of 3.0x, the mid-cycle valuation.
Sino-Ocean 3377 HK 4.75 NEUTRAL 5.3 Our price target of HK$5.3 is based on a 40% Upside risks: 1) faster-than-expected progress
discount to our end-11 NAV estimate of HK$8.83, on share disposal; and 2) better-than-expected
reflecting concerns on share disposal. contracted sales in Beijing. Downside risks: 1)
slower-than-expected sales; 2) over-aggressive
in land banking; 3) a new round of tightening
measures
Sinopec 386 HK 7.28 BUY 9.6 Our price target of HK$9.60 is based on 2011F Downside risks to our view include: 1) rising
ROACE/WACC (14.3%/10.3%). Sinopec is trading inflation; 2) chemical downcycle, and; 3)
at a compelling valuation of 6.4x 11F P/E, 4.1x resources tax. Upside risks: 1) potential change
EV/EBITDA and 1.1x P/BV, while ROACE is in oil product pricing mechanism and 2) lifting of
14.3%. the windfall tax hurdle rate.
1 Dec
closing Nomura Price
Company Ticker price rating target Valuation basis Investment risks
Sinopharm Group 1099 HK 28.35 NEUTRAL 32.5 We set our 12-month valuation target at HK$32.5, 1) The Chinese government aims to cut drug
based on 36x FY11F P/E, or equivalent to 1x PEG prices in the EDL and national drug
to our earnings growth projection from 2011-12. reimbursement list (NDRL) in 2011, which may
have short-term negative effects on the profit
margin of drug makers and distributors; 2)
synergy effects from new asset integration are
hard to gauge and predict until they are reflected
in the interim or annual results; 3) major
competitors are expected to list on the Hong
Kong Stock Exchange; 4) upside earnings
surprise could come from faster-than-expected
M&A progress and better-than-expected benefits
from the integration with its new M&A assets.
Sinotrans Shipping 368 HK 2.98 BUY 4.6 Our price target of HK$4.60 is based on mid-cycle Key risks for the bulk sector include decline in
P/B of 1.1x in 2010, which is equivalent to a target freight rates due to less-than-expected
EV/fleet of 1.2x, as we maintain our positive view newbuilding cancellations/delays, and slower
on the bulk shipping industry. demand growth. Company-specific risks include
lower contract rates if spot rates decline,
counter-party risks with its customers and
operational risks resulting from fleet expansion.
SJM 880 HK 12.18 BUY 15 SOTP-based valuation methodology. Risks include: 1) regulatory changes in China, 2)
Oceanus’ / legacy casinos’ underperformance, 3)
uncertainty over the health of Dr Ho.
Sohu SOHU US 69.43 REDUCE 64 SOTP peer group P/E multiple for FY11F serves as Risks to our PT and earnings forecasts include:
the basis for our PT. a significant ramp in new games; rebound in
advertising spend; and a lower cost structure on
video.
Taiwan Cement 1101 TT 32.2 BUY 40.8 Our price target at NT$40.80 is based on a sum-of- Risks to our rating and price target include:
the-parts net asset value (NAV) and the same 1) deviation in China’s GDP and FAI growth
multiple of 7.7x EV/EBITDA for FY11F. assumptions; 2) any change in raw material
prices, and; 3) execution risks.
Tencent 700 HK 174 BUY 210 Our price target of HK$210 is equivalent to an Downside risks: faster-than-expected slowdown
FY11F PEG of 0.81, largely in line with the peer in online advertising; rapid migration of
group average. SNS/gaming users to competing sites; and
renegotiations with mobile operators.
Tingyi 322 HK 19.22 BUY 23.2 Valuation of 30x 12m forward EPS, a 30% Downside risks: weaker-than-expected sales
premium to the F&B sector average. growth and larger-than-expected cost pressure.
Trina Solar TSL US 22.39 BUY 36 We use the average forward P/E of vertically Downside risks to our price target: 1) slower
integrated peers in YTD-FY10 to value the market share gains in new regions; and 2)
company, and give Trina a 10% discount to the demand at new growth centres being unable to
average multiples for a target P/E of 10.4x. offset lower demand from Germany.
Tsingtao Brewery 168 HK 41.65 REDUCE 37 PT set at 25x 12-month forward EPS. Upside risks: stronger-than-expected volume
growth and significant M&A.
United Laboratories 3933 HK 14.44 NEUTRAL 14.56 We set our 12-month price target at HK$14.56, Negative risks: 1) any delay in GMP approval for
representing 16x FY11F P/E, which is below the the company's new semi-synthetic penicillin
sector average of 19x P/E. workshop; and 2) worse-than-expected product
price cuts by the government. Positive risks: 1)
recovery in 6-APA and 7-ACA prices; and 2)
approval of the company's other three new
insulin products before the year-end.
Want Want 151 HK 6.81 BUY 8.2 Our PT of HK$8.20 is set at 28x 12-m forward Downside risks include slower-than-expected
EPS. sales growth and a sharper-than-expected hike
in input costs.
Zhuzhou CSR 3898 HK 29.25 NEUTRAL 28 Our price target is based on P/E of 22x and our Downside risks include negative market
FY11F EPS forecast of RMB1.06 (assuming sentiment from possible low margins. Upside
RMB1:HK$1.2). risks include higher-than-expected 4Q10F
earnings and significant breakout in the
localisation of key components.
ZTE 763 HK 29.30 BUY 36 The stock has traded at 2.5x 12-month forward Downside risks include: 1) any regulatory policy
P/BV and 23x 12-month forward P/E on average change that is unfavourable to Chinese vendors;
since 2005. Since on our forecasts its net profit 2) larger-than-expected capex reduction plans by
CAGR from FY10 to FY12F is higher (24%) than Chinese and overseas operators; 3) mounting
that from FY05 to FY09 (around 19%), we believe price competition in the 2G/3G market; and 4) a
it is reasonable to apply a 24x P/E multiple to significant increase in bad debt and failure to
FY11F EPS of RMB1.29 (HK$1.50) to derive our control operating costs.
revised price target of HK$36 per share.
CONTACTS
STRATEGY SECTOR
Sean Darby 852 2252 2182 sean.darby@nomura.com BANKS & OTHER FINANCIALS
Amy Lee 852 2252 2181 amy.lee@nomura.com Lucy Feng 852 2252 2165 lucy.feng@nomura.com
Mixo Das 852 2252 1424 mixo.das@nomura.com David Chung 852 2252 6210 david.m.chung@nomura.com
CHINA Ben Huang 852 2252 6242 ben.huang@nomura.com
Henry Wu 852 2252 2122 henry.wu@nomura.com Donger Wang 852 2252 1590 donger.wang@nomura.com
Yang Luo 852 2252 2141 yang.luo@nomura.com Sunny Ding 852 2252 1559 sunny.ding@nomura.com
Michael Shen 852 2252 2140 michael.shen@nomura.com CONSUMER
Candy Huang 852 2252 1407 candy.huang@nomura.com
QUANTITATIVE STRATEGY Cherry Liu 852 2252 2183 qian.liu@nomura.com
Sandy Lee 852 2252 2101 sandy.lee@nomura.com Emma Liu 852 2252 6172 emma.liu@nomura.com
Yasuhiro Shimizu 852 2252 2107 yasuhiro.shimizu@nomura.com Anita Chu 852 2252 1425 anita.chu@nomura.com
Kenneth Chan 852 2252 2104 kenneth.chan@nomura.com GAMING
Rico Kwan 852 2252 2102 rico.kwan@nomura.com Charlene Liu 852 2252 6134 charlene.liu@nomura.com
Tacky Cheng 852 2252 2105 tacky.cheng@nomura.com HEALTHCARE / PHARMACEUTICAL
Desmond Chan 852 2252 2110 desmond.chan@nomura.com Gideon Lo 852 2252 6190 gideon.lo@nomura.com
AUTOS & AUTO PARTS
Yankun Hou 852 2252 6234 yankun.hou@nomura.com
Ming Xu 852 2252 1569 ming.xu@nomura.com
INDUSTRIALS
Yankun Hou 852 2252 6234 yankun.hou@nomura.com
Paul Gong 852 2252 6177 paul.gong@nomura.com
INFRASTRUCTURE
Jim Wong 852 2252 2195 jim.wong@nomura.com
Yankun Hou 852 2252 6234 yankun.hou@nomura.com
Paul Gong 852 2252 6177 paul.gong@nomura.com
INSURANCE
David Chung 852 2252 6210 david.m.chung@nomura.com
INTERNET/MEDIA
Jin Yoon 852 2252 6204 jinkyu.yoon@nomura.com
George Meng 852 2252 1409 george.meng.1@nomura.com
METALS & MINING / BASIC MATERIALS
Josephine Ho 852 2252 2177 josephine.ho@nomura.com
Jialong Shi 852 2252 1594 jialong.shi@nomura.com
OIL & GAS AND CHEMICAL
Cheng Khoo 852 2252 6180 cheng.khoo@nomura.com
Gordon Wai 852 2252 6176 gordon.wai@nomura.com
Yong Liang Por 852 2252 6220 yongliang.por@nomura.com
Michael Lo 852 2252 6225 michael.lo@nomura.com
POWER, UTILITIES & RENEWABLE ENERGY
Ivan Lee 852 2252 6213 ivan.lee@nomura.com
Joseph Lam 852 2252 2106 joseph.lam@nomura.com
Daniel Raats 852 2252 2197 daniel.raats@nomura.com
Nitin Kumar 65 6433 6967 nitin.kumar@nomura.com
Matty Zhao 852 2252 1397 matty.zhao@nomura.com
Alan Hon 852 2252 2193 alan.hon@nomura.com
Elaine Wu 852 2252 2194 elaine.wu@nomura.com
Zi Ying Xia 852 2252 1552 ziying.xia@nomura.com
TRANSPORTATION
Jim Wong 852 2252 2195 jim.wong@nomura.com
Shirley Lam 852 2252 2196 shirley.lam@nomura.com
Andrew Lee 852 2252 6197 andrew.lee@nomura.com
Cecilia Chan 852 2252 6181 cecilia.chan@nomura.com
PROPERTY / REITS
Paul Louie 852 2252 6189 paul.louie@nomura.com
Perveen Wong 852 2252 6254 perveen.wong@nomura.com
Alvin Wong 852 2252 1563 alvin.wong@nomura.com
Sunny Tam 852 2252 6226 sunny.tam@nomura.com
Jianping Chen 852 2252 2139 jianping.chen@nomura.com
TELECOMMUNICATIONS
Danny Chu 852 2252 6209 danny.chu@nomura.com
Leping Huang 852 2252 1598 leping.huang@nomura.com
Any Authors named on this report are Research Analysts unless otherwise indicated
ANALYST CERTIFICATIONS
I, Henry Wu, hereby certify (1) that the views expressed in this Research report accurately reflect my personal views about any or all of the
subject securities or issuers referred to in this Research report, (2) no part of my compensation was, is or will be directly or indirectly related to
the specific recommendations or views expressed in this Research report and (3) no part of my compensation is tied to any specific investment
banking transactions performed by Nomura Securities International, Inc., Nomura International plc or any other Nomura Group company.
Conflict-of-interest disclosures
Important disclosures may be accessed through the following website: http://www.nomura.com/research/Disclosures/public/main.asp. If you
have difficulty with this site or you do not have a password, please contact your Nomura Securities International, Inc. salesperson (1-877-865-
5752) or email researchportal@nomura.co.uk for assistance.
Distribution of Ratings:
Nomura Global Equity Research has 1878 companies under coverage.
48% have been assigned a Buy rating which, for purposes of mandatory disclosures, are classified as a Buy rating; 41% of companies with this
rating are investment banking clients of the Nomura Group*.
37% have been assigned a Neutral rating which, for purposes of mandatory disclosures, is classified as a Hold rating; 54% of companies with
this rating are investment banking clients of the Nomura Group*.
13% have been assigned a Reduce rating which, for purposes of mandatory disclosures, are classified as a Sell rating; 16% of companies with
this rating are investment banking clients of the Nomura Group*.
As at 30 September 2010.
*The Nomura Group as defined in the Disclaimer section at the end of this report.
Explanation of Nomura's equity research rating system in Europe, Middle East and Africa, US and Latin
America for ratings published from 27 October 2008:
The rating system is a relative system indicating expected performance against a specific benchmark identified for each individual stock.
Analysts may also indicate absolute upside to price target defined as (fair value - current price)/current price, subject to limited management
discretion. In most cases, the fair value will equal the analyst's assessment of the current intrinsic fair value of the stock using an appropriate
valuation methodology such as discounted cash flow or multiple analysis, etc.
Stocks:
A rating of 'Buy', indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months.
A rating of 'Neutral', indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months.
A rating of 'Reduce', indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months.
A rating of 'RS-Rating Suspended', indicates that the rating and target price have been suspended temporarily to comply with applicable
regulations and/or firm policies in certain circumstances including when Nomura is acting in an advisory capacity in a merger or strategic
transaction involving the company.
Benchmarks are as follows: United States/Europe: Please see valuation methodologies for explanations of relevant benchmarks for stocks
(accessible through the left hand side of the Nomura Disclosure web page: http://www.nomura.com/research);Global Emerging Markets (ex-
Asia): MSCI Emerging Markets ex-Asia, unless otherwise stated in the valuation methodology.
Sectors:
A "Bullish" stance, indicates that the analyst expects the sector to outperform the Benchmark during the next 12 months.
A "Neutral" stance, indicates that the analyst expects the sector to perform in line with the Benchmark during the next 12 months.
A "Bearish" stance, indicates that the analyst expects the sector to underperform the Benchmark during the next 12 months.
Benchmarks are as follows: United States: S&P 500; Europe: Dow Jones STOXX® 600; Global Emerging Markets (ex-Asia): MSCI
Emerging Markets ex-Asia.
Explanation of Nomura’s equity research rating system for Asian companies under coverage ex Japan
published from 30 October 2008 and in Japan from 6 January 2009:
Stocks:
Stock recommendations are based on absolute valuation upside (downside), which is defined as (Price Target – Current Price) / Current Price,
subject to limited management discretion. In most cases, the Price Target will equal the analyst’s 12-month intrinsic valuation of the stock,
based on an appropriate valuation methodology such as discounted cash flow, multiple analysis, etc.
A "Buy" recommendation indicates that potential upside is 15% or more.
A "Neutral" recommendation indicates that potential upside is less than 15% or downside is less than 5%.
A "Reduce" recommendation indicates that potential downside is 5% or more.
A rating of "RS" or "Rating Suspended" indicates that the rating and target price have been suspended temporarily to comply with applicable
regulations and/or firm policies in certain circumstances including when Nomura is acting in an advisory capacity in a merger or strategic
transaction involving the subject company.
• Stocks labelled as "Not rated" or shown as "No rating" are not in Nomura's regular research coverage.
Sectors:
A "Bullish" rating means most stocks in the sector have (or the weighted average recommendation of the stocks under coverage is) a positive
absolute recommendation.
A "Neutral" rating means most stocks in the sector have (or the weighted average recommendation of the stocks under coverage is) a neutral
absolute recommendation.
A "Bearish" rating means most stocks in the sector have (or the weighted average recommendation of the stocks under coverage is) a negative
absolute recommendation.
Explanation of Nomura's equity research rating system in Japan published prior to 6 January 2009 (and
ratings in Europe, Middle East and Africa, US and Latin America published prior to 27 October 2008):
Stocks:
A rating of "1", or "Strong buy", indicates that the analyst expects the stock to outperform the Benchmark by 15% or more over the next six
months.
A rating of "2", or "Buy", indicates that the analyst expects the stock to outperform the Benchmark by 5% or more but less than 15% over the
next six months.
A rating of "3", or "Neutral", indicates that the analyst expects the stock to either outperform or underperform the Benchmark by less than 5%
over the next six months.
A rating of "4", or "Reduce", indicates that the analyst expects the stock to underperform the Benchmark by 5% or more but less than 15% over
the next six months.
A rating of "5", or "Sell", indicates that the analyst expects the stock to underperform the Benchmark by 15% or more over the next six months.
Stocks labeled "Not rated" or shown as "No rating" are not in Nomura's regular research coverage. Nomura might not publish additional
research reports concerning this company, and it undertakes no obligation to update the analysis, estimates, projections, conclusions or other
information contained herein.
Sectors:
A "Bullish" stance, indicates that the analyst expects the sector to outperform the Benchmark during the next six months.
A "Neutral" stance, indicates that the analyst expects the sector to perform in line with the Benchmark during the next six months.
A "Bearish" stance, indicates that the analyst expects the sector to underperform the Benchmark during the next six months.
Benchmarks are as follows: Japan: TOPIX; United States: S&P 500, MSCI World Technology Hardware & Equipment; Europe, by sector —
Hardware/Semiconductors: FTSE W Europe IT Hardware; Telecoms: FTSE W Europe Business Services; Business Services: FTSE W Europe;
Auto & Components: FTSE W Europe Auto & Parts; Communications equipment: FTSE W Europe IT Hardware; Ecology Focus: Bloomberg
World Energy Alternate Sources; Global Emerging Markets: MSCI Emerging Markets ex-Asia.
Explanation of Nomura's equity research rating system for Asian companies under coverage ex Japan
published prior to 30 October 2008:
Stocks:
Stock recommendations are based on absolute valuation upside (downside), which is defined as (Fair Value - Current Price)/Current Price,
subject to limited management discretion. In most cases, the Fair Value will equal the analyst's assessment of the current intrinsic fair value of
the stock using an appropriate valuation methodology such as Discounted Cash Flow or Multiple analysis etc. However, if the analyst doesn't
think the market will revalue the stock over the specified time horizon due to a lack of events or catalysts, then the fair value may differ from the
intrinsic fair value. In most cases, therefore, our recommendation is an assessment of the difference between current market price and our
estimate of current intrinsic fair value. Recommendations are set with a 6-12 month horizon unless specified otherwise. Accordingly, within this
horizon, price volatility may cause the actual upside or downside based on the prevailing market price to differ from the upside or downside
implied by the recommendation.
A "Strong buy" recommendation indicates that upside is more than 20%.
A "Buy" recommendation indicates that upside is between 10% and 20%.
A "Neutral" recommendation indicates that upside or downside is less than 10%.
A "Reduce" recommendation indicates that downside is between 10% and 20%.
A "Sell" recommendation indicates that downside is more than 20%.
Sectors:
A "Bullish" rating means most stocks in the sector have (or the weighted average recommendation of the stocks under coverage is) a positive
absolute recommendation.
A "Neutral" rating means most stocks in the sector have (or the weighted average recommendation of the stocks under coverage is) a neutral
absolute recommendation.
A "Bearish" rating means most stocks in the sector have (or the weighted average recommendation of the stocks under coverage is) a negative
absolute recommendation.
Price targets
Price targets, if discussed, reflect in part the analyst's estimates for the company's earnings. The achievement of any price target may be
impeded by general market and macroeconomic trends, and by other risks related to the company or the market, and may not occur if the
company's earnings differ from estimates.
DISCLAIMERS
This publication contains material that has been prepared by the Nomura entity identified on the banner at the top or the bottom of page 1
herein and, if applicable, with the contributions of one or more Nomura entities whose employees and their respective affiliations are specified
on page 1 herein or elsewhere identified in the publication. Affiliates and subsidiaries of Nomura Holdings, Inc. (collectively, the 'Nomura Group'),
include: Nomura Securities Co., Ltd. ('NSC') Tokyo, Japan; Nomura International plc, United Kingdom; Nomura Securities International, Inc.
('NSI'), New York, NY; Nomura International (Hong Kong) Ltd., Hong Kong; Nomura Financial Investment (Korea) Co., Ltd., Korea (Information
on Nomura analysts registered with the Korea Financial Investment Association ('KOFIA') can be found on the KOFIA Intranet at
http://dis.kofia.or.kr ); Nomura Singapore Ltd., Singapore (Registration number 197201440E, regulated by the Monetary Authority of Singapore);
Nomura Securities Singapore Pte Ltd., Singapore (Registration number 198702521E, regulated by the Monetary Authority of Singapore);
Capital Nomura Securities Public Company Limited; Nomura Australia Ltd., Australia (ABN 48 003 032 513), regulated by the Australian
Securities and Investment Commission and holder of an Australian financial services licence number 246412; P.T. Nomura Indonesia,
Indonesia; Nomura Securities Malaysia Sdn. Bhd., Malaysia; Nomura International (Hong Kong) Ltd., Taipei Branch, Taiwan; Nomura Financial
Advisory and Securities (India) Private Limited, Mumbai, India (Registered Address: Ceejay House, Level 11, Plot F, Shivsagar Estate, Dr.
Annie Besant Road, Worli, Mumbai- 400 018, India; SEBI Registration No: BSE INB011299030, NSE INB231299034, INF231299034, INE
231299034).
THIS MATERIAL IS: (I) FOR YOUR PRIVATE INFORMATION, AND WE ARE NOT SOLICITING ANY ACTION BASED UPON IT; (II) NOT TO
BE CONSTRUED AS AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITY IN ANY JURISDICTION WHERE
SUCH OFFER OR SOLICITATION WOULD BE ILLEGAL; AND (III) BASED UPON INFORMATION THAT WE CONSIDER RELIABLE.
NOMURA GROUP DOES NOT WARRANT OR REPRESENT THAT THE PUBLICATION IS ACCURATE, COMPLETE, RELIABLE, FIT FOR
ANY PARTICULAR PURPOSE OR MERCHANTABLE AND DOES NOT ACCEPT LIABILITY FOR ANY ACT (OR DECISION NOT TO ACT)
RESULTING FROM USE OF THIS PUBLICATION AND RELATED DATA. TO THE MAXIMUM EXTENT PERMISSIBLE ALL WARRANTIES
AND OTHER ASSURANCES BY NOMURA GROUP ARE HEREBY EXCLUDED AND NOMURA GROUP SHALL HAVE NO LIABILITY FOR
THE USE, MISUSE, OR DISTRIBUTION OF THIS INFORMATION.
Opinions expressed are current opinions as of the original publication date appearing on this material only and the information, including the
opinions contained herein, are subject to change without notice. Nomura is under no duty to update this publication. If and as applicable, NSI's
investment banking relationships, investment banking and non-investment banking compensation and securities ownership (identified in this
report as 'Disclosures Required in the United States'), if any, are specified in disclaimers and related disclosures in this report. In addition, other
members of the Nomura Group may from time to time perform investment banking or other services (including acting as advisor, manager or
lender) for, or solicit investment banking or other business from, companies mentioned herein. Further, the Nomura Group, and/or its officers,
directors and employees, including persons, without limitation, involved in the preparation or issuance of this material may, to the extent
permitted by applicable law and/or regulation, have long or short positions in, and buy or sell, the securities (including ownership by NSI,
referenced above), or derivatives (including options) thereof, of companies mentioned herein, or related securities or derivatives. In addition, the
Nomura Group, excluding NSI, may act as a market maker and principal, willing to buy and sell certain of the securities of companies mentioned
herein. Further, the Nomura Group may buy and sell certain of the securities of companies mentioned herein, as agent for its clients.
Investors should consider this report as only a single factor in making their investment decision and, as such, the report should not be viewed as
identifying or suggesting all risks, direct or indirect, that may be associated with any investment decision. Please see the further disclaimers in
the disclosure information on companies covered by Nomura analysts available at www.nomura.com/research under the 'Disclosure' tab.
Nomura Group produces a number of different types of research product including, among others, fundamental analysis, quantitative analysis
and short term trading ideas; recommendations contained in one type of research product may differ from recommendations contained in other
types of research product, whether as a result of differing time horizons, methodologies or otherwise; it is possible that individual employees of
Nomura may have different perspectives to this publication.
NSC and other non-US members of the Nomura Group (i.e. excluding NSI), their officers, directors and employees may, to the extent it relates
to non-US issuers and is permitted by applicable law, have acted upon or used this material prior to, or immediately following, its publication.
Foreign-currency-denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of,
or income derived from, the investment. In addition, investors in securities such as ADRs, the values of which are influenced by foreign
currencies, effectively assume currency risk.
The securities described herein may not have been registered under the US Securities Act of 1933, and, in such case, may not be offered or
sold in the United States or to US persons unless they have been registered under such Act, or except in compliance with an exemption from
the registration requirements of such Act. Unless governing law permits otherwise, you must contact a Nomura entity in your home jurisdiction if
you want to use our services in effecting a transaction in the securities mentioned in this material.
This publication has been approved for distribution in the United Kingdom and European Union as investment research by Nomura International
plc ('NIPlc'), which is authorized and regulated by the UK Financial Services Authority ('FSA') and is a member of the London Stock Exchange.
It does not constitute a personal recommendation, as defined by the FSA, or take into account the particular investment objectives, financial
situations, or needs of individual investors. It is intended only for investors who are 'eligible counterparties' or 'professional clients' as defined by
the FSA, and may not, therefore, be redistributed to retail clients as defined by the FSA. This publication may be distributed in Germany via
Nomura Bank (Deutschland) GmbH, which is authorized and regulated in Germany by the Federal Financial Supervisory Authority ('BaFin').
This publication has been approved by Nomura International (Hong Kong) Ltd. ('NIHK'), which is regulated by the Hong Kong Securities and
Futures Commission, for distribution in Hong Kong by NIHK. This publication has been approved for distribution in Australia by Nomura
Australia Ltd, which is authorized and regulated in Australia by the Australian Securities and Investment Commission ('ASIC'). This publication
has also been approved for distribution in Malaysia by Nomura Securities Malaysia Sdn Bhd. In Singapore, this publication has been distributed
by Nomura Singapore Limited ('NSL') and/or Nomura Securities Singapore Pte Ltd ('NSS'). NSL and NSS accepts legal responsibility for the
content of this publication, where it concerns securities, futures and foreign exchange, issued by their foreign affiliates in respect of recipients
who are not accredited, expert or institutional investors as defined by the Securities and Futures Act (Chapter 289). Recipients of this
publication should contact NSL or NSS (as the case may be) in respect of matters arising from, or in connection with, this publication. Unless
prohibited by the provisions of Regulation S of the U.S. Securities Act of 1933, this material is distributed in the United States, by Nomura
Securities International, Inc., a US-registered broker-dealer, which accepts responsibility for its contents in accordance with the provisions of
Rule 15a-6, under the US Securities Exchange Act of 1934.
This publication has not been approved for distribution in the Kingdom of Saudi Arabia or to clients other than 'professional clients' in the United
Arab Emirates by Nomura Saudi Arabia, Nomura International plc or any other member of the Nomura Group, as the case may be. Neither this
publication nor any copy thereof may be taken or transmitted or distributed, directly or indirectly, by any person other than those authorised to
do so into the Kingdom of Saudi Arabia or in the United Arab Emirates or to any person located in the Kingdom of Saudi Arabia or to clients
other than 'professional clients' in the United Arab Emirates. By accepting to receive this publication, you represent that you are not located in
the Kingdom of Saudi Arabia or that you are a 'professional client' in the United Arab Emirates and agree to comply with these restrictions. Any
failure to comply with these restrictions may constitute a violation of the laws of the Kingdom of Saudi Arabia or the United Arab Emirates.
No part of this material may be (i) copied, photocopied, or duplicated in any form, by any means; or (ii) redistributed without the prior written
consent of the Nomura Group member identified in the banner on page 1 of this report. Further information on any of the securities mentioned
herein may be obtained upon request. If this publication has been distributed by electronic transmission, such as e-mail, then such transmission
cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or
contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of this publication, which may arise as
a result of electronic transmission. If verification is required, please request a hard-copy version.
CH80-90
Caring for the environment: to receive only the electronic versions of our research, please contact your sales representative.